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SUMMARY
The suckling-weaning transition naturally begins at around 16 days of age in 
rats and continues to 25-30 days when the pups consume the solid, maternal diet. 
Throughout this transition, the dietary content changes from dominantly fats in the 
milk to carbohydrates in the adult diet. This marked change in diet is accompanied 
by dramatic changes in the metabolic priorities and the carbon flux. Although the 
role of pyruvate dehydrogenase in controlling the carbon flux during other metabolic 
adaptations, such as the starved-refed transition and diabetes, has already been shown 
to be essential, this enzyme has not been investigated in detail during the suckling- 
weaning transition. This has been addressed in this thesis.
Pyruvate dehydrogenase activity was measured spectro-photometrically in 
isolated liver and heart of rats between 10 and 30 days old, and compared to citrate 
synthase activity. Initially, the rat pups were left to wean themselves naturally 
(spontaneously). Hepatic pyruvate dehydrogenase activity was found to be low during 
suckling (<7.3mU/U) and to increase gradually throughout the suckling-weaning 
transition, reaching a maximum approximately 4-times suckling levels, at 25 days. 
Cardiac pyruvate dehydrogenase activity increased more rapidly and doubled between 
suckling (<  17.0mU/U) and weaning, peaking at 22 days.
Weaning could be condensed and an accurate starting point for the post- 
weaning period established, by imposing weaning by removing the mother and forcing 
the pups to adapt to the new diet immediately. Weaning was imposed at 20 days, and
pyruvate dehydrogenase activity measured. Hepatic pyruvate dehydrogenase activity 
rose 10-fold between 20 day and 22 days, faster and to a higher peak (52.4mU/U) 
than seen during spontaneous weaning. Cardiac activity, however, was largely 
unaffected by the altered weaning conditions and rose as in the spontaneously weaned 
animals. Weaning was also imposed at 18 days in order to minimise the carbohydrate 
intake by the pups before weaning. Premature weaning in this way advanced the 
activation of both hepatic and cardiac pyruvate dehydrogenase, by two days and one 
day respectively. In both cases the post-weaning peak reached was higher than after 
weaning at 20 days (94.4 and 38.5mU/U respectively).
Total pyruvate dehydrogenase was measured spectro-photometrically after 
activation of the inactive enzyme with dichloroacetic acid, during suckling and 
weaning at 20 days. Total pyruvate dehydrogenase was found to be 3- to 8- fold 
higher than the active form during suckling and weaning in the liver and heart, 
indicating that the pyruvate dehydrogenase complex was present in high levels even 
at 10 days of age, but remained largely inactive until weaning. The increase in PDH 
activity at weaning is therefore due to activation of enzyme already present and not 
due to synthesis of enzyme.
In order to distinguish the effects of the increased carbohydrate content of the 
diet from the effects of the weaning process itself, weaning to a synthetic high- 
fat/low-carbohydrate diet was imposed at 20 days. Pyruvate dehydrogenase activity 
did not increase after weaning in either the liver or the heart. Total activity increased 
as with carbohydrate weaning suggesting that the dietary content and not the weaning
process itself was responsible for activation of pyruvate dehydrogenase.
Hepatic glycogen content was measured during both spontaneous and imposed 
weaning to high-carbohydrate and high-fat diets. The glycogen content of the liver 
increased 2-fold after weaning to a high-carbohydrate diet but not a high-fat diet. 
The increase after imposed weaning to a high-carbohydrate diet, occurred 24hrs in 
advance of the activation of hepatic pyruvate dehydrogenase.
The expression of hepatic pyruvate dehydrogenase kinase mRNA levels 
throughout the suckling-weaning transition were investigated by Northern Blotting. 
However, due to the apparent lack of specificity of the cDNA probe used, no 
indication of the developmental profile of this enzyme was obtained.
The immediate synthesis of glycogen and delay in pyruvate dehydrogenase 
activation in the liver, after weaning to a carbohydrate-rich diet suggests a regulatory 
role for pyruvate dehydrogenase in promoting glycogen synthesis before allowing 
flow of carbohydrate metabolites into the citric acid cycle or lipogenesis. Hepatic 
pyruvate dehydrogenase is therefore likely to be an important enzyme regulating the 
carbon flux during the suckling-weaning transition. Cardiac pyruvate dehydrogenase 
activation, however, is not delayed after weaning, possibly due to the low glycogen 
content of the heart and the difference in the tissue function, and thus may not be 
instrumental in controlling carbon flux during the suckling-weaning transition.
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CHAPTER 1 
INTRODUCTION
22
1.1 GENERAL INTRODUCTION
The growth of all animals is marked by a series of developmental stages, some 
more dramatic and others less remarkable. During the neonatal period the rate of 
development is faster than at any other time, with rapid increases in body weight, 
mobility, intelligence, and general awareness. Coupled with these are the less 
obvious but equally essential metabolic changes, such as the suckling-weaning 
transition (for review see Girard et al 1992).
During the neonatal period most mammals receive milk from the mother which 
supplies them with nutrients vital for growth and energy production, enzyme cofactors 
and hormones. The content of fats, carbohydrates and proteins in the milk varies 
from species to species (Figure 1.1), however, in general milk is a high-fat/low 
carbohydrate diet. The rat milk represents an extreme example since it contains only 
10% carbohydrates and 50% fat in terms of weight (Jenness 1974; Figure 1.2). As 
the young become more mobile and curious, they venture away from the mother and 
begin to sample the mothers food, initially in conjunction with the milk, but 
eventually as a replacement. Again the composition of the adult diet is varied but 
generally it contains less fat and more carbohydrate. The adult rat diet is high in 
carbohydrates, especially in the laboratory situation where the diet is constant and 
typically contains 50-60% carbohydrates (by weight). The time period involved in 
the weaning process also displays species variations; in the rat, spontaneous weaning 
takes 10-12 days whereas in the human the same adaptation requires 3-9 months. 
This period of transfer from the neonatal diet supplied by the mother to the adult diet
23
Figure 1.1 Comparison of the Nutrient Composition 
of Milk from Different Species
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Data taken from Jenness 1974
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Figure 1.2 Variations in Content of Rat Diet 
throughout Development and Spontaneous Weaning
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is the suckling-weaning transition.
The suckling-weaning transition has been intensely studied since it marks a 
major growth stage and because it also provides an unique environment in which to 
investigate the development of enzyme activities and associated gene regulation, their 
controlling factors, their functions in terms of regulation of metabolic pathways and 
their response to various physiological stimuli. Despite the huge amounts of work 
invested, the factors controlling the onset of the suckling-weaning transition remain 
undefined. Although various hormones have been implicated in the initiation of this 
changeover period no individual hormone or factor has yet been found which actually 
starts the transition. Increasingly the stimuli appear to be series of small 
modifications, all contributing to the overall change and initiating the next step. No 
single step is responsible for the suckling-weaning transition but each step is vital for 
continued development. The importance of the physical changes around this time in 
regulating the dietary changes remain uncertain but the magnitude of these changes 
means that involvement is also likely.
Since the suckling-weaning transition is common to all mammals, the 
importance of work into this developmental stage arises because of the vast range of 
adaptations which have to be coordinated for efficient functioning of the animal 
thereafter. Maladjustments first evident during this developmental stage may have 
persistent consequences throughout life. By establishing the ‘normal’ situation and 
sequence in which modifications arise, any aberrations may be quickly identified and 
possibly prevented or minimized. Therefore studies of the suckling-weaning
26
transition may eventually enable early identification of metabolic and 
pathophysiological problems in man and other species which may then receive 
corrective treatment at the earliest possible opportunity.
In the adult mammal, one enzyme that appears to be very important in 
controlling the metabolic fate of glucose is pyruvate dehydrogenase. This enzyme 
finely controls the direction of metabolic flux allowing conservation of glucose during 
reduced glucose availability or channelling of glucose into glycogen or lipids when 
glucose is in plentiful supply. However, the influence and control of pyruvate 
dehydrogenase during the suckling-weaning transition has received very little attention 
to date (Knowles & Ballard 1974; Bailey et al 1976).
Hence, a brief summary of some of the physiological changes occurring during 
the neonatal period and a short synopsis of the metabolic state during suckling is 
given, in advance of a review of the adaptations of the metabolic environment for fats 
and carbohydrates during the suckling-weaning transition. Following this, a review 
of pyruvate dehydrogenase is given, highlighting some of the conditions in which this 
enzyme is of the upmost importance, and explaining the potential role of this enzyme 
in the suckling-weaning transition.
Although most of the work done in this field has been in the rat, where 
available details for other species are included. Since the liver and adipose tissue 
control much of the overall disposition of carbon flux in the body, metabolic studies 
have centred around these organs. Input from other organs however, cannot be
27
ignored and are included where information is available.
1.2 PHYSIOLOGICAL CHANGES OCCURRING DURING THE
NEONATAL PERIOD
The maturity of the newborn animal varies from species to species. The rat 
is born relatively immature in contrast to the guinea pig and human which are 
considerably more advanced. This can be seen in physical differences such as 
mobility, strength of sight, hearing and muscle tone. At the suckling-weaning 
transition many of these physical characteristics quickly mature either just before or 
with the metabolic changes (see Henning 1981).
The rat is born blind, deaf, unable to regulate its own temperature by 
shivering, to defecate or urinate, or respond to stress (Bolles & Wood 1964; Alberts 
1978; Gunn & Gluckman 1989). Rat pups are born with their eyes shut and open 
them around day 14, but it is unlikely that their sight is very good initially. As sight 
improves, mobility and curiosity increases (Bolles & Woods 1964) and the pups begin 
to roam further and to nibble at the mothers diet and bedding (Redman & Sweney 
1976).
The ability of the pup to suckle is mature at birth, and activity begins a few 
hours after the mother has delivered all her pups and has started lactating. The 
appetite function does not appear to be fully developed in the newborn pup, since 
pups offered unlimited milk supplies, continue to suckle even when their stomachs are
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so distended they cannot walk (Gisel & Henning 1979). Studies with starved versus 
fed neonatal rats revealed no difference in the milk uptake. Henning et al (1979) 
measured the time taken for pups to attach to nipples at different ages after an 18 
hour fast and found no difference between starved and fed rats up to 14 days but 
beyond 17 days, a marked decline in latency was seen in starved pups. Hence the 
satiety response appears to be immature at birth and throughout suckling but matures 
as weaning commences.
Around the time of the onset of weaning the sense of taste also matures. 
Experiments in which quinine was added to the water showed that suckling pups were 
unable to distinguish the quinine over water, however acceptance of the quinine 
decreases between 10 and 14 days and falls to within 10% of adult values at 20 days 
(Jacobs & Sharma 1969).
Newborn rat pups are unable to produce heat by shivering and since they 
contain very little brown adipose tissue at birth, temperature has to be maintained by 
external factors. This is achieved by heat transfer from the mother during suckling 
and rotation of pups into the centre of the nest (Alberts 1978). As weaning 
commences, the increased time spent away from the mother necessitates the 
development of temperature control by the pup.
Development of behavioural properties have been investigated by Thiels et at 
(1990). They found that young pre-weaning rats spent most of their active time 
suckling and as weaning began, the time spent feeding, drinking, grooming and play-
29
fighting increased and suckling decreased. At 34 days pups ceased to suckle. This 
is indicative of a more active mental and physical status.
1.2.1 Development of Circadian Rhythms
The development of circadian (circa - about, diem - day) rhythmicity is 
important for the maintenance of a normal dietary routine. At birth most mammals 
require regular feeding throughout day and night regardless of whether the adult 
animal is normally nocturnal or diurnal. Gradually the constant requirement for food 
is replaced by a regular rhythm of eating in either the day or night. Many metabolic 
enzymes and hormones show circadian rhythms reflecting the nutritional expectations 
of the body and not necessarily the actual state. Acetyl coenzyme-A carboxylase 
(ACC) (Davies et al 1991; Fukuda & Iritani 1991), fatty acid synthase, malic enzyme 
and glucose 6-phosphate dehydrogenase (Fukuda & Iritani 1991), and insulin (Lesault 
et al 1991) all show diurnal rhythms.
At birth circadian feeding rhythms are weak and inconsistent, and do not 
become established until around the end of the second week in the rat pup and 
hamster (Redman & Sweney 1976; Tamarkin et al 1980) i.e. around the suckling- 
weaning transitional period. Since the rat is born blind and its eyes do not open until 
about day 14, the light/dark cycle normally responsible for entrainment of rhythms 
has no influence (Rivkees & Reppert 1992). The regular influence of the light-dark 
cycle at 14 days may therefore influence the development of a regular rhythm of food 
ingestion and metabolism (Redman & Sweney 1976). Since the carbohydrate-rich
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chow provides more nutrients than the milk, sustaining the rat through the short 
period of starvation associated with the adult dietary habits, the increased intake of 
the solid food may therefore be more compatible with the established circadian 
rhythmicity.
1.3 METABOLISM DURING THE PERINATAL AND SUCKLING PERIOD
The ability of new born animals to move, see and hear have a great influence 
on their ability to fend for themselves and to find their own food. In mammals, the 
need to support themselves with food is initially satisfied by the mother who provides 
them with milk, simultaneously keeping them warm and protected. In the rat, the 
marked rates of growth from birth, trebling in weight in the first 10 days (Vernon & 
Walker 1972) means that considerable amounts of energy are required for 
development, all of which are initially provided by the milk.
Soon after birth, hepatic glycogen stores accumulated during the last few days 
of interuterine life are mobilised and glucose released (Ballard & Oliver 1963; 
Dawkins 1963; Snell and Walker 19736). Hypoglycaemia develops immediately after 
birth and continues for up to 2 hours before glycogenolysis begins (Snell & Walker 
19736; Snell 1991). Glycogen stores are used to maintain glucose concentrations 
until the onset of suckling 2-4 hours later. The newborn rat stores enough glycogen 
to maintain normoglycaemia for approximately 12 hours (Ballard & Oliver 1963; 
Dawkins 1963) after which pups are entirely dependent on milk which is high in fat 
content and low in carbohydrates.
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The daily glucose requirement of rat pups during development has been 
calculated for 2 and 10 day olds and was found to be far higher than that provided 
by the diet. The glucose supplied in the diet (in the form of lactose), accounts for 
only 30% of the daily requirement in 2 day old rats and 50% in the 10 day olds 
(Vernon & Walker 1972; Snell & Walker 19736). The limited glucose supply in milk 
however, is counter-balanced by the high levels of fat, the oxidation of which provide 
more energy than the oxidation of glucose. Thus during the suckling period the 
metabolic profile has to undergo a series of adaptations to allow maximisation of the 
available energy sources. The interaction of metabolic pathways during the suckling- 
weaning transition are shown in Figure 1.3.
The first of these adaptations is to reduce the glucose requirements of all 
tissues to their minimum. This is more easily achieved in some tissues than in others 
since some tissues cannot metabolise other fuel sources such as fatty acids. For 
example, the liver readily reduces its glucose requirements by increasing its oxidation 
of fatty acids (Lockwood & Bailey 1970), however in contrast, the brain, renal 
medulla and erythrocytes can only reduce their glucose requirements slightly since 
they are unable to metabolise fatty acids (Wallace et al 1992). Glycolysis and 
glycogen synthesis are reduced in liver and muscle by reductions in the activities of 
glycogen synthase (Ballard & Oliver 1963; Walker & Snell 1973: Biondi & Viola- 
Magni 1977) and glucose metabolism enzymes (Girard et al 1977). Glucokinase 
activity reflects this need to conserve glucose and is normally absent until the onset 
of weaning in the rat liver (Walker & Holland 1965; Jamdar & Greengard 1970; 
Perdereau et al 1990).
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Figure 1.3 Schematic Representation of Interactions of Metabolic
Pathways During the Suckling-Weaning Transition
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The second adaptation is for production of glucose from non-carbohydrate 
sources to increase and for increased glucose cycling via the Cori cycle. As insulin 
concentrations fall after birth, glucagon concentrations increase and channelling of 
compounds such as lactate, pyruvate and glycerol through gluconeogenesis into 
glucose begins (Snell & Walker 1973a). In mammals, complete gluconeogenesis is 
restricted solely to the liver and to a lesser extent, the kidneys, due to the absence of 
glucose 6-phosphatase from other tissues.
Studies on the activities of gluconeogenic enzymes in the foetus have revealed 
that most are present at adult levels before birth in the guinea pig, rat and rabbit 
(Jones & Ashton 1976; Callikan et al 1979; Ballard & Hanson 1967). Exceptions to 
this appear to be phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6- 
phosphatase. PEPCK is present in very low levels in the cytosol of the rat (Hanson 
et al 1975), rabbit, guinea pig and sheep (see Girard 1986). At birth PEPCK activity 
and mRNA concentrations increase 25-fold reaching a peak after approximately 6 hrs 
in the rat (Ballard & Hanson 1967; see Girard 1992). Since the rapid increase in 
PEPCK activity can be prevented by injection of insulin into near-term fetuses, the 
activity of PEPCK must be regulated, at least in part, by the hormonal conditions 
(Girard et al 1973a). Glucose 6-phosphatase activity is low during late foetal life and 
increases rapidly at birth (Vernon & Walker 1968&; Girard et al 1973a). However 
the increase in activity is less marked than for PEPCK and thus it appears that 
PEPCK may play a regulatory role in the activation of gluconeogenesis in the neonate 
(Girard et al 1973). The interactions and activities of key regulatory enzymes 
associated with glucose metabolism during the suckling-weaning transition are
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summarised in Figure 1.4.
The importance of gluconeogenesis in the suckling period is highlighted by 
studies in which PEPCK was inhibited by administration of 3-mercaptopicolinate, 
causing a fall in blood glucose concentrations within one hour in 16 hour and 10 day 
old pups, in vivo and in vitro (Ferré et al 1977; Snell 1981). Concentrations of 
lactate and pyruvate increased indicating sufficient precursor concentrations for 
PEPCK activity (Ferré et al 1977). Starvation of suckling rats does not elevate the 
rate of gluconeogenesis, suggesting that the rate of gluconeogenesis is maximal during 
suckling (Beaudry et al 1977).
The third major adaptation is for the requirement for glucose to be reduced 
by the metabolism of other fuels. The endogenous fat stores at birth are able to 
sustain the infant for a few hours at most before suckling commences and exogenous 
fat supplied in the milk is used for /J-oxidation thereafter (Lockwood & Bailey 1970). 
Fatty acids are readily released by adipose tissue for oxidation in the liver and 
muscles to acetyl-CoA which is metabolised in the tricarboxylic acid cycle to produce 
energy, CO2  and H2 O.
In the liver however, some acetyl-CoA is converted to water-soluble ketone 
bodies which can be carried in the blood to tissues which are unable to metabolise 
fats themselves, but can metabolise their products (see Bailey & Lockwood 1973; 
Robinson & Williamson 1980). Ketone bodies act as major fuels for the kidneysj|and 
heart, and for the brain in situations of reduced glucose intake, such as suckling.
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Figure 1.4 Schematic Representation of Glucose Metabolic
Pathways Identifying Actions of Some Regulatory Enzymes
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It has been shown by several workers that the plasma fatty acid and ketone 
body concentrations in the suckling rat are increased, allowing reduced glucose 
metabolism compared to adults (see Bailey & Lockwood 1973). Indeed, since 
ketogenesis can be induced in hepatocytes from weaned rats by addition of cAMP, 
but not in hepatocytes from suckling rats (Benito et al 1979), rates of ketone body 
synthesis, like gluconeogenesis, are thought to be maximal during suckling (Benito 
et al 1979; Beaudry et al 1977). Inhibition of /5-oxidation in the suckling newborn 
rat with pent-4-enoate causes a 60% decrease in ketone bodies and blood glucose 
concentrations, although glucose utilization is not increased (Pegorier et al 1977; 
Ferré et al 1979). Thus j6-oxidation and ketogenesis and ketone body utilization are 
highly active throughout suckling.
The nutritional demands of the neonate to sustain growth prevents 
accumulation of significant energy stores, and hence glycogen and fat stores remain 
low until weaning (Ballard & Oliver 1963; Walker & Snell 1973). The hormonal 
conditions throughout suckling favour this metabolic environment since the 
insulin/glucagon ratio remains low (Girard et al 1977). Glucagon appears to be the 
most important hormone during this period and levels are high allowing full 
expression of many of the essential regulatory enzymes and maintaining their activity. 
This activity is seen in adults in situations of starvation and illness when similar 
metabolic changes occur. Disruption of the hormonal pattern can cause rapid changes 
in some enzymes, but others appear to be more resistant.
The metabolic environment of the neonatal rat remains as above for the
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duration of the suckling period and only begins to change once weaning commences. 
Since naturally this process takes 10-12 days (Redman & Sweney 1976; Henning 
1981) the changes are normally small and slow. However, laboratory conditions 
provide the ideal situation for studying the metabolic changes under controlled 
conditions and hence study of rapid changes in enzyme activities and priorities can 
be carried out by enforced weaning, normally when pups are about 20 days old. The 
metabolic changes occurring around the suckling-weaning transition, both in gradual 
and enforced weaning, are described below.
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1.4 METABOLISM DURING THE SUCKLING-WEANING TRANSITION
1.4.1 INTRODUCTION
In the rat weaning begins around day 16 when the pup begins to nibble chow 
and bedding. This naturally continues for 10-12 days with an increasing carbohydrate 
and reducing milk intake (Redman & Sweney 1976; Henning 1981). Hence there is 
an overlap in which suckling and weaning are active simultaneously. As a result of 
the increased carbohydrate concentrations, insulin levels rise and the insulin/glucagon 
ratio rises (Blazquez et al 1974; Girard et al 1977; see section 1.5). Concomitantly, 
the metabolic pathway requirements now alter to allow synthesis of glycogen and fat 
stores and to reduce gluconeogenesis, /5-oxidation and ketone body synthesis as prime 
energy sources (see Figure 1.3), since these pathways are no longer necessary (see 
Girard et al 1992). The metabolic conditions established during weaning remain in 
place into adulthood, so long as the dietary status remains the same. Starvation or 
illness may however, alter the balance of these pathways.
Thus the suckling-weaning transition is vital for establishing the balance of 
metabolic pathways necessary for continued healthy life where sufficient food is 
available. The activity of the fat and carbohydrate metabolic pathways and 
development of many regulatory enzymes established at weaning are described below 
(see Figure 1.4).
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1.4.2 GLYCOGEN SYNTHESIS AND BREAKDOWN
Since the liver of the 15 days old suckling rat has the ability for glycogen 
storage when blood glucose levels are increased by an oral load, the availability of 
glucose seems to be limiting for glycogen synthesis during suckling (Casado & Snell 
1993). The increased glucose intake at weaning reduces the need for glycogen 
breakdown and actually allows glycogen synthesis and storage. Redirection of 
glycogenic flux is achieved by modification of the enzyme status.
The glycogen phosphorylase a/teW  synthase ratio slowly increases throughout 
suckling to reach adult levels at 20 days. Certainly during the first 2 days of life this 
is due to an increase in phosphorylase a activity and a decrease in synthase a (Gold 
& Haverstick 1977). However, the capacity for synthase b to synthase a conversion 
increases from 2 days onwards through to weaning. It is thought that during 
suckling, glycogen synthesis is inhibited by the higher concentrations of glycogen 
phosphorylase and the reduced ability to stimulate synthase activity. Hepatic 
glycogen stores, as measured by incorporation of ^'^C-glucose, slowly increase from 
around day 5 and continue until adult levels are reached (Gold & Haverstick 1977). 
Glucocorticoid administration caused a slight increase in the rate of glycogen 
synthesis in 16 to 18 day old rats but was without effect in newborn rats (Gold & 
Haverstick 1977).
Glycogen accumulation may also be connected to the low level of insulin 
sensitivity in adipose tissue seen during the suckling period which then increases at
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weaning (Issad et al 1987 & 1988; Leturque et al 1991). This insensitivity is the 
result of reduced numbers of glucose transporters (GLUT) 4 in adipose tissue 
(Leturque et al 1991) which then increase slowly at weaning in the presence of 
glucose and insulin. It is suggested that immediately after weaning the GLUT4 
concentrations remain low despite the increased glucose concentrations and rising 
insulin levels, and sometime is required for transcription and enzyme levels to 
increase. This delay may allow the increased blood glucose levels to be channelled 
into glycogen stores in the liver and muscles before fat stores in adipose tissue can 
begin to develop (Ferré et al 1990). Hence the insensitivity of adipose tissue glucose 
transporters to insulin immediately after weaning may be metabolically advantageous 
since it allows glycogen stores to be replenished in advance of fat stores. Since 
glycogen acts as an emergency fuel in situations of starvation or danger, the rapid 
replenishment of stores soon after weaning may be a metabolic priority.
1.4.3 GLYCOLYSIS
At weaning, the glycolytic activity of the rat pup increases as a result of the 
increased carbohydrate intake. Measurements of and [6-^H] glucose
metabolism to lactate show increased activity at weaning when glucose utilization is 
double that of suckling rats. Recycling via the Cori cycle remains constant at 
suckling levels (Vernon & Walker 1972).
The increased glucose metabolism is due to the direct effect of raised glucose 
concentrations, and also indirectly to the change in insulin/glucagon ratio and elevated
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insulin sensitivity. At weaning the insulin/glucagon ratio increases 20-fold as a result 
of the elevated concentrations of blood glucose (Girard et al 1977). Insulin sensitivity 
has been measured in suckling rats and rats weaned to both high-carbohydrate and 
high-fat diets (Issad et al 1987 & 1988). Basal glucose turnover was similar in all 
three groups (14mg/min per kg). In euglycaemic-hyperinsulinaemicj%uBies the 
plasma insulin concentrations in the suckling rat were almost double those of the 
high-carbohydrate and high-fat weaned rats suggesting a lower rate of insulin 
clearance in the suckling pup (Ferré et al 1985; Issad et al 1987). In contrast, the 
glucose utilization rate was 43% lower in suckling rats and 20% lower in high-fat 
weaned compared with high-carbohydrate weaned animals. Endogenous glucose 
production was reduced by 90% in carbohydrate weaned rats but only 40% in both 
the suckling and high-fat weaned rats (Issad et al 1987). These results indicate that 
the increase in glucose metabolism and inhibition of glucose production, in response 
to insulin, in the suckling and high-fat weaned rats, is diminished in comparison to 
high-carbohydrate weaned animals.
1.4.3.1 Development of Glucokinase (E.G. 2.7.1.2)
Glucokinase (Hexokinase type IV) controls the irreversible uptake of glucose 
into the liver, kidneys and pancreas when blood glucose concentrations are high, but 
remains largely inactive during periods of reduced glucose concentrations (DiPietro 
& Weinhouse 1960). Since glucokinase has a high Km for glucose (lOmM; DiPietro 
et al 1962), it only allows entrance of glucose into the liver when glucose supplies 
are plentiful. During suckling, when the glucose content of the milk is low, the
42
hepatic requirement for glucokinase is minimal. However, in order to change to solid 
foods, the young have to acquire the means of homeostatic control, and glucokinase 
activity increases.
The importance of glucokinase in regulating glucose homeostasis means that 
its development in the liver, has received much attention (Walker & Holland 1965; 
Jamdar & Greengard 1970; Haney et al 1986; Partridge et al 1975; Narkewicz et al 
1989; Perdereau et al 1990; Girard et al 1991). Glucokinase activity normally 
appears at 16 days in rat and increases slowly to adult values at 30 days if the pups 
are left with their mother (Walker & Holland 1965; Jamdar & Greengard 1970). 
Weaning of the rat pups at 21 days however, causes rapid increases in the activity of 
glucokinase (Perdereau et al 1990; see table 1.1). That this rise in activity is the 
result of new protein synthesis was confirmed by the use of actinomycin D and 
puromycin, and /7-fluorophenylalanine (protein synthesis antagonists), all of which 
prevented the normal development of glucokinase (Walker & Holland 1965).
Glucokinase mRNA is first detectable at day 14, two days before activity can 
be measured and increases 40-fold reaching a peak at 31 days, after weaning at 22 
days (lynedjian et al 1987). Studies in which rats were weaned at 21 days having had 
no previous access to carbohydrate diet, demonstrated that glucokinase activity and 
mRNA concentrations were low before weaning and increased to maximal levels 
within 24 hours (Perdereau et al 1990; table 1.1). More detailed time studies showed 
a small increase in hepatic glucokinase mRNA 1 hour after a glucose load and a 
higher rate of synthesis at 2 hours. Activation of glucokinase mRNA by addition of
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insulin but not glucose to primary cultures of hepatocytes, suggest that insulin may 
act as the prime regulator for glucokinase activation (Narkewicz et al 1989). 
Insulin/glucagon ratio changes begin within 30 minutes of carbohydrate forced-feeding 
(Perdereau et al 1990; see sections 1.5.1 and 1.5.2).
Glucokinase 
(% of maximum)
Age in Days
21 22 23 25
Activity 10 100 60 50
mRNA 5 100 90 60
Insulin 45 100 80 75
Glucagon 100 45 45 45
Table 1.1 Activity and mRNA levels for glucokinase in rats weaned at 21 days. 
Activity is expressed as a percentage of the maximum found between 21 and 25 days 
in the rat. Data taken from Perdereau et al 1990.
The lower Km of the other hexokinases (0.2mM) than for the glucokinase 
isoenzyme allows glucose to be metabolised by tissues other than the liver, pancreas 
and kidney, at lower blood glucose concentrations. Hepatic hexokinase activity 
decreases by 50% at birth and thereafter falls only slightly to adult values (Walker 
& Holland 1965; Jamdar & Greengard 1970). In contrast, cardiac hexokinase
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remains approximately constant between 7 and 42 days (Baldwin et al 1977). Liver 
glucokinase activity is very low throughout the early part of suckling and hexokinase 
is higher, but at weaning this situation is reversed reflecting the change in glucose 
available for metabolism.
The role of pancreatic glucokinase in the improved insulin sensitivity after 
weaning is of great interest with regards to the increased glucose metabolism found 
at weaning, although no ontogenic studies are currently described. Glucokinase in 
the /5-cells of the pancreas regulates glucose utilization by the cells and appears to 
regulate the release of insulin (Weinhouse 1976; Meglasson & Matschinsky 1986). 
Pancreatic glucokinase gene expression appears to be stimulated by glucose, in 
contrast to liver glucokinase which is stimulated by insulin (Bedoya et al 1986). 
Hyperinsulinaemia induced by insulinoma causes reduced glucose concentrations and 
concomitant reduction of glucokinase activity in jS-cells to only 30% (Bedoya et al 
1986). Work by Magnuson and Shelton has found two distinct promoter sites 
contained in the glucokinase gene, one active in the liver and the other in the 
pancreas (Magnuson & Shelton 1989). This would account for the apparent 
difference in the tissue-specific regulation of activity of these two types of 
glucokinase.
1.4.3.2 Precocious Induction of Glucokinase
Various attempts have been made to induce hepatic glucokinase activity before 
16 days both in whole animals (Walker & Holland 1965; Jamdar & Greengard 1970;
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Partridge et al 1975; Wakelam et al 1979; Haney et al 1986) and in cultured 
hepatocytes (Narkewicz et al 1990). These experiments have included the use of 
glucose (Haney et al 1986), insulin, the insulinogenic agent, chlorpropamide (Walker 
& Holland 1965; Adelman & Freeman 1972), hydrocortisone (Jamdar & Greengard 
1970) and corticotrophin (Partridge et al 1975), ACTH (Adelman & Freeman 1972) 
and thyroid hormone (Partridge et al 1975).
Initial studies by Walker & Holland (1965) failed to induce glucokinase 
activity in rat pups before 14 days with daily injections of glucose and insulin. 
Glucokinase activity was however induced at 13 days to 30% of adult values by oral 
glucose administration, and inhibited by simultaneous injection of mannoheptulose to 
prevent insulin secretion (Wakelam et al 1979). Using indwelling gastric cannulae, 
Haney and colleagues recorded a 30% increase in glucokinase activity at 4 days and 
71% at 10 days after administration of a high-carbohydrate diet for 21-29 minutes 
every 2 hours from 2 days. Insulin concentrations rose to 4- or 5- times that of milk 
fed pups of the same age (Haney et al 1986). The dissimilarity in these results may 
arise from the differences in the frequency of the glucose administration, but would 
nevertheless support a role for insulin in the induction of glucokinase.
The use of hydrocortisone and glucose to induce glucokinase action 
prematurely in 9 day olds, resulted in activities equal to those normally found in 21 
day old pups (Jamdar & Greengard 1970). Activity could not be induced before 5 
days and it was suggested that this may be due to the elevated concentrations of 
oestrogen found in newborn pups. The premature induction of glucokinase was
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prevented by administration of actinomycin D and manno-heptulose, and oestradiol 
administration 6 hours before each hydrocortisone injection (Jamdar & Greengard 
1970). Precocious induction of glucokinase was not seen after administration of 
corticosterone or corticotrophin with glucose (Partridge et al 1975; Jamdar & 
Greengard 1970).
Partridge and colleagues measured glucokinase activity in rat pups as young 
as 2 days, after administration of thyroid hormone (Partridge et al 1975). 
Triiodothyronine was injected intraperitoneally followed by a glucose injection 24 or 
48 hours later. Activity was 7- to 31-fold higher for triiodothyronine treated pups 
than controls of the same age. Thyroxine injections also stimulated glucokinase 
activity but required double the dose given for triiodothyronine. Glucokinase activity 
was not induced in the absence of the glucose loads (Partridge et al 1975).
Using primary culture of neonatal rat hepatocytes, triiodothyronine and insulin 
induced glucokinase mRNA in 12 hours in the presence of glucose (Narkewicz et al 
1990). The effects of the hormones were additive and dose-dependent. 
Dexamethasone did not induce glucokinase mRNA either alone or in the presence of 
triiodothyronine (the glucokinase induction by triiodothyronine was actually reduced 
in the presence of dexamethasone), but when insulin was also present the induction 
was maximal. Insulin and dexamethasone together are able to stimulate glucokinase 
gene expression to the same extent with triiodothyronine as without. Thus although 
triiodothyronine is able to produce some glucokinase activity in hepatocytes from 12- 
14 day rats, in the presence of insulin the effects of either triiodothyronine or
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dexamethasone are enhanced and mRNA concentrations double (Narkewicz et al 
1990). Thus insulin appears to be essential for appreciable hepatic glucokinase 
induction.
Hence, it is difficult to establish a clear picture from these studies into the 
precocious induction of glucokinase without further work. Since isolated hepatocytes 
represent a relatively simple metabolic situation devoid of internal hormonal 
complications, this may be an ideal environment in which to continue studies into the 
hormonal control of glucokinase activation.
1.4.4 GLUCONEOGENESIS
The increased intake of glucose from exogenous sources obviates the need for 
gluconeogenesis and activity starts to fall soon after weaning. However,
gluconeogenesis appears to remain active at weaning for a short time to allow rapid 
replenishment of glycogen stores. The reduction in gluconeogenesis is regulated by 
the PEPCK activity which in turn, is controlled by the insulin/glucagon ratio.
1.4.4.1 Gluconeogenesis after Weaning to High-Carbohydrate Diet
The gluconeogenic rate has been shown by several studies to decrease at 
weaning to a solid chow (high-carbohydrate) diet. Glucose turnover studies in 
suckling and weaned rats in vivo showed a 2-fold increase in 30 day old pups, 
suggesting a lower rate of glucose synthesis and a higher rate of utilization (Vernon
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and Walker 1972). In addition, studies of incorporation of gluconeogenic substrates 
such as lactate, bicarbonate and amino acids into glucose and glycogen, before 
and after weaning, show a markedly reduced hepatic gluconeogenic activity after 
weaning in hepatocytes and in vivo (Ballard & Hanson 1967; Yeung & Oliver 1967; 
Vernon & Walker 1972; Snell & Walker 1974; Beaudry et al 1977; Decaux et al 
1986).
Work by Vernon and Walker (1968a) measured three gluconeogenic enzymes, 
PEPCK, glucose 6-phosphatase and fructose 1,6-bisphosphatase in rats that had been 
allowed to wean naturally and were not removed from their mother until 30-32 days. 
Their results demonstrated a gradual decline in the hepatic activity of all these 
enzymes from the onset of weaning at day 15 onwards, reaching adult values at 27 
days for glucose 6-phosphatase and PEPCK, although fructose 1,6-bisphosphatase 
remained above adult values past 30 days.
In experiments in which the mother was fed a high-fat diet from day 15 to 
prevent pups from accessing any carbohydrate before force-feeding a high- 
carbohydrate load at 21 days, the insulin peaked within 30 mins whereas glucagon 
took a full 6 hrs to fall to a minimum (Perdereau et al 1990; see table 1.2). PEPCK 
mRNA fell by 90% to fed adult levels within 2 hours and activity fell 50% in the first 
6 hrs. The apparent contradiction between these time courses can be accounted for 
by the differences in half lives: the half-life for PEPCK mRNA is 30 mins and that 
for the enzyme is 6hrs (Cimbala et al 1982). Insulin blocks the transcription of 
PEPCK and reduces the half-life of its mRNA (Lyonnet et al 1988). The rise in
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insulin concentrations preceded the fall in PEPCK mRNA (Perdereau et al 1990) 
indicating that insulin may regulate hepatic PEPCK by suppression of gene 
transcription (Girard et al 1991).
Enzyme
Hours After Force-Feeding
0 1 2 4 6
PEPCK 100 30 10 15 20
Fatty Acid Synthase 50 50 50 65 100
Acetyl-CoA Carboxylase 50 45 40 100 100
Glucokinase 5 20 70 95 100
Insulin 20 100 90 100 75
Glucagon 100 95 75 50 35
Table 1.2 Hepatic mRNA of some regulatory enzymes after force-feeding a high- 
carbohydrate diet at 21 days. Values are expressed as a percentage of the maximum 
attained during the first six hours after feeding. Data taken from Perdereau et al 
1990.
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1.4.4.2 Gluconeogenesis after Weaning to High-Fat or High-Protein Diet
The enzymatic changes associated with the decline of gluconeogenesis at 
weaning can be prevented by weaning to a high-fat diet (Vernon & Walker 1968). 
This has the effect of prolonging the suckling nutritional pattern and allows the 
factors regulating enzyme expression to be investigated. Weaning to a high-fat diet 
prevents the fall in glucagon and increase in insulin which otherwise occurs naturally 
at this time.
Experiments in which rats were weaned to high-protein and high-fat diets were 
performed by Vernon and Walker (1968). They found gluconeogenic enzyme 
activities similar to suckling pups for glucose 6-phosphatase, fructose 1,6- 
bisphosphatase and PEPCK, with both a high-fat and high-protein diet (Vernon & 
Walker 1968).
In adipose tissue, the activity of PEPCK in 30 day rats after weaning at 21 
days to a high-fat diet, was 33% higher than in the suckling rat, although mRNA 
concentrations remained the same (Coupé et al 1990). Since adipose tissue does not 
contain glucose 6-phosphatase, it cannot function as a gluconeogenic tissue with 
regards to releasing glucose. However, glucose 6-phosphate is essential as a substrate 
for the pentose-phosphate pathway which provides NADPH for use in the low levels 
of lipogenesis found during suckling (Ferré et al 1990). In contrast, when weaned 
to a high-carbohydrate diet PEPCK concentrations fell by 67% and mRNA by 94% 
(Coupé et al 1990). In the liver the same situation is found, with activity being 50%
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higher and mRNA 200% higher in high-fat weaned compared to high-carbohydrate 
weaned rats (Perdereau et al 1990).
Since weaning to a high-fat or high-protein diet abolishes the rapid fall in 
PEPCK mRNA and activity found after weaning to a high-carbohydrate diet, PEPCK 
would appear to be under nutritional and hormonal control rather than any age-related 
regulation (Perdereau et al 1990). Unfortunately, no information appears to be 
available on the effects of insulin administration to rats weaned to high-fat or high- 
carbohydrate diets. Such experiments would confirm the role of insulin in the 
inhibition of gluconeogenesis at weaning.
After weaning, the gluconeogenic capacity of the liver remains at sufficient 
levels for the maintenance of glucose levels between meals. In starvation and 
situations of restricted glucose intake, gluconeogenic activity increases to allow 
sufficient glucose synthesis for the maintenance of normal glucose homeostasis. The 
gluconeogenic activity of the kidneys remains low except in prolonged starvation (see 
Sugden et al 1989).
1.4.5 FATTY ACID SYNTHESIS
After weaning to a high-carbohydrate diet, the rate of lipogenesis increases 
and fat stores begin to fill (Ballard & Hanson 1967; Smith & Abraham 1970; 
Gandemer et al 1982; Kochan & Swierczynski 1992; Foufelle et al 1992a). Total 
lipid content remains at pre-weaning levels in the liver, but increases by
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approximately 75 % in perirenal white adipose tissue in the 20 days following weaning 
(Gandemer et al 1982).
In adult rats, glucose has been shown to stimulate lipogenesis in vivo as 
measured by the incorporation of into fatty acids in liver and brown adipose 
tissue (Sugden et al 1981 & 1982). These effects are mediated via insulin since 
increased lipogenesis is not seen in diabetic rats (Sugden et al 1981 & 1982). 
Triiodothyronine administration also increases hepatic lipogenesis in fed, but not 
starved rats unless glucose is also administered. Triiodothyronine had no effect on 
lipogenesis in brown adipose tissue (Sugden et al 1982).
The rate of lipogenesis increases markedly in both liver and white adipose 
tissue at weaning to a high-carbohydrate diet (Gandemer et al 1982). Lipid synthesis 
increases 10-fold in perirenal adipose tissue and 6-fold in subcutaneous adipose tissue, 
in the 14 days following weaning. Activity thereafter falls back to adult levels 
(Gandemer et al 1982). In the liver, a 6- to 8- fold increase in total lipid synthesis 
is observed at weaning (Gandemer et al 1982; Kochan & Swierczynski 1992). 
However, the post-weaning profile for total lipid synthesis rate recorded by Gandemer 
et al (1982) shows a continued increase beyond 80 days whereas that recorded by 
Kochan & Swierczynski (1992) shows a rapid decline between 35 and 45 days.
In brown adipose tissue the developmental profile is slightly different since 
lipogenic rates peak just after spontaneous weaning and then slowly decline to adult 
values at 100 days (Kochan & Swierczynski 1992).
53
1.4.5.1 Development of Lipogenic Enzymes
The activities of regulatory lipogenic enzymes increase at weaning in the liver 
and adipose tissue. The activity of fatty acid synthase, acetyl-CoA carboxylase 
(ACC), malic enzyme and ATP-citrate lyase all show marked increases at weaning 
in liver (Ballard & Hanson 1967; Foufelle et al 1992; Kochan & Swierczynski 1992; 
Gandemer et al 1982; Taylor et al 1967; Lockwood et al 1970; Perdereau et al 1990) 
and white (Foufelle et al 1992 a 8cb\ Ferré et al 1990; Coupé et al 1990; Gandemer 
et al 1982) and brown adipose tissue (Kochan & Swierczynski 1992).
Enzyme 
(% max.activity)
Age in Days
21 22 23 25
PEPCK Liver 100 20 15 30
Adipose 100 50 40 30
Fatty Acid 
Synthase
Liver 5 15 65 100
Adipose 10 15 50 100
ACC Liver 10 20 60 100
Adipose 10 30 80 100
Table 1.3 Activity of hepatic PEPCK, fatty acid synthase and ACC after weaning 
to a high-carbohydrate diet at 21 days. Values represent % of maximum observed 
at 25 days for fatty acid synthase and ACC and 21 days for PEPCK. Data taken 
from Coupé et al 1990; Perdereau et al 1990; Foufelle et al 1992a.
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i) Liver Enzymes
In the liver, spontaneous weaning to a high-carbohydrate diet induces increases 
in the activity of fatty acid synthase and ACC in the mouse (Smith & Abraham 1970). 
Activity increased to a peak at 25 days for fatty acid synthase and 40 days for ACC 
(Kochan & Swierczynski 1992; Lockwood et al 1970). Using specific DNA probes 
for these two enzymes, increased transcription of mRNA has been shown to precede 
these activations (Perdereau et al 1990). ACC and fatty acid synthase mRNA was 
barely detectable before weaning at 21 days and increased to 40% and 55% of the 
peak value respectively 24 hours later (Perdereau et al 1990; see table 1.3). Force- 
feeding experiments in which the rats were gavaged with a high-carbohydrate /low-fat 
diet at 21 days indicated that mRNA for these two enzymes did not increase 
significantly within the first 6 hours (Perdereau et al 1990; see table 1.2). 
Unfortunately, the experiments were not continued beyond 6 hours and the time 
course for activation was not established.
Weaning of rat pups to a carbohydrate rich diet containing 49-50% 
carbohydrates and 32-33 % of either long- or medium-chain fatty acids produced 
different effects on transcription of fatty acid synthase and ACC in liver (Foufelle et 
al 1992a). The long-chain fatty acids prevented mRNA production for both enzymes 
and reduced, but did not prevent the decrease in PEPCK mRNA and activity. In 
contrast, medium-chain fatty acids induced slow increases in fatty acid synthase and 
ACC mRNA which eventually reached levels found in high-carbohydrate/low-fat 
weaned rats (Foufelle et al 1992a). Since these differences between long- and
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medium-chain fatty acid fed rats are seen in spite of similar amounts of carbohydrate, 
the rate of induction of lipogenic enzymes cannot be the result of uptake of critical 
amounts of carbohydrate as suggested by Iritani and colleagues (Iritani et al 1992; 
Foufelle et al 1992a). It is suggested that this disparity may result from the different 
metabolic pathways involved with long- and medium-chain fatty acids. Since 
medium-chain fatty acids are activated to their respective acyl-CoA in the 
mitochondria, and ACC and fatty acid synthase are both cytoplasmic, these acyl-CoAs 
are unable to impose much of an inhibitory effect. In contrast, long-chain fatty acids 
are activated in the cytoplasm and may therefore inhibit these enzymes. Additionally, 
long-chain fatty acids have lower insulin releasing properties (Iritani et al 1992).
Premature weaning of rat pups to a high-carbohydrate diet at 15 days resulted 
in a delayed increase in the activity of ACC (Lockwood et al 1970) with little 
difference found at 17 days, but a larger increase at 19 days. The same effect was 
seen in mice where fatty acid synthase and ACC activities were increased 4- and 1.5- 
fold respectively at 19 days after weaning at 16 days (Smith & Abraham 1970). This 
can be explained to some extent by the time taken to synthesis^RNA, but may also 
be partly due to a lack of feeding since at 15 days pups are relatively immobile and 
their sight is poor suggesting that they may not actually consume much carbohydrate 
until later. Stress induced by the removal of the mother is also likely to contribute 
to the metabolic state of the pups since stress has marked effects on the hormonal 
status of animals (see section 1.5). Unfortunately, no indication is given by 
Lockwood and colleagues of the rate of lipid synthesis or the hepatic lipid content 
(Lockwood et al 1970) although pups are reported to ‘thrive and gain weight at the
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normal rate’. However, the possibility of a regulatory factor other than diet 
controlling the activation of ACC cannot be excluded by these points.
Short-term regulation of ACC by insulin, citrate and long-chain fatty acids is 
also important during the suckling-weaning transition. Experiments with purified 
hepatic ACC have demonstrated enhanced polymerization and activation in the 
presence of citrate (Jamil & Madsen 1987). Phosphorylation and hence inactivation 
of ACC is catalysed by AMP-activated protein kinase, stimulated by adrenaline and 
possibly glucagon at /J-receptors (Holland et al 1984; Haystead et al 1990). In 
adults, insulin has been shown to stimulate ACC activity (Hardie 1980; Haystead & 
Hardie 1986) by phosphorylation at a site distinct from that phosphorylated by cAMP- 
dependent protein kinase. Thus the changing insulin/glucagon ratio found during the 
suckling-weaning transition may alter the activity of ACC via allosteric factors and 
phosphorylation/dephosphorylation as well as at the transcriptional level.
Hepatic ATP-citrate lyase activity increases 6 -fold after weaning at 20 days, 
peaking at 35 days (Ballard & Hanson 1967; Kochan & Swierczynski 1992). Activity 
then falls slowly to adult levels. Interestingly, the activity attained at 25 days is 
approximately equal to that found in adults, suggesting that further increases during 
the subsequent 1 0  days are largely a result of an over-shoot in enzyme synthesis. 
Premature weaning to a high-carbohydrate diet at 15 days induced early rises in ATP- 
citrate lyase activity at 18 days in rats and mice (Lockwood et al 1970; Smith & 
Abraham 1970) although the rate of enzyme increase was approximately equal to that 
found when weaned at 2 0  days.
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Malic enzyme activity is important for lipogenesis since it provides NADPH 
for fatty acid synthesis (Andrés et ol 1980). It also recycles oxaloacetate from the 
cytosol into the mitochondria where it can recombine with acetyl-CoA for carriage 
into cytosol. Hepatic malic enzyme activity increases rapidly at weaning at 20 days 
to reach a peak at 30 days (Taylor et al 1967; Andrés et al 1980; Kochan & 
Swierczynski 1992). Thereafter, the activity falls again to adult levels at 70 days. 
The activity falls more slowly for female rats than males and falls to an adult value 
that is double that of the males (Taylor et al 1967; Andrés et al 1980). Precocious 
induction of malic enzyme at 4 days has been reported by Haney et al (1986). A 
carbohydrate rich solution was administered by gastrostomy to 2  day old rat pups. 
At 4 days the malic enzyme activity had risen to 18% and at 10 days to 96% of adult 
concentrations. Insulin concentrations were 4-5 times higher in glucose fed pups than 
in the milk fed controls still with their mother. Triiodothyronine appeared to enhance 
the effects of glucose (Haney et al 1986).
Weaning to a high-carbohydrate diet at 15 days caused an increase in malic 
enzyme within 24 hours (Lockwood et al 1970). Before weaning, activity was 
undetectable but within 24 hours it had increased to 0.3jnmol/min/gww of liver. 
Activity continued to rise, doubling every 2 days beyond the normal weaning point. 
Weaning to a high-fat diet from 16 days onwards resulted in a slow increase in malic 
enzyme activity despite the absence of carbohydrate in the diet (Lockwood et al 
1970). Activity remained constant after 32 days but at concentrations well below 
those found in high-carbohydrate weaned rats (Lockwood et al 1970). Thus the rise 
in malic enzyme activity appeared to be stimulated by the change to a high-
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carbohydrate diet but not prevented in its absence, suggesting another controlling 
factor in stimulation. No information regarding transcription of gene and 
concentrations of mRNA is currently available for malic enzyme.
The controlling point of the metabolic pathways, responsible for directing 
glucose metabolites into lipogenesis and the citric acid cycle is pyruvate 
dehydrogenase, since it catalyses the irreversible production of acetyl-CoA. The 
activity of PDH has been shown to be important in directing the carbon flow during 
refeeding following starvation (see Sugden & Holness 1989) and in diabetes and 
obesity (Randle et al 1988). Hepatic PDH activity is generally low when glucose 
supplies are reduced such as in starvation and to increase at refeeding with 
carbohydrates. By analogy, hepatic PDH was expected to be low during suckling and 
to increase quickly at weaning allowing flow of glucose metabolites into lipogenesis. 
However, the available work on the development of PDH suggests low activity in the 
suckling rat and elevated levels in the adult but the transition between suckling and 
weaning was not studied (Knowles & Ballard 1974; Bailey et al 1976).
ii) Adipose Tissue Enzymes
Since adipose tissue is the major site of fatty acid storage in most mammals, 
it seems likely that at weaning when dietary supplies may be in excess of 
requirements, the activity of lipogenic enzymes will increase. Indeed this has been 
shown to be the case, at least in the rat.
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At weaning, the activity and mRNA of fatty acid synthase and ACC in white 
adipose tissue, increases (Coupé et al 1990; Foufelle et al 1992 a and b). Fatty acid 
synthase mRNA increases to 75 % of maximal values (approximately 8 -fold) within 
24 hours of weaning at 21 days. Activity increases after mRNA, reaching 50% at 
23 days and 100% at 25 days (Coupé et al 1990). ACC mRNA rises more slowly 
to 20% (a 4-fold increase) at 22 days and 75% at 23 days, but activity rises slightly 
faster than for fatty acid synthase suggesting a faster translation of the mRNA (Coupé 
et al 1990). In suckling rats force-fed a high-carbohydrate diet at 21 days 
concentrations of mRNA increased 4-6 fold within 6  hours for fatty acid synthase and 
ACC (Coupé et al 1990).
In contrast, suckling rats force-fed a high-fat diet at 21 days demonstrated no 
increase in fatty acid synthase and ACC mRNA in 6  hours. At 30 days the activity 
of both enzymes was approximately double those in suckling pups but only 10-15% 
of the activities found in high-carbohydrate weaned rats (Coupé et al 1990). This is 
very similar to the situation found in the liver (Perdereau et al 1990) however, since 
absolute values are not given, comparisons of the total activities cannot be made.
Work by Foufelle and colleagues into the factors stimulating the activation of 
lipogenic enzymes at weaning has centred on the ability of various substrates to cause 
activation (Foufelle et al 1992b). Using inguinal white adipose tissue cultures 
extracted from 19 days old suckling rats, pyruvate and lactate were shown to have no 
stimulatory effects on the lipogenic enzymes, fatty acid synthase and ACC. Addition 
of insulin had no effect. In the presence of glucose however, mRNA increased 5-7
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fold for both enzymes, an effect which was doubled by the addition of insulin. Since 
3-0-methylglucose could not and 2-deoxyglucose could stimulate enzyme 
transcription, it was concluded that glucose 6 -phosphate may be a factor regulating 
the onset of lipogenesis and transcription of the necessary enzymes (Foufelle et al 
\992b).
Weaning to a high-carbohydrate diet appears to increase the sensitivity of 
adipocytes to insulin, increasing glucose metabolism and lipogenesis (Ferré et al
1990). In contrast, adipocytes from high-fat weaned rats show no sensitivity to 
insulin and continue to metabolise glucose at basal rates similar to those found in 
suckling rats. Concentrations of glucose transporters in the microsomal pool are 
reported to be lower for the fat-weaned cells than for the carbohydrate weaned 
suggesting that weaning to a high-carbohydrate diet stimulates production or mobility 
of glucose transporters which in turn increases the adipocytes sensitivity to insulin 
(Ferré et al 1990).
Comparison of the effects of long- and medium-chain fatty acids on the 
activity of fatty acid synthase and ACC after weaning at 21 days showed little 
difference between medium-chain fatty acids and carbohydrate feeding on mRNA for 
either enzyme at 30 days (Foufelle et al 1992a). Long-chain fatty acids however, 
reduce the mRNA for both enzymes to approximately 30% of carbohydrate fed 
values. The disparity between the two types of fatty acid chain may arise from the 
differences in their metabolism since medium-chain fatty acids are largely metabolised 
in the liver (see section 1.4.5.1 above) before reaching the adipose tissue and hence
61
they are unable to have any marked effect in adipose tissue. Despite the high 
concentrations of ACC mRNA seen in the adipose tissue, the activity is much lower 
than in the carbohydrate-fed control for the medium-chain diet. This may result from 
short-term regulation rather than an effect at the pre-transcriptional level. Activity 
for long-chain fatty acids falls in line with the decrease in mRNA concentrations 
(Foufelle et al 1992a).
In brown adipose tissue, activities of fatty acid synthase, ATP-citrate lyase and 
malic enzyme all increased 15-20 fold with weaning to a carbohydrate rich diet 
(Kochan & Swierczynski 1992). Maximum activities were reached within 5 days, the 
first point measured after weaning and thereafter decreased only slightly to adult 
values (Kochan & Swierczynski 1992). Unfortunately, no information is available 
about the concentrations of mRNA, or the effects of weaning to a high-fat diet.
1.4.6 FATTY ACID |3-OXIDATION
The ketone body concentration in the plasma decreases at weaning to a high- 
carbohydrate diet, implying a reduced rate of jS-oxidation (see Girard et al 1992). 
The hepatic capacity for NEFA uptake in hepatocytes does not appear to decrease 
from suckling to weaning and fatty acid estérification does not increase (Benito et al 
1979) suggesting that the reduction in /5-oxidation found at weaning is due to a 
decreased rate of oxidation rather than a reduced supply of substrates (Benito et al 
1979; Decaux et al 1988).
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Regulation of the rate of j8 -oxidation in the liver appears to be by Carnitine 
Palmitoyltransferase (CPT) 1. During suckling the activity of CPT 1 is high but 
CPT 2 activity remains at foetal levels (Lockwood & Bailey 1970; Foster & Bailey 
1976; Saggerson & Carpenter 1982). At weaning, the activities of CPT 1 and 
carnitine decanoyl-transferase fall more markedly than any of the other oxidative 
enzymes to less than half their original values (Foster & Bailey 1976; Chalk et al 
1983). Enoyl-CoA hydratase activity actually increases by 50% from day 15 to adult 
values and cytoplasmic oxoacyl-CoA thiolase activity doubles over the same period 
(Foster & Bailey 1976). Hydroxyacyl-CoA dehydrogenase and mitochondrial 
oxoacyl-CoA thiolase activities decrease slowly from 15 days (Foster & Bailey 1976).
In addition to the reduced concentration of CPT 1, increased sensitivity of the 
enzyme to malonyl-CoA inhibition enhances the fall in activity during the suckling- 
weaning and starved-refed transition (Decaux et al 1988; see Sugden et al 1994). 
The hepatic malonyl-CoA content however, does not increase at weaning (Benito et 
al 1979; Decaux et al 1988). This reflects an increased production by acetyl-CoA 
carboxylase and utilisation by fatty acid synthase (see section 1.4.5). During suckling 
the activity of hepatic CPT 1 is double that found in weaned rats and the IQ value for 
malonyl-CoA is 7-fold higher (Decaux et al 1988). The insensitivity of CPT 1 to 
malonyl-CoA during suckling is believed to be induced by glucagon and inhibited by 
insulin, since induction of oxidation in foetal cells by glucagon or cAMP can be 
antagonised by insulin (Pegorier et al 1989). Similar levels of control by malonyl- 
CoA are found in high-fat weaned rats as in suckling rats. In fact, there is increasing 
evidence to suggest that the sensitivity of CPT 1 to malonyl CoA is restricted to
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situations of low level fat oxidation such as are found with a normal feeding pattern. 
However, in conditions of high jS-oxidation the malonyl-CoA regulation appears to 
be over-ridden (Decaux et al 1988; see McGarry & Foster 1980). Whilst no 
information is available at present about the mechanisms involved with the decreased 
sensitivity, the delay required for the onset of oxidation in the newborn would tend 
to exclude the possibility of control by phosphorylation/dephosphorylation (Pegorier 
et al 1992). Since weaning to a high-fat diet prevents these alterations in oxidative 
enzymes (Decaux et al 1988), diet and the concomitant change in insulin/glucagon 
ratios may regulate the development of fatty acid oxidation, rather than age.
1.4.7 KETOGENESIS AND KETONE BODY METABOLISM
In fed adult rat hepatocytes, the rate of ketogenesis from oleate is 80% 
lower than in newborn rats (Ferré et al 1983). At spontaneous weaning free fatty 
acids and total ketone body concentrations in the blood decrease reaching adult values 
at 30 days (Lockwood & Bailey 1971; Page et al 1971), indicating a reduced rate of 
/5-oxidation (Decaux et al 1988). Hepatic ketogenic enzyme activities fall over the 
same time period to normal adult levels (see Bailey & Lockwood 1973; Figure 1.5).
Measurement of total and active 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) 
synthase during development have shown a marked decrease in activity and enzyme 
concentration at 28-30 days after weaning to a high-carbohydrate diet (Quant et al
1991). In contrast, weaning to a high-fat diet maintains the total concentration at 
approximately the same levels as found throughout suckling. The active portion of
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the enzyme increases from 78% to 99% (Quant et al 1991). The change in % 
activity is a result of the reduced amount of succinylation of HMG-CoA synthase in 
the high-fat weaned rat. In the high-carbohydrate weaned rat the enzyme is 54% 
succinylated. It is suggested that at weaning the change in % succinylation is a result 
of the changing insulin/glucagon ratio, a small change which is seen even with the 
high-fat diet (Perdereau et al 1990). Thus the changes in HMG-CoA synthase activity 
can be ascribed to decreased concentration and increased % succinylation at weaning 
to standard diet suggesting regulation by nutritional factors (via insulin/glucagon ratio) 
at both pre- and post-translation sites (Quant et al 1991).
At weaning to a high-carbohydrate diet activities of ketone utilization enzymes 
decrease in the brain (Bailey & Lockwood 1973; Page et al 1971). In contrast, in the 
kidney these enzymes increase steadily from birth and continue throughout suckling 
and weaning to reach adult values around 32 days (Page et al 1971).
In the brain, the use of ketone bodies for myelination and lipid synthesis 
during suckling, declines around weaning when myelination is complete. As a result, 
the ketone metabolising enzymes activities fall around the time of weaning although 
this is not thought to be due to nutritional effects but due instead to ‘age’.
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1.5 HORMONAL ENVIRONMENT DURING THE SUCKLING-WEANING
TRANSITION
Hormonal changes around the suckling-weaning transition are essential for the 
activation or inactivation of some enzymes. Whilst the most dramatic changes are in 
insulin and glucagon levels, other hormones such as glucocorticoids and thyroid 
hormones may have essential permissive roles rather than direct effects (see Figure 
1.6). The changes in some hormones involved with regulation of glucose metabolism 
and their relevance to the suckling-weaning transition are outlined below.
1.5.1 INSULIN
During late foetal life, blood insulin concentrations are high (lOOjuU/ml) as a 
result of the carbohydrate rich diet supplied by the mother (Battaglia & Meschia 
1978). At birth insulin levels fall by 80% within one hour and glucagon levels 
increase (Girard 1986). Throughout suckling the insulin/glucagon ratio remains low 
until at weaning, the high-carbohydrate content of the diet stimulates release of insulin 
from the jS-cells of the pancreas (Girard et al 1977; Figure 1.6). Force feeding a 
carbohydrate-rich diet at 21 days produced a 4-fold increase in circulating insulin 
levels within one hour. Force feeding a high-fat diet reduced the increase in insulin 
levels but did not prevent it entirely (Coupé et al 1990; Perdereau et al 1992).
The release of insulin has been shown by several workers to play a large part 
in the changing activities of key regulatory enzymes at weaning (Perdereau et al
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1990; Girard et al 1991; see Girard et al 1992). Glucokinase, acetyl-CoA 
carboxylase and fatty acid synthetase activity in adipose tissue and liver increase to 
adult levels at weaning from almost undetectable levels during suckling (Girard et al 
1973a; Coupé et al 1990; Perdereau et al 1990; Girard et al 1991; Penicaud et al 
1991; see Girard et al 1992). PEPCK activity in liver and adipose tissue is high 
throughout the suckling period but falls to 2 0 % within 2  hours after a glucose load 
at 21 days (Perdereau et al 1990; Girard et al 1991). Increases in the 
insulin/glucagon ratio precede these changes in enzyme activity (Perdereau et al 1990; 
Girard et al 1991). Weaning to a high-fat diet maintains a high concentration of 
glucagon preventing increases in fatty acid synthetase and ACC in adipose tissue 
(Coupé et al 1990) and liver (Perdereau et al 1990), and allowing hepatic glucokinase 
activity and mRNA, to increase to only 40% of that found in rats weaned to a high- 
carbohydrate diet (Perdereau et al 1990). PEPCK mRNA increases by 30% in liver 
and decreases slightly in adipose tissue whereas enzyme activity decreases (25%) in 
liver and increases (20%) in adipose tissue (Coupé et al 1990; Perdereau et al 1990).
Thus the release of insulin by a high-carbohydrate diet at weaning is important 
for the induction and reduction of enzymes controlling metabolic flux. In the absence 
of insulin and/or glucose these changes do not occur. This would suggest that some 
of the changing enzyme activities at weaning are a result of the changing diet rather 
than an age-related phenomenon (Perdereau et al 1990; Coupé et al 1990).
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1.5.1.1 Insulin Resistance
Another insulin-related characteristic of the suckling-weaning transition is the 
apparent change in insulin resistance/sensitivity. Insulin sensitivity during the 
suckling period is lower than after weaning in the rat (Issad et al 1987 & 1988; 
Girard 1990; Leturque et al 1991), the dog (Varma et al 1973), the lamb (Cowett et 
al 1978) and the human baby (Cowett et al 1983). This insensitivity is based on the 
observation that in suckling rats (13-15 days), unlike weaned and adult rats, insulin 
is unable to inhibit hepatic glucose production (Issad et al 1987). In suckling rats, 
a glucose infusion or oral dose produces marked hyperglycaemia which increases with 
continued perfusion. However, in the weaned rat the circulating glucose levels 
remained constant throughout the infusion period. After 90 minutes infusion, insulin 
levels in weaned rats had increased 2 -fold whereas a 15-fold increase was seen in 
suckling rats (Issad et al 1987). Thus reduced insulin production cannot be an 
explanation. Binding studies have demonstrated that insulin-receptor binding does not 
appear to differ between suckling and weaning (Blazquez et al 1976), and thus the 
insensitivity would appear to be a post-receptor effect. The differences in glucose 
concentrations can only be explained by either continued production of glucose by the 
liver (and to a lesser extent, kidney) or by a reduced capacity for glucose removal 
(Issad et al 1987).
The increase in insulin levels with glucose infusion in suckling rats does not 
reduce glucagon levels to post-weaning basal levels and since glucagon is able to 
exert anti-insulin effects on the liver this may inhibit the effects of insulin in reducing
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hepatic glucose production (Felig et al 1979). Moreover, glucose production is 
mainly via gluconeogenesis and not glycogen breakdown, during the suckling period 
(Ferré et al 1977) and since gluconeogenesis is less susceptible to inhibition by insulin 
than glycogenolysis, this might allow hepatic glucose production to continue despite 
the elevated circulating glucose levels (Issad et al 1987).
Recent research into insulin insensitivity during the suckling period has centred 
on the efficiency of glucose transporter systems (GLUT). In vitro studies in rat 
skeletal muscles and adipocytes have shown that the protein concentrations and 
mRNA for GLUT 4 were elevated 2- to 3-fold in weaned rats compared to suckling 
rats. GLUT 4 protein and mRNA levels were stimulated by insulin and found to be 
3-fold higher in high-carbohydrate weaned rats than in suckling or high-fat weaned 
animals. In contrast, GLUT 1 concentrations and mRNA remained similar in 
suckling rats and rats weaned to both a high-fat and high-carbohydrate diet. Thus 
GLUT 1 appears to be unaffected by nutritional or developmental factors whereas the 
low levels of GLUT 4 may account for the reduced sensitivity of suckling rats and 
rats weaned to a high-fat diet, to insulin (Leturque et al 1991; see Wallace et al
1992).
1.5.2 GLUCAGON
Glucagon is secreted by the a-cells of the pancreas when glucose 
concentrations are low and acts to maintain glucose homeostasis and to ensure 
sufficient metabolite supplies to essential organs. Glucagon levels are high (400-500
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pg/ml) throughout the suckling period (Girard et al 19736) and only begin to fall to 
adult levels as the carbohydrate content of the diet increases (see Figure 1.6). 
Glucagon and insulin have largely opposing actions and thus glucagon stimulates 
gluconeogenesis, glycolysis, jS-oxidation and ketogenesis (Exton et al 1981; Wagle 
1974; Vandenheede et al 1976; Plas & Nunez 1976; Sugden et al 1980; McGarry 
& Foster 1980; Rodbell 1980; Groen et al 1983; Sistare & Haynes 1985) and inhibits 
glycogen synthesis and fatty acid synthesis (Exton et al 1981; Witters et al 1979) in 
the adult.
In contrast with insulin, the mechanisms by which glucagon exerts its effects 
are well understood. Glucagon-receptor binding in plasma membranes stimulates 
adenylate cyclase (Johnson & Mukku 1979; Rodbell 1980) and release of cAMP 
(Exton et al 1981). The increased cAMP levels then activate cAMP-dependent 
protein kinases, which in turn phosphorylate specific enzymes (Witters et al 1979; 
Exton et al 1981). Phosphorylation causes inactivation of anabolic enzymes and 
stimulation of catabolic enzymes.
Weaning of rats to a high-fat diet maintains the high glucagon levels found in 
the suckling pup and prevents insulin release (Coupé et al 1990). Gluconeogenesis 
and ketogenesis remain high. The stimulus for the onset of the catabolic pathways, 
gluconeogenesis and glycogenolysis, appear to be the change in the insulin/glucagon 
ratio at birth. In the adult, glucagon stimulates ketogenesis and lipolysis but whether 
glucagon is instrumental in the control of these processes during the suckling period 
has not yet been confirmed.
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1.5.2.1 Glucagon Resistance
As with insulin there is some evidence of glucagon resistance during foetal and 
neonatal life. Work by Blazquez and colleagues (Blazquez et al 1976) suggested that 
the presence of high concentrations of glycogen in the foetal liver, despite the adult 
concentrations of glucagon, was due to a reduced sensitivity. The sensitivity of the 
glucagon response does not reach adult levels until 30 days of age. Binding studies 
using I] iodoglucagon suggest that binding at the 15th day of foetal life was only 
1% of that found in adults and remained low throughout foetal life. Glucagon 
binding increased throughout suckling but did not reach adult levels until 90 days 
(Blazquez et al 1976). However the finding that an injection of glucagon into a rat 
foetus can stimulate PEPCK transcription suggests that glucagon sensitivity at this age 
is sufficient to stimulate gluconeogenesis and glycolysis (Hanson et al 1975).
1.5.3 GLUCOCORTICOIDS
The role of glucocorticoids in the development of young mammals has been 
studied by many workers (Henning 1978; reviewed in Henning 1981). In the rat pup, 
corticosterone has been shown to be important in maintaining the actions of other 
hormones and in activating or deactivating enzymes involved with growth and 
nutrition (Plas et al 1973: Plas & Nunez 1976; Henning 1978; Schudt 1979 & 1980; 
Wilson & McMurray 1981).
At birth, concentrations of free corticosterone in the rat decrease rapidly from
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foetal levels to lug/100ml and remain at these levels until about day 12. Thereafter, 
concentrations increase slowly to a peak at 24 days (12ug/100ml) and then fall to 
adult levels (3ug/100ml) (Allen & Kendall 1967; Henning 1978; see Figure 1.6). 
Similar profiles are found for the rabbit and the guinea pig (Allen & Kendall 1967). 
The ontogenic profile for total corticosterone shows a more marked increase from day 
14, but this is counteracted by the increased binding to plasma corticosteroid-binding 
globulin, concentrations of which also rise throughout this period (Henning 1978). 
The percent bound corticosterone increases slowly from 9 days of age to adult values.
The low levels of glucocorticoids found throughout the suckling period may 
be a reflection on the catabolic effects of glucocorticoids. The suckling period is 
essentially anabolic and the counter effects of glucocorticoids can be quite detrimental 
(Sapolsky & Meaney 1986). Indeed, rats administered with glucocorticoids during 
days 2-7 show reduced brain weights and DNA content, and a reduced rate of 
myelination (Howard & Benjamin 1975) which persist throughout life. They also 
exhibit altered social behaviour and learning paradigms (Olton et al 1974; Meaney 
et al 1981).
As with insulin and glucagon, corticosterone activity appears to be lower in 
the neonate than in the adult rat. The secretion of corticosterone in response to stress 
is markedly reduced in the young rat. This has been termed the ‘stress-non- 
responsive period’ and continues into the second week of life. The response is 
greater in foetal life than in the neonate. The negative feedback of glucocorticoids 
found in adults appears to be immature in the neonate since injection of
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dexamethasone into neonates failed to reduce the secretion of glucocorticoids. In the 
adult the initial stress response is followed by an inhibitory phase in which corticoid 
released in response to stress begins to inhibit the adrenocortical activity (Sapolsky 
& Meaney 1986). Secretion of ACTH or reactivity of the adrenal cortex to ACTH 
are the most likely sites of neonatal unresponsiveness (Sapolsky & Meaney 1986; 
Walker et al 1986). ACTH concentrations in plasma do not appear to increase 
appreciably in response to stress until day 14 (Walker et al 1986).
Glucocorticoid administration to suckling and weaning rats did not alter the 
triiodothyronine (T3 ) receptor number (as measured by binding capacity) or 
dissociation constant in the pancreas. However, the receptor number was increased 
2-fold in the suckling rats. Adrenalectomized weaned rat pups show reduced Tg 
binding capacity and a consequential reduction in exocrine enzyme concentrations. 
Administration of glucocorticoids or thyroxine (T4) alone restored the T 3  receptor 
capacity and exocrine enzyme concentrations, and administration of both stimulated 
the levels of pancreatic Tg receptors and enzyme concentrations in an additive 
relationship. Thus the presence of glucocorticoids throughout weaning appears to be 
essential for development of Tg receptors (Lee et al 1991; see section 1.5.4).
Glucocorticoids have been proposed as the major hormone responsible for 
many developmental changes especially around the suckling-weaning transition, acting 
as a cue for many enzymatic changes (Henning 1978; Henning 1981). The increase 
in circulating levels of free corticosterone from day 1 2  occur in advance of the 
suckling-weaning transition and are thought to play a large part in this transition
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period. Certainly some enzymes and hormones appear to be dependent on the 
presence of glucocorticoids for their normal development but most evidence suggests 
that thyroxine has an equally important role in the developmental process (Partridge 
et al 1975; Kumegawa et al 1980).
1.5.4 THYROID HORMONES
Levels of free Tg and T4  increase from birth to peak at 26 and 12 days 
respectively, before falling to adult levels (Walker et al 1980). This significant rise 
in the 2 nd postnatal week has lead to the suggestion that thyroid hormones may play 
an important role in the initiation of weaning (Henning 1981). Indeed, some enzymes 
have been shown to be precociously induced by administration of thyroxine or 
triiodothyronine. Glucokinase has been induced in the presence of glucose in 2 days 
old pups when compared to control pups receiving no thyroxine (Partridge et al 
1975). Intubation of glucose and triiodothyronine to 13 day old rat pups resulted in 
a rapid increase in glucokinase activity within 4 hours (Wakelam et al 1979). 
However, these results have been disputed since intubation causes stress and the 
consequential release of corticosterone (Henning 1981).
T4  regulation of intestinal enzymes has been demonstrated in 
hypophysectomised rats. Decreases in lactase and rises in sucrase and alkaline 
phosphatase are delayed in hypophysectomised rats but are not prevented. Normal 
development of lactase and alkaline phosphatase can be restored by T4  therapy, but 
sucrase requires corticosterone for activation. These results suggest a permissive role
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for thyroid hormones in the development of some enzymes such as sucrase and a 
primary role for others such as lactase, alkaline phosphatase and glucokinase (for 
review see Henning 1981).
Hyper- and hypothyroidism has been investigated in relation to the maturation 
of satiety mechanisms. At 17 days hyperthyroid starved pups showed significantly 
larger food intakes than euthyroid controls. Hypothyroid pups showed delayed food 
uptake (Henning 1981). These results suggest that development of the hunger 
response may be stimulated by the rise in T4  production that occurs in the 2 nd 
postnatal week (Gisel & Henning 1979). Another physiological change cued by 
thyroid hormones is myelination which is delayed in hypothyroid rats and advanced 
in hyperthyroid rats.
Thus thyroid hormones appear to regulate the development of some enzymes 
and physiological responses, but its role in the initiation of weaning remains 
unconfirmed. Since concentrations of both thyroxine and triiodothyronine increase 
to high levels well before the onset of weaning, it seems unlikely that thyroid 
hormones themselves initiate weaning although an indirect action is not precluded (see 
Henning 1981).
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1.6 SUMMARY OF METABOLISM DURING THE SUCKLING-WEANING
TRANSITION
As animals grow they become more mobile, curious and aware of their 
surroundings. With this develops various senses such as sight, hearing and taste. 
Once maturity reaches sufficient levels, these animals begin to sample the mothers 
food and reduce their intake of milk.
Since the adult food tends to contain a higher proportion of carbohydrates and 
a lower proportion of fats than the milk, the pathways involved with metabolism and 
energy production have to adjust at weaning in order to maximise benefits from the 
new food source (see Figures 1.3 & 1.4). The initial response of the weaning animal 
is to accumulate some energy stores which can be used to maintain energy levels in 
the body between feeds and to provide glucose quickly in situations of danger. 
Glycogen stores fulfil these requirements and are quickly replenished at weaning. 
Glycogen stores in muscles are used as immediate glucose supplies if the animal is 
in danger, a situation more likely to occur once the protection offered by the mother 
is removed. In addition the acquisition of the hepatic glycogen stores allows the 
animal to maintain its glucose levels in between meals, which may influence the 
development of a nocturnal feeding pattern and circadian rhythmicity. The 
importance placed on the glycogen stores in the animal are reflected at weaning by 
the continued glucose production by gluconeogenesis, despite exogenous glucose 
uptake, until sufficient stores are established.
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Once glycogen stores are replenished glucose metabolism becomes active via 
glycolysis, and glucose production from other substrates is switched off. In parallel 
with the increased glucose metabolism, use of other fuels becomes less essential and 
these pathways are reduced. Hence fatty acid oxidation, and ketone body production 
and utilization are inhibited. Excess carbohydrates can also be stored as fats and thus 
lipogenesis becomes active.
The metabolic pathways active once weaning is complete are therefore the 
opposite to those found during suckling. Active glucose metabolism and fatty acid 
synthesis remain dominant for as long as a carbohydrate-rich diet is available. In the 
fully weaned animal major changes in metabolism only normally occur during 
starvation or disease although minor shifts follow the natural circadian pattern of 
feeding behaviour.
The hormonal status during the suckling-weaning transition is very important 
in determining the activity of various metabolic pathways (see Figure 1.6). High 
glucagon levels during suckling are able to minimise glucose utilization and maximise 
production by regulating the activity of key enzymes. At weaning glucagon levels fall 
and insulin increases. As a result the activity of key enzymes change increasing 
glucose utilization and storage. Some of these changes can be induced by these 
hormones alone, however others require the presence of other components such as 
glucose for full adjustment.
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The timing of the development of other hormones such as corticosterones and 
thyroid hormone may suggest a role for these hormones in initiating weaning, 
although appreciable levels are found in advance of weaning. These hormones may 
however have vital roles as permissive factors, which enhance the stimulus given by 
other hormones. Thus this type of hormone may be vital for the initiation of weaning 
although their role may be to allow the actions of other hormones rather than through 
a direct activation effect.
In summary, the suckling-weaning transition marks an important 
developmental stage for all mammals, in which metabolic and physical changes occur 
very rapidly. The controlling factors are numerous and include diet, hormones and 
possibly age. Some of the metabolic changes can be induced by hormones, but others 
appear to need the maturity of the animal to reach a specific stage before activity of 
enzymes can be induced.
In most cases the controlling enzymes in a metabolic pathway are those that 
require more than one factor for transcription and induction of activity. This seems 
unlikely to be coincidental, but rather to be a regulatory check point, ensuring that 
each stage of development occurs in the correct sequence. An example of this is the 
delayed activation of fatty acid synthesis, dependent on the filling of glycogen stores 
before redirection of glucose into glycolysis and subsequently into fat synthesis. 
Activation of ACC is delayed at weaning to a high-carbohydrate diet, thereby 
regulating the concentrations of malonyl-CoA and CPT 1 activity. Reduced 13- 
oxidation in turn prevents ketone body synthesis. Thus controlled activation of just
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a few enzymes ensures fine regulation of the entire metabolic system in the healthy 
animal.
Research into the suckling-weaning transition has revealed many of the factors 
involved with the development of nutritional pathways, their regulatory influence and 
the order in which they are expected to become important. This knowledge can and 
has been used in the identification of metabolic problems in human infants (for 
examples see Girard et al 1992) and in some cases the subsequent treatment. Whilst 
the picture is by no means complete, the importance of such work is already apparent 
and the case for continued work very strong.
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1.7 PYRUVATE DEHYDROGENASE
1.7.1 INTRODUCTION
Pyruvate dehydrogenase (PDH) is a complex of enzymes located on the inner- 
mitochondrial membrane of mammalian cells. It is responsible for the essentially 
irreversible oxidation of pyruvate to acetyl-CoA in a series of three reactions (see 
Wieland 1983; Patel et al 1990). The PDH complex is the key regulatory enzyme 
group controlling the direction of carbon flux towards the citric acid cycle or fat 
synthesis and thus the changes in complex activity are of great importance during 
periods of dietary change.
PYRUVATE + COENZYME A + NA D > ACETYL-COA + NADH + CO^
The complex consists of pyruvate dehydrogenase (EC 1.2.4.1; E l), lipoate 
acetyltransferase (EC 2.3.1.12; E2) and dihydrolipoyl dehydrogenase (EC 1.6.4.3; 
E3) (Linn et al 1972). The complex also contains an ATP-dependent kinase and a 
loosely associated Mg^'^'-dependent phosphatase. The lipoate acetyltransferase is 
situated at the core of the complex attached to which is a lipoate flexible arm which 
is able to move to the active sites of the other component enzymes (Reed 1969; see 
Figure 1.7).
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Pyruvate dehydrogenase (El) catalyses the decarboxylation of pyruvate and 
transfers the remaining acetyl moiety to thiamine pyrophosphate (TP?) to produce 
hydroxyethyl-TPP. Lipoate acetyltransferase (E2) then catalyses the transfer of the 
C2 fragment to the lipoic acid arm and the E l is reformed. The acetyl group is 
readily transferred to Coenzyme-A and dihydrolipoyl dehydrogenase reforms the E2 
enzyme by reduction of NAD via the prosthetic group, FAD (see Figure 1.8). The 
resulting acetyl-CoA is used either for fatty acid synthesis via malonyl-CoA or enters 
the citric acid cycle where it is completely oxidised to CO2  (see Wieland 1983). PDH 
therefore controls the rate of carbon flux into fatty acids or the citric acid cycle (see 
Denton & Halestrap 1979).
The absolute amounts of PDH in each tissue and the proportion in the active 
form vary (see table 1.4). These differences reflect the different requirements of each 
tissue and the different metabolic profiles. The heart has a high metabolic rate and 
most of the acetyl-CoA produced is channelled into the citric acid cycle. Also, the 
heart does not synthesis fatty acids and all acetyl-CoA produced enters the citric acid 
cycle, hence PDH activity is high. In contrast, the liver functions mainly as a 
glucose homeostatic organ, and is mainly found in the gluconeogenic state, providing 
glucose for other tissues or storage as glycogen. This is emphasised by the very low 
levels of PDH in the active form in the liver. Adipose tissue functions as a fat store 
and glucose is readily metabolised to acetyl-CoA for fat synthesis, and hence although 
PDH activity is low, the potential for activation is large (see Wieland 1983).
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Figure 1.8 Series of Reactions Catalysed by the Pyruvate 
Dehydrogenase Complex.
CO
^  Pyruvate 
CHg CHOH-TPP Dehydrogenase
Hydroxyethyl-TPP \ f
E2 E2
s— S SH SC0CH3
Lipoate
Acetyltransferase
CoANAD
FADH
Dihydrolipoyl
Dehydrogenase
^  FAD E2
NADH, Acetyl-CoASH SH
The series of reactions involved with the synthesisof acetyl-CoA 
from pymvate, catalysed by pyruvate dehydrogenase complex, is 
shown. E2 represents the lipoate acetyltransferase enzyme with 
attached lipoate group. Reactions catalysed by lipoate 
acetyltransferase and dihydrolipoyl dehydrogenase are reversible, 
although this has not been shown for reasons of clarity.
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TISSUE TOTAL ACTIVITY 
(/imol Acetyl-CoA/min per mg 
DNA at 37“C)
% ACTIVE 
FORM
H eart 4.2 70
Kidney 0.7 65
Liver 0 . 8 17
Adipose Tissue 1 . 2 2 0
Brain 1.5 6 8
Table 1.4 PDH content of various rat tissues in the fed state. The relative total 
activity and the proportion in the active form is shown. Data taken from Wieland 
1983.
1.7.2 CONTROL OF PDH ACTIVITY
Within the complex, the pyruvate dehydrogenase E l activity is essentially 
irreversible but the subsequent steps are reversible (Walsh et al 1976; see Figure 
1.8). It is therefore the E l reaction which is thought to be rate limiting for the entire 
complex. Substrate/product control is exerted by high ratios of ATP/ADP, acetyl- 
CoA/CoA and NADH/NAD^, and pyruvate (Garland & Randle 1964; Bremer 1969; 
Wieland et al 1969; Tsai et al 1973). PDH activity decreases at high concentrations 
of acetyl-CoA and NADH such as are found during high rates of fatty acid oxidation
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and ketogenesis in the heart, liver, kidneys and brain of the rat (Bremer 1969; Kerbey 
et al 1976; Wieland et al 1972; Portenhauser & Wieland 1972) and guinea pig (Ogata 
et al 1975). The end-product inhibitory effects of NADH and acetyl-CoA are thought 
to be mediated via increased reduction and acétylation of the lipoyl group of the E2 
enzyme (Wieland 1983; Patel et al 1990), which in turn decrease the concentration 
of oxidised lipoic acid, thereby inhibiting E2 activity. As a consequence, E l activity 
is reduced since it is unable to transfer the acetyl moiety to the E2 enzyme (Denton 
et al 1975). The Kz for acetyl-CoA (5-lOjuM) and NADH (40//M) are similar to the 
Yjh values for CoA (SfxM) and NAD"  ^ (50^M) (Bremer 1969) and hence it is the 
ratios of these factors that are likely to be the controlling factors rather than the 
absolute values. However, the regulatory effects of ATP/ADP, acetyl-CoA/CoA, 
NADH/NAD^ and pyruvate are also due to their action on the PDH kinase and 
phosphatase (Kerbey et al 1976; Dennis et al 1979; Wieland 1983).
1.7.3 PYRUVATE DEHYDROGENASE KINASE
Phosphorylation of the PDH complex, and hence inactivation, is catalysed by 
PDH kinase and occurs during periods of starvation, high-fat oxidation and diabetes 
(see Randle et al 1988). This ATP-dependent kinase is found as an integral part of 
the PDH complex bound to the E2 subunit of the complex (Li et al 1992), and as an 
unbound form, known as kinase activator protein (KAP), in heart, skeletal muscle and 
liver (Kerbey & Randle 1982; Kerbey et al 1984; Denyer et al 1986; Mistry et al 
1991; Priestman et al 1992). Tight binding of the kinase to the PDH core allows a 
rapid 5-fold increase in the activity of the kinase and hence fast control of the PDH
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activity (Li et al 1992; Radke et al 1993). PDH kinase phosphorylates the a-subunit 
of the E l component of the complex causing a marked decrease in the (Yeaman 
1986). Phosphorylation has been shown to occur at three serine residues per 
molecule of bovine kidney PDH (Davis et al 1977; Sugden et al 1978; Yeaman et al 
1978). Phosphorylation of the first site is sufficient to inactivate the complex and 
occurs much faster than phosphorylation of the other sites (Barrera et al 1972; Davis 
et al 1977; Yeaman et al 1978; Sugden et al 1978). The reasons for phosphorylation 
at the second and third sites are not clear, but reactivation has been shown to be 
delayed in the presence of additional phosphorylated sites (Sugden et al 1978) and this 
may prove to be important as a method for controlling the carbon flux during 
refeeding after starvation, glucose feeding at weaning or in other situations where the 
glycogen stores have become depleted.
PDH kinase activity can be increased by the action of NADH and acetyl-CoA 
suggesting that the effects of these compounds are not solely allosteric inhibitors of 
the dihydrolipoyl dehydrogenase but may also be stimulators of PDH kinase (Pettit 
et al 1975; Cate & Roche 1978). Acetyl-CoA is unable to stimulate the kinase in the 
absence of NADH. Inhibition of the dihydrolipoyl dehydrogenase is thought to result 
from NADH reduction of the lipoyl group which allows interaction of the lipoyl 
group with the kinase and hence activation (Cate & Roche 1978).
The long-term maintenance of inactivity by phosphorylation during starvation 
or diabetes appears to be due to increased concentrations of PDH kinase activator 
protein (KAP) in the heart (Kerbey & Randle 1982) and liver (Denyer et al 1986;
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Priestman et al 1992). The activity of KAP in heart mitochondria is increased 3 to 
6 -fold in 48 hour starved adult rats (Kerbey & Randle 1982). Puromycin and 
cycloheximide partially and completely prevented this increased activity respectively, 
thereby suggesting at least some synthesis of new enzyme (Kerbey & Randle 1982). 
Hepatic KAP purified from starved rats shows a 4-fold increase in specific activity 
compared to fed rats (Priestman et al 1992). Refeeding restores PDH complex 
activity and KAP concentrations fall to normal levels within 20 hours (Priestman et 
al 1992).
PDH kinase has been shown to be sensitive to glucagon and zz-octanoate 
(Fatania et al 1986). A 2.5-fold increase in PDH kinase activity was seen after 
administration of 55nM glucagon and ImM zz-octanoate to long-term cultures of rat 
hepatocytes. The addition of glucagon and octanoate mimics the effects of starvation, 
diabetes or suckling (Fatania et al 1986).
PDH kinase activity is inhibited by dichloroacetate, causing activation of the 
PDH complex in the rat heart, kidneys, adipose tissue, liver and diaphragm 
(McAllister et al 1973; Whitehouse & Randle 1973; Dennis et al 1979; Whitehouse 
et al 1974) and in purified pig heart PDH complex (Whitehouse & Randle 1973). 
This effect of dichloroacetate to reduce phosphorylation of the PDH complex is 
exerted by a direct effect on the kinase (for review see Crabb et al 1981).
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1.7.4 PYRUVATE DEHYDROGENASE PHOSPHATASE
Dephosphorylation of the PDH complex and hence activation, is catalysed by 
PDH phosphatase. PDH phosphatase action is dependent on the presence of 
and can be further stimulated by Ca^ "^  in white adipose tissue and pig heart (Severson 
et al 1974; Thomas et al 1986). Ca^ "^  appears to decrease the of the phosphatase 
for Mg^ "^  rather than altering the V„,ax (Thomas et al 1986; Midgley et al 1987). 
Activation of PDH by PDH phosphatase, using toluene-permeabilized mitochondria 
from white adipose tissue, showed a lag period of 5-10 minutes before maximal 
activation was achieved in the presence of 0.18mM Mg '^^. This lag period however 
was abolished in the presence of saturating concentrations of Mg^ "^  (1.8mM). The 
lag period is also reduced when phosphorylation of the PDH complex is low (Midgley 
et al 1987).
Control of PDH activity by hormones such as adrenaline and vasopressin 
appears to be via increases in the intramitochondrial Ca^ "^  concentrations (Hems et al 
1978; see Denton et al 1987), which in turn stimulate PDH phosphatase, in the liver 
and heart. Intracellular Ca^ "^  is released by the hormone into the cytosol and then 
carried via Ca^ "^  transporters, into the mitochondria (Yeaman 1986). Removal of 
extracellular Ca '^  ^ does not affect the response of hepatic PDH to the hormones but 
removal of intracellular Ca '^  ^with EGTA markedly impairs the response (Blackmore 
et al 1978; Blackmore et al 1982). Similar responses were found by Cheng & Lamer 
(1985) in rat adipocytes where «j-adrenergic agonists, vasopressin and angiotensin II 
stimulated PDH activity and lipogenesis by mobilisation of intracellular Ca^ "^ .
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Whether these effects are due to direct binding of the calcium to the phosphatase or 
indirectly after binding to an unknown activator molecule is not yet known. Insect 
and plant PDH does not exhibit sensitivity to the actions of Ca^ "*" as a second 
messenger and this responsiveness appears to only occur in higher animals 
(McCormack & Denton 1986; see Denton et al 1987).
1.7.5 INSULIN ACTIVATION OF PDH
Insulin stimulates PDH activity in adipose tissue and to a lesser extent, the 
liver, but does not alter the total PDH content (Coore et al 1971; Jungas 1971; 
Wieland et al 1972; Assimacopoulos-Jeannet et al 1982; Caterson et al 1982; Kilgour 
& Vernon 1991; see Wieland 1983). However, cardiac PDH appears to be 
insensitive to insulin stimulation (Caterson et al 1982). The stimulatory effects of 
insulin on PDH are not thought to arise from an increased rate of glucose transport 
into cell and hence substrate supply, but instead are due to reduced phosphorylation 
and subsequent activation of the PDH complex (Coore et al 1971; Jungas 1971; 
Wieland et al 1972; Wieland et al 1972; Taylor et al 1973; Seals & Jarett 1980). 
Insulin does not appear to affect the acetyl-CoA/CoA, NADH/NAD or ATP/ADP 
ratios or the kinase activity (Hughes & Denton 1976; Denton et al 1978; Popp et al 
1980) but to increase the PDH phosphatase activity (Mukherjee & Jungas 1975; Popp 
et al 1980; Denton et al 1984; Thomas & Denton 1986). This has been shown by 
noting that insulin activity is absent when PDH phosphatase is inhibited but retains 
its stimulatory actions in the absence of kinase activity (Mukherjee & Jungas 1975; 
Popp et al 1980).
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Although the actions of most other hormones on PDH are thought to be linked 
to release of Ca^ "^  and cAMP, albeit by different mechanisms, the actions of insulin 
are not (Cheng & Lamer 1985; Marshall et al 1984; Denton et al 1984; see Yeaman 
1986). This conclusion is based on the evidence that insulin activation is not 
prevented by Ruthenium Red (which inhibits transfer of Ca^ "^  into mitochondria) and 
that the other mitochondrial dehydrogenases, NADH-isocitrate dehydrogenase and 
oxoglutarate dehydrogenase, are not stimulated by insulin although they are activated 
by Ca^ "^  release (Marshall et al 1984; see Denton et al 1987). There have been 
several reports of insulin stimulating the release of a factor which activates PDH 
phosphatase causing the dephosphorylation and subsequent activation of PDH in vitro 
(Seals et al 1979; Popp et al 1980). In 1979, Seals and colleagues reported the 
release of a unique second messenger by insulin after binding to a specific receptor 
on the plasma membrane of rat adipocytes (Seals et al 1979). The stimulatory effects 
of insulin could be mimicked by the addition of concanavalin A (a mitogen) or 
insulin-receptor antibodies to adipocytes (Seals & Jarrett 1980). In each case, 
activation of PDH was only seen in the presence of the plasma membrane and could 
not be induced in mitochondrial preparations alone, suggesting that the actions of 
insulin are mediated by a factor released or activated by the plasma membrane which 
is transmitted to the mitochondria (Denton et al 1984; Thomas & Denton 1986). 
Since the purified insulin-dependent activator had its isoelectric point at pH 4.5 and 
was susceptible to destmction with proteases, it was concluded that the activator was 
a negatively-charged peptide compound (Seals & Czech 1980).
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Insulin stimulation of the phosphatase was also shown to be mimicked by 
spermine-like polybasic compounds in purified pig heart and ox kidney PDH 
phosphatase (Damuni et al 1984). Similar results are obtained using intact 
mitochondria from adipose tissue, in which spermine and similar compounds reduce 
the Ka of PDH phosphatase for Mg^ "^  both in the presence and absence of Ca^ "^  
(Thomas & Denton 1986). Attempts to reproduce these effects in toluene- 
permeabilized mitochondria failed despite spermine being a small, highly charged and 
therefore easily transferred molecule (Thomas & Denton 1986; Denton et al 1987). 
Recent work has examined the effects of spermine-like compounds on PDH 
phosphatase activity in electropermeabilized fat-cells and found activation of the PDH 
complex (Rutter et al 1992). However, since immediate changes in spermine 
concentrations were not seen after addition of insulin, it is suggested that spermine 
and similar compounds may be responsible for the long-term effects of insulin, but 
possibly not the acute response (Rutter et al 1992).
The activation of PDH by insulin in adipose tissue is much higher than in liver 
in the fed state, reflecting the need for very high rates of carbon channelling into fats. 
Indeed, insulin action is associated with a parallel rise in the lipogenic rate in adipose 
tissue (Coore et al 1971; Weiss et al 1974; Caterson et al 1982). Similar stimulatory 
effects of insulin on PDH activity in white adipose tissue are also seen in brown 
adipose tissue (Denton et al 1977; Paetzke-Brunner et al 1979) and lactating rat 
mammary glands (Baxter & Coore 1978 & 1979).
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The stimulatory action of insulin on the liver is attributed to a reduction in the 
circulating concentrations of free fatty acids (Wieland et al 1972). Simultaneous 
intravenous injection of oleate reversed the effects of insulin (Wieland et al 1972). 
The results for activation of PDH by insulin in hepatocytes are conflicting, since 
some workers report increased activity in hepatocytes isolated from fed rats in the 
presence (Assimacopoulos-Jeannet et al 1982) and absence of glucose (Wieland et al 
1972) and others report increased activity only in hepatocytes from starved rats 
(Marchington et al 1987).
Thus insulin stimulation of PDH activity has been shown to be extensive in 
adipose tissue and to occur via stimulation of the PDH phosphatase (see Wieland 
1983). Stimulation is much lower in the liver and negligible in the heart (Caterson 
et al 1982). This probably reflects the different metabolic roles of these tissues 
within the mammal, adipose tissue being mainly responsible for the production of fat 
and hence requiring substantial amounts of substrate. Since basal PDH activity is 
much higher in the heart than in adipose tissue or liver, even during starvation, and 
cardiac acetyl-CoA is not required for fatty acid synthesis, the added demand for 
PDH activation is minimal when insulin levels are raised.
1.7.6 PYRUVATE DEHYDROGENASE ACTIVITY DURING THE
STARVED-REFED TRANSITION
Many of the metabolic changes occurring during the starved-refed transition 
have similarities with those found during the suckling-weaning transition (see Sugden
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et al 1989; Girard et al 1992). After prolonged starvation refeeding causes changes 
in metabolism from oxidation of fatty acids, ketogenesis and gluconeogenesis, to 
lipogenesis and glycogen storage with concomitant changes in the activity of some 
regulatory enzymes. Parallel alterations in the metabolic fuel is found during the 
suckling-weaning transition although the source of the fuel is different (see Girard et 
al 1992). Fats metabolised during the suckling-weaning transition are provided in the 
milk obtained from the mother; in the starved animal, fats are released from 
endogenous sources. The starved-refed transition requires the adaptation of the 
metabolic pathways from using endogenous fats as the main fuel, to using an 
exogenous diet normally higher in carbohydrates. The suckling-weaning transition 
requires the adaptation from oxidation of fats supplied in the maternal milk, to use 
of exogenous carbohydrate as the main food source. Although differences exist 
between the two situations described, the similarities mean that some indication of the 
adaptations in metabolic enzymes may be drawn from studies of the starved-refed 
transition and investigated with respect to the suckling-weaning transition, and in this 
instance PDH during the suckling-weaning transition.
The increased concentrations of acetyl-CoA and NADH arising from the j8 - 
oxidation of fatty acids during starvation, activate PDH kinase and inhibit the PDH 
activity in adipose tissue, liver, kidney, skeletal muscle and heart, and activity 
remains low until refeeding (Wieland et al 1972; Patzelt et al 1973; Kerbey et al 
1976; Fuller & Randle 1984; Denyer et al 1986; Fatania et al 1986; Holness et al 
1986; Marchington et al 1987).
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The reactivation rate for PDH varies from tissue to tissue and is dependent on 
the length of the starvation period (Holness & Sugden 1989; Sugden et al 1993). 
Skeletal muscle PDH is restored to 50-80% within Ihr of refeeding after 48hrs 
starvation. In contrast, liver PDH requires 4hrs to resume its original activity and 
heart more than 8 hrs (Sugden & Holness 1990). For shorter periods of starvation, 
the activation rates are increased, with cardiac PDH activity being restored to 75% 
and 35% of fed levels within Ihr of refeeding following 6 hr and 24 hr starvation 
periods respectively (Holness & Sugden 1989). This may reflect the differences in 
glycogen content of the various tissues, the effectiveness of long-term inhibitory 
factors and the degree of phosphorylation of the enzyme (Sugden et al 1978; Kerbey 
& Randle 1982; Denyer et al 1986; Holness et al 1988). It has also been suggested 
that the delayed reactivation especially in the heart may result from increased levels 
of KAP and hence higher PDH kinase activity (Kerbey & Randle 1982; Denyer et al 
1986). However, the difference in the rate of activation in the liver and heart would 
suggest that other factors may also be involved (Holness & Sugden 1989).
The lag period found between refeeding and PDH activation allows rapid 
replenishment of glycogen stores, especially in the liver, in advance of increased 
metabolism of glucose to acetyl-CoA (Sugden & Holness 1990). Hepatic 
gluconeogenesis remains active for up to 6 hrs after refeeding despite increased 
glucose being supplied by the diet, but the glucose 6 -phosphate appears to be directed 
towards glycogen synthesis rather than glucose release (Sugden et al 1983). 
Lipogenic rates in the liver increase only very slowly at refeeding after a 48hr 
starvation period (Holness et al 1988). PDH activity remains low for 3-4hrs after
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refeeding preventing the movement of carbohydrate derivatives into the citric acid 
cycle for complete oxidation to CO2  or direction into fat stores (Holness et al 1988). 
Glycogen stores are replenished faster as a result of the reduced pyruvate metabolism 
and prolonged gluconeogenesis. When glycogen stores are essentially replenished 
PDH levels increase to allow carbon flow into lipogenesis and the citric acid cycle 
(Holness et al 1988).
In conclusion, the importance of PDH as a regulatory enzyme controlling the 
irreversible flux of glucose into fats and the citric acid cycle have been highlighted 
by work on the starved-fed transition period (see Sugden et al 1989). The fine 
control exerted by PDH allows glucose stores to be used to maximum benefit during 
starvation and allows cautious restoration of the fed metabolic status upon refeeding.
1.8 RESEARCH PROPOSAL AND AIMS OF THESIS
Since hepatic PDH activity is critical for the distribution of glucose-derived 
carbon into glycogen or fatty acids, it occupies a pivotal role in the direction of 
metabolism of the increased dietary carbohydrate intake found at weaning. Very little 
information is available for the development of PDH in the liver or other tissues 
(Cremer & Teal 1974; Knowles & Ballard 1974; Bailey et al 1976; Land et al 1977; 
Chitra et al 1985; Issad et al 1989; Serrano et al 1989; Maury et al 1992; Sperl et 
al 1992). In view of this, a detailed study of PDH activity around the suckling- 
weaning transition has been undertaken with the aim to increase our knowledge of the 
‘normal’ situation and the role PDH plays in directing metabolism around this time.
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I have investigated whether hepatic PDH constrains the direction of carbon into 
lipogenesis at weaning, thus allowing use of glucose for replenishment of glycogen 
stores before surplus carbon is channelled into lipogenesis for triglyceride storage in 
the liver and other tissues.
The experimental approach that was adopted is outlined below. Initially, the 
normal development of active PDH was measured since previous studies were 
inadequate and incomplete. This was used as a baseline against which manipulations 
of the normal spontaneous weaning pattern could be compared. In order for 
comparisons to be made with the development of other glucose metabolising enzymes 
which are often carried out using imposed weaning conditions, measurements of 
active PDH were also made throughout development when weaning was imposed at 
20 days by the removal of the mother from the cage. Activity was measured in the 
liver because of its pivotal role in glucose metabolism and in the heart in which the 
metabolic priority is energy production and which serves as an extreme for 
comparison.
The dietary conditions at weaning were further altered by firstly weaning to 
a high-fat diet that resembled the maternal milk in fat content and secondly by 
weaning at an earlier age (18 days). These studies were undertaken in an attempt to 
show whether the changes seen at weaning were solely age or diet related or a 
combination of both.
98
In an attempt to establish whether changes in activity were due to activation 
of enzyme already present or due at least in part, to enzyme synthesis, total PDH 
activity was measured in rats weaned at 2 0  days to both the chow (high-carbohydrate) 
and the high-fat diet. These studies were extended to adults weaned either 
spontaneously, or at 2 0  days to high-carbohydrate or high-fat diets, to see if different 
weaning conditions had any prolonged effects on total PDH content.
PDH kinase mRNA activity was investigated using Northern blots in order to 
determine the developmental profile for the transcription of this enzyme. Changes 
in the levels of this enzyme may influence the activity of PDH throughout 
development and provide us with information about the mechanisms involved with 
changes in PDH activity throughout the suckling-weaning transition.
Liver glycogen was determined throughout this work since the timing of PDH 
activation in comparison with glycogen stores being filled may provide information 
about the role of PDH in directing metabolism at weaning. Replenishment of 
glycogen stores in advance of hepatic PDH activation would suggest that PDH is 
contributory to promoting glycogen synthesis before lipogenesis.
Finally, insulin levels were measured since insulin is known to have a small 
stimulatory effect on hepatic PDH and levels are known to increase with weaning to 
a high-carbohydrate diet.
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CHAPTER 2
PYRUVATE DEHYDROGENASE ACTIVITY DURING 
SPONTANEOUS WEANING
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Pyruvate Dehydrogenase Activity During Spontaneous Weaning
2.1 INTRODUCTION
Under natural conditions, rats begin to wean around day 16 and continue for 
10-12 days. The uptake of milk slowly decreases and carbohydrate intake increases 
throughout this transition (Redman & Sweney 1976). Over this period the content of 
the diet changes from around 50% fat, 40% protein and 10% carbohydrate to 20% 
fat, 20% protein and 60% carbohydrate (wt/wt Jennesse 1974, see Figure 1.1). 
Around 28-30 days the mother ceases to lactate and the pups are therefore completely 
dependent on food found for themselves. Gradual weaning allows slow adaptation 
of the metabolic profile to accommodate the change in diet and is generally termed 
‘natural’ or ‘spontaneous’ weaning. For the purposes of this thesis this transition will 
be referred to as spontaneous weaning.
The information available about spontaneous weaning in most mammals and 
its effects on the metabolic enzymes is somewhat limited since for most purposes the 
faster, more dramatic changes associated with weaning enforced by removal of the 
mother at around 20 days are more interesting (see Vernon & Walker 1968a; 
Lockwood & Bailey 1971). Details about enforced weaning give indications of the 
potential for acute stimulation, inhibition and control of enzymes (for examples see 
Coupe et al 1990; Perdereau et al 1990 and Tables 1.1-1.3). In contrast however, 
the advantages of spontaneous weaning investigations are that the ‘natural’ change is 
measured, giving information about the normal changes in enzyme control, activity
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and hormonal sensitivity and any potential stress effects caused by the sudden removal 
of the mother are eliminated. In addition, the clinical situation to which work of this 
nature might be applied, resembles spontaneous weaning more closely than imposed 
weaning.
PDH is an important regulatory enzyme, responsible for the controlling the 
metabolism of pyruvate by the citric acid cycle and fatty acid synthesis. The further 
fate of the acetyl-CoA varies from tissue to tissue depending on their functions and 
metabolic requirements. The liver requires production of acetyl-CoA mainly for use 
in fat synthesis, adipose tissue uses acetyl-CoA almost exclusively for fat synthesis 
but in the heart, the high energy demands of contraction mean that acetyl-CoA is 
channelled into the citric acid cycle for energy production. In situations of reduced 
availability of glucose such as starvation and diabetes, when gluconeogenesis is high, 
PDH activity is normally low (see Randle et al 1988; Sugden et al 1989; section 
1.7.6). Activation occurs as glucose concentrations rise. By comparison, it therefore 
follows that PDH activity might be expected to be low during suckling to allow 
conservation of minimal glucose supplies and to rise after weaning.
Although many regulatory enzymes have been studied throughout 
development, PDH has received very little attention either for spontaneous or 
enforced weaning. Cremer & Teal (1974) and Land et al (1977) investigated PDH 
activity in rat brain homogenate and found it to increase throughout suckling. Studies 
into PDH activity in the liver (Knowles and Ballard 1974; Bailey et al 1976) and 
adipose tissue (Knowles and Ballard 1974; Bailey et al 1976; Maury et al 1992) have
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so far been limited to very few ages, normally just before and just after weaning but 
not covering the changes at the suckling-weaning transition.
Hence, in order to investigate the impact of the change of diet on metabolic 
enzymes at spontaneous weaning, PDH activity was measured in pups left with their 
mother until 36 days of age. Activity was measured in the liver since this is a major 
site of control of lipogenesis and in the heart, a muscle with a high energy 
requirement and thus a completely different metabolic profile to the liver. The 
activity of PDH during spontaneous weaning has been measured using the standard 
spectrophotometric assay. In addition, hepatic glycogen content and citrate synthase 
activity have been measured.
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2.2 MATERIALS AND METHODS
2.2.1 Animals
Male Wistar Albino Rats of the University of Surrey strain were used for all 
experiments. They were housed under conditions of a constant temperature range of 
19-22°C and humidity of 45-50%, with a regular light-dark cycle (lights on at 0700 
and off at 1900). The rats had free access to water and standard laboratory chow 
which contained 67% carbohydrates, 6 % fat and 27% protein (% calorific content). 
The day of birth was taken as day 1 throughout this work. Litters were culled to 10 
within the first 72 hours of life and housed with the mother until 36 days.
Expressed values for PDH represent the mean value of > 4  rats from 2 or 
more litters and were measured on more than one day.
2.2.2 Dissection of Tissues
All dissections were performed between 0800 and 0930 hours. Rats were 
anaesthetised by intraperitoneal injection of 8 mg pentobarbitone/saline solution per 
lOOg body weight (see French et al 1986). Dissection was begun once levels of 
anaesthesia were found to be sufficiently deep, as assessed by paw pinch (usually 2-5 
minutes). A midline abdominal incision was made through the ribs and the sternum 
removed, exposing the heart. The heart was rapidly excised and frozen between 
metal tongs that had previously been cooled in liquid nitrogen. The frozen tissue was
104
wrapped in aluminium foil and placed in liquid nitrogen. The liver was quickly 
excised and frozen in the same way. Samples were then kept in liquid nitrogen for 
assay later the same day. The time lapse between the initial puncture of the 
diaphragm and freezing the liver did not exceed 2 0  seconds.
Occasionally, animals between 14 and 20 days appeared to be more resistant 
to the pentobarbitone than the adults, exhibiting delayed or shallow anaesthesia after 
the same dose per g whole animal. In these cases, one further dose of approximately 
10% of the original dose was given. Rats still resistant were excluded from the 
experiment.
2.2.3 Materials
The dye, p-(p-acetylaminophenylazo)-benzenesulphonate (AABS) was kindly 
donated by Drs M. Sugden and M. Holness, Queen Mary & Westfield College, 
London. Initially pigeon liver acetone powder was purchased from Sigma chemicals, 
Poole, but some supplies were also donated by Drs. S. Mistry and D. Priestman, 
John Radcliffe Hospital, Oxford University. Pyruvate was supplied by BDH 
Chemicals, Poole. All other chemicals were purchased from Sigma Chemicals, 
Poole.
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2.2.4 Assay of Active Form of Pyruvate Dehydrogenase 
2.2.4.1 Sample Preparation
PDH activity was measured using the methods of Coore et al (1971) with the 
addition of 5% Triton. Samples were analyzed on the same day as removal of 
tissues. Frozen tissue samples were crushed with a heavy weight and 200mg 
homogenized in 500/liI of phosphate buffer (pH 7.8) containing 50mM KH2 PO4 , 
50mM K2 HPO4 , 5mM EDTA, lOmM EGTA, 300uM tosyl-lysyl-chloromethylketone 
(TLCK), ImM benzamidine, lOmM pyruvate, lOuM leupeptin and 2mM 
dithiothreitol. A Potter homogeniser, equipped with a Teflon pestle, was used at 
ISOOrpm giving 30 strokes for heart and 20 for liver. A further 500/^1 of the above 
buffer containing 5% Triton was added and mixed with the homogeniser on a slow 
speed before transferring the homogenate to an Eppendorf tube and freezing in liquid 
nitrogen. Two samples of liver were used for each animal and one of heart.
Samples were freeze/thawed three times in liquid nitrogen and a water bath 
at 30°C in order to assist disruption of the mitochondria. After centrifugation at 200g 
for 1  minute to clarify the samples, the supernatant was transferred to a clean 
eppendorf tube and stored in liquid nitrogen until activity measurements were 
performed.
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2.2.4.2 Measurement of Activity of Pyruvate Dehydrogenase
PDH activity was measured spectrophotometrically by recording the change 
in absorbance of the yellow dye, AABS, a p-nitroalanine derivative, as it was 
acetylated. The reaction of PDH with pyruvate produces acetyl-CoA, the acetyl 
group of which is transferred to the dye using a following enzyme, arylamine 
acetyltransferase (AAT; see section 2.2.5), causing it to change colour and 
absorbance at 460nm. The activity of the A AT is limited by the activity of the PDH.
Activity was measured in 750/xl of lOOmM Tris HCl buffer, pH 7.8, 
containing ImM MgCl, 0.5mM EDTA, 0.02mg/ml AABS dye and 0.3/xl/ml 
mercaptoethanol. 7.5jLtl of NCT solution (containing 500jlcM NAD"^, 130jnM 
Coenzyme A and ImM thiamine pyrophosphate)7.5/il of luM pyruvate and 5/xl of 
AAT were added and the blank rate recorded before addition of the homogenate and 
measurement of activity. The actual volume of homogenate added to the cuvettes 
depended on the tissue used and the PDH activity of the tissue, but in general 30/xl 
liver homogenate and lOfil of heart homogenate were added to a total volume of 
0.77ml of buffer and cofactors. These differences in volume were accounted for in 
the calculations.
Changes in the absorbance of the AABS were measured at 460nm for 10 
minutes. The activity of PDH was found to be linear between 3 and 10 minutes and 
these latter 7 minutes were used for calculations. The lag phase seen during the first 
three minutes is probably due to the slow rate of AABS acétylation at the low initial
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concentrations of acetyl-CoA.
1)
Calculations were performed using a molar extinction coefficient of 6.5x10 
^Imol'^cm'^ for the unacetylated AABS dye. Activity is expressed as a ratio to citrate 
synthase to correct for any differences in mitochondrial extraction (see section 2 .2 . 6 ). 
A unit refers to the conversion of I/jM  of pyruvate to acetyl-CoA per minute at 3(PC.
2.2.5 Purification of Arylamine Acetyltransferase
AAT was purified from pigeon liver acetone powder (supplied by either Sigma 
or Drs Mistry and Priestman, John Radcliffe Hospital, Oxford University) by 
continual extraction with acetone (Jacobson 1961). lOg of the pigeon liver acetone 
powder was homogenized in 100ml of ice-cold distilled water for 3 minutes and 
centrifuged at 5000g for 15 minutes. The supernatant was retained and the pellet re­
extracted by homogenising with a further 1 0 0 ml of water, centrifuging and combining 
the two supernatants. Ice-cold acetone was added drop-wise to the supernatant, with 
continuous stirring, to a concentration of 28% (v/v). Throughout the rest of the 
procedure the extraction mixture was held at -10°C by the addition of aluminium 
chloride to the surrounding ice bucket. After centrifugation at 5000g, the supernatant 
was again retained and further acetone added to a concentration of 40% (v/v). After 
centrifugation, the acetone concentration was increased to 47% (v/v) and centrifuged. 
The pellet was resuspended in a minimum amount of lOmM potassium phosphate 
buffer at pH 7.0 and the supernatant retained. Acetone was added to the supernatant 
to give a final concentration of 58% (v/v). The acetone solution was centrifuged and
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the pellet resuspended in potassium phosphate buffer and combined with the first 
suspension. Residual acetone was removed by blowing oxygen/carbon dioxide over 
the AAT solution. 200jnl aliquots were stored at -20°C. Activity was measured in 
PDH system with 20jitl of S.lmg/ml acetyl-CoA solution in 750^1 of the Tris HCl 
buffer (section 2.2.4.2) and found to range between 2-4 U/ml depending on the batch 
of liver acetone powder.
2.2.6 Measurement of Citrate Synthase Activity
Citrate Synthase activity (EC 4.1.3.7) was measured in frozen homogenised 
samples retained from the PDH assays, to correct for any differences in the efficiency 
of mitochondrial extraction, according to the methods of Srere et al (1950) and 
modifications of Coore et al (1971). The reaction of acetyl-CoA with oxaloacetate 
in the presence of citrate synthase released Co A, which reacted with a yellow dye, 
5,5’-dithiobis-2-nitrobenzoic acid (DTNB), causing cleavage of the disulphide bond 
and releasing a mercaptide ion. The released mercaptide ion absorbed light at 412nm 
and the changes in absorbance were recorded spectrophotometrically.
Homogenates from the PDH assay were diluted in lOOmM Tris HCl buffer 1:5 
(v/v) for liver and 1:25 (v/v) for heart. 20^1 of lOmM acetyl-CoA, 20jLtl of lOmM 
DTNB and 20/^ 1 of diluted homogenate were added to 1.5ml of lOOmM Tris HCl 
buffer, pH 8.0 and the blank rate activity measured for 5 minutes at 30°C. 20/>il of 
75mM oxaloacetate was added to activate the citrate synthase and activity was 
measured for a further 5 minutes. Citrate synthase activity was expressed per g wet
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3lweight of tissue and calculated using a molar extinction coefficient of 13.6x10 Imol' 
c^m'^  for the mercaptide ion, and subtracting the blank rate.
2.2.7 Measurement of Glycogen Content of Liver
Liver samples stored at -2CfC after PDH assays were used for glycogen 
measurements (Keppler & Decker 1974). After homogenisation of liver 1:5 in 3.5% 
perchloric acid (w/v), 200/xl aliquots were incubated with lOOjul of IM KHCO3  and 
2ml acetate buffer containing Img/ml amyloglucosidase, for 2 hours at 40°C. 
Samples were neutralised with solid KHCO3  (using Universal indicator to mark the 
end-point), and centrifuged for 15 minutes at 1500g. 10/xl of the supernatant was 
used for measurement of the glucosyl units using a Sigma Hexokinase diagnostic kit, 
containing hexokinase, ATP and NAD. Samples were incubated with 1ml of assay 
buffer at room temperature for 10 minutes. Glucose was phosphorylated by the 
hexokinase in the presence of ATP and then oxidized to 6 -phosphogluconate by NAD. 
The reduction of NAD to NADH was measured spectrophotometrically at 340nm, and 
was directly proportional to the glycosyl unit concentration. Glycogen was only 
measured in the liver since this represents the major store of glycogen in the body 
and the levels in the heart are negligible. Glycogen content is expressed in jjM 
glucose units per gram wet liver weight (/^M/gww).
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2.2.8 Statistical Analysis
Statistical differences were determined by Analysis of Variance (ANOVA) and 
comparison of means made by post-hoc analysis using Duncan’s Multiple Range Test.
I l l
2.3 RESULTS
At 36 days the mothers had stopped lactating (as assessed by the complete lack 
of milk in the mammary glands at dissection) and weaning must therefore have been 
completed. The 36 days old rats were therefore only consuming the high- 
carbohydrate adult, chow diet. Weight increases for the pups were approximately 
linear from day 10 until day 36 (Figure 2.1).
The activity of hepatic PDH increased slowly throughout suckling and up to 
23 days. Thereafter, activity rose quickly doubling by 25 days before falling slightly 
(20%) to the activity levels found at 30 and 36 days (Figure 2.2). A significant 
increase in activity was recorded with age (p<  0.0001) and days 25-36 were 
statistically higher than days 21 and below (p<0.05).
In the heart, activity was low between 10 and 18 days but had doubled by 21 
days. Between 20 and 22 days activity rose from 17.7 ±  3.5 to 34.3 ±  3.3 mU/U. 
Activity peaked transiently at 22 days after which activity fell slightly but still 
remained well above suckling values (Figure 2.3). A significant increase in PDH 
activity was seen with age (p< 0.0001) and days 22, 23 and 36 were statistically 
higher than days 10, 14 and 18 (p<0.05). When expressed relative to weight of wet 
tissue, PDH activity in liver was approximately only 5-10% of heart values (eg.
157.4 ±  30.56 mU/gww in liver compared with 2346.5 ±  200.4 mU/gww in heart 
for 30 day old rats), although as a ratio to citrate synthase, the values were much 
closer.
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Hepatic glycogen content increased rapidly by 50% between 20 and 21 days 
and continued, albeit more slowly, to a peak at 25 days at just over 400 /xM/gww. 
Thereafter levels fell to around 300 juM/gww (Figure 2.4). A significant increase with 
age was seen (p<  0.0001) and days 21, 22, 23, 25 and 36 higher than 20 days and 
below (p < 0 .0 1 ).
In the liver, citrate synthase activity remained approximately constant from 
day 14 to day 22 and only consistently increased after 23 days (Figure 2.5) although 
statistically a significant age effect was seen (p<  0.0001). Cardiac citrate synthase 
activity increased significantly with age, doubling between 10 days and 36 days 
(p < 0.0001; Figure 2.6). Again, values were approximately 10-fold higher in the 
heart than in the liver.
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Figure 2.1 Weight Increases During Spontaneous Weaning
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Increases in weights during suckling and spontaneous 
weaning. Each value represents the mean (n ^  5) ± 
S.E.M. Where errors are not shown, S.E.M. is below 
the limits of the symbol.
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Figure 2.2 The Development of Hepatic Pyruvate
Dehydrogenase in the Rat during Spontaneous Weaning
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Hepatic pyruvate dehydrogenase activity is expressed relative to 
citrate synthase activity as rats wean themselves from the maternal 
milk. Each point represents the mean (n :> 4) ± S.E.M. A significant 
increase in PDH activity with age was seen, p<0.0001 (ANOVA). 
Days ^ 25 days significantly higher than days < 21; *p<0.05 
(Duncans Multiple Range).
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Figure 2.3 The Development of Cardiac Pyruvate
Dehydrogenase in the Rat during Spontaneous
Weaning
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Cardiac pyruvate dehydrogenase activity is expressed relative
to cilrate synthase activity as rats wean themselves from the
maternal milk. Each point represents the mean (n ^ 4) +
S.E.M. A significant increase in PDH activity with age was
seen, p<0.0001 (ANOVA).
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Figure 2.4 Glycogen Content of the Rat Liver
during Spontaneous Weaning
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Glycogen content of the liver is expressed in glucose units per 
g wet weight during spontaneous weaning. Each point represents 
the mean (n ^ 4) ± S.E.M. A significant increase in glycogen 
content with age was seen, p<0.0001 (ANOVA). **p<0.01, 
significantly higher than 20 days and below.
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Figure 2.5 The Development of Hepatic Citrate Synthase
in the Rat during SpontaneousWeaning
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Hepatic citrate synthase activity isexpressed per g of wet weight 
during spontaneous weaning. Each point represents the mean (n 
^ 4) ± S.E.M. A significant increase in citrate synthase activity 
with age was seen, p<0.001 (ANOVA). Day 36 was significantly 
higher than all other days, **p<0.05 (Duncans Multiple Range).
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Figure 2.6 The Development of Cardiac Citrate Synthase
in the Rat during Spontaneous Weaning
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Cardiac citrate synthase activity is expressed per g wet weight 
during spontaneous weaning. Each point represents the mean (n 
^ 4) ± S.E.M. A significant increase in citrate synthase activity 
with age was seen, p<0.0001 (ANOVA).
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2.4 DISCUSSION
A marked increase in PDH activity was evident in the liver and heart during 
the suckling-weaning period. Between 14 days and 36 days the hepatic activity 
increased 4-fold and cardiac activity 2.5-fold. These values were moderated by the 
levels of citrate synthase which also rose during the suckling-weaning transition, 
confirming the results of Glatz & Veerkamp 1982 for the heart. In both tissues little 
change was seen before 2 0  days when the diet was still thought to be largely milk 
(approximately 80-85%; Redman & Sweney 1976). From 20 days onwards the 
proportion of the diet originating from the adult chow grows rapidly (Redman & 
Sweney 1976).
The rise in PDH activity seen in these tissues during spontaneous weaning, 
reflects a change in the content of the diet and a raised glucose content. The 
increased carbohydrate content of the diet after weaning has a dual effect on the 
metabolic profile. Firstly, it reduces the need to conserve glucose for use by tissues 
unable to metabolise fats such as the brain, renal medulla and erythrocytes and 
secondly it reduces the need for fatty acid oxidation and ketone production 
(Lockwood & Bailey 1971; Page et al 1971; Benito et al 1979). The exact changes 
in metabolism vary for each tissue because of their different energy requirements and 
enzyme profiles.
The gradual increase in PDH activity in the rat liver at spontaneous weaning 
is complemented by the fall in activity of PEPCK, glucose 6 -phosphatase and fructose
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1,6-bisphosphatase reported for the same time period (Vernon & Walker 1968a). 
Since the liver controls the circulating glucose concentrations, mainly by 
gluconeogenesis during suckling, the activation of PDH and hence loss of 
gluconeogenic precursor appears to occur as the gluconeogenic requirements are 
reduced.
Hepatic PDH activity increased more slowly than glycogen stores 
replenishment. This may be metabolically advantageous since restricted entrance of 
pyruvate into the citric acid cycle allows faster glycogen synthesis, either by the 
direct or indirect, gluconeogenic route. Glycogen synthase activity has been shown 
to be high during late foetal life and to fall during suckling (Gold & Haverstick 
1977). Total glycogen synthase activity falls slightly through suckling but the 
capacity and rate of activation {b to a conversion) in the presence of glucose 6 - 
phosphate increases. Therefore, elevated concentrations of glucose provided by the 
diet may allow rapid glycogen synthesis since glycogen synthase activation is fast and 
does not require enzyme synthesis.
Cardiac PDH activity increased more steadily and faster than hepatic PDH 
with spontaneous weaning. This is presumably a reflection of the different metabolic 
priorities of these two tissues and possibly the differences in regulatory properties 
(Caterson et al 1982). During suckling the heart oxidises circulating fats for energy. 
As the glucose content of the blood increases at weaning, and the circulating levels 
of fatty acids fall, the heart switches to glucose as its major fuel. As the level of 
circulating fatty acids falls, the rate of jS-oxidation in the heart is also reduced and
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concentrations of NADH and acetyl-CoA decrease. Consequentially, PDH kinase 
activity is likely to be reduced (Cate & Roche 1978), although KAP may delay this 
(Kerbey & Randle 1982), and PDH may be activated in this way.
The heart appeared to respond to exogenous glucose faster than the liver. This 
is in contrast to the situation found at refeeding after prolonged starvation since 
reactivation of PDH is faster in the liver than in the heart (Holness & Sugden 1989; 
Sugden & Holness 1990). The reason for these differences is not clear. Cardiac 
PDH sensitivity to insulin is a matter of some debate but is generally accepted to be 
low (Caterson et al 1982), whereas liver PDH is stimulated by insulin (for review see 
Wieland 1983). KAP activity is shown to be raised by starvation in both tissues 
(Kerbey et al 1984; Denyer et al 1986) and possibly to delay reactivation after 
prolonged starvation, but no difference between tissue activities have yet been found 
that might account for these differences in PDH activation rates in the suckling- 
weaning state. Activation rates may also be limited by the dephosphorylation rate, 
which in turn is controlled by the number of serine residues phosphorylated (Sugden 
et al 1978) or the activity of the PDH kinase and phosphatase. Alternatively, 
activation may be regulated by the rate of PDH enzyme synthesis and mRNA 
transcription.
In previous studies of hepatic PDH development, contrasting results were 
obtained (Knowles & Ballard 1974; Bailey et al 1976). In agreement with the results 
presented in this thesis, Bailey and colleagues showed PDH activity to be higher in 
adults than in neonates. In contrast, Knowles and Ballard found active form and % 
active form to decrease from birth to adulthood, although total PDH content of liver
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increased. However, close comparison of our results with even Bailey et al (1976) 
is difficult because of the many differences in the studies including ages used, 
expression of results and methods of assay. These differences are outlined below.
Bailey and colleagues studied the development of PDH in liver and brown 
adipose tissue in rats using a radiometric assay in which release of radioactive CO2  
was measured. They grouped ages between 1-3, 7-23 and >30 days and found a 
steady increase in the activity of PDH of the liver from birth to 30+ when expressed 
relative to protein content of the liver. No details are given of the weaning conditions 
used.
Further, their results were expressed relative to liver protein. However, this 
is complicated by the rapid increase in cytoplasmic protein content during growth 
which are not found to the same extent in the mitochondria. This may in fact lead 
to some masking of the extent of increase and comparison to another mitochondrial 
factor (citrate synthase) is now preferred (for examples see Caterson et al 1982; 
Sugden et al 1992).
The reduction in PDH activity after weaning found by Knowles and Ballard 
(1976) contrast with the predicted change in PDH activity (see section 2.1) and does 
not agree with the results found in this study or by Bailey et al (1976). Knowles and 
Ballard found PDH activity to be lower in adults than either 2 or 14 day old rat pups, 
although total activity increased. Since the results were expressed relative to g of 
liver a direct comparison cannot be made with the results shown here however even
123
after recalculating the results in this study in units per g liver, increased activity is 
still observed in adults compared to neonates.
The methods employed by Knowles and Ballard (1974) are different again to 
those used in this thesis and by Bailey et al. Measurement of PDH activity was 
performed with the spectrophotometric assay used in the work presented here, but the 
precise details varied. Several factors may have allowed alteration of the 
phosphorylation status of the PDH including an incubation step before measurement 
of PDH activity at 400nm (cf 460nm used here) and the use of ’lightly anaesthetised’ 
rats which may have had marked effects on the stress experienced by the animal and 
would have caused release of adrenaline. Both of these factors may have altered the 
phosphorylation state of the PDH and lead to variable estimates of activity, but 
whether they would have differing effects in the young compared to adult rats is 
unknown.
There do not appear to be any previous studies into development of PDH in 
the heart. Arguably, comparisons can be made with the starved-refed transition 
where PDH activity in the heart has been shown to increase as fatty acid oxidation 
falls and glycolysis rises (Sugden & Holness 1989a). The high levels of PDH activity 
in the heart compared to the liver are likely to be due to the difference in the 
metabolic function of the two tissues, since the heart is a highly oxidative muscle with 
large and continual demands on its energy sources, whilst the liver regulates the 
circulating glucose concentrations for the rest of the body and is not a contractile 
tissue, its energy requirements are much lower. The increasingly high oxidative state
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of the heart is confirmed by the steady increase in citrate synthase activities seen 
throughout suckling and weaning (see Glatz & Veerkamp 1982) and is in contrast to 
the lower citrate synthase activity found in the liver.
Therefore, the rise in PDH activity during spontaneous weaning seems likely 
to be at least partially a result of the increase in carbohydrate content of the diet. 
Whether this increase is the result of enzyme synthesis or activation is not known at 
this stage although previous developmental studies suggest an increase in total enzyme 
concentrations, in the liver, adipose tissue and brain, throughout development 
(Knowles & Ballard 1974; Cremer & Teal 1974; Bailey et al 1976; Land et al 1977; 
Maury et al 1992). In the subsequent chapters, the extent to which the change in diet 
is responsible for the increase in PDH activity is further investigated in the liver and 
heart, along with measurement of the total activity of PDH throughout the suckling- 
weaning transition.
125
CHAPTERS
PYRUVATE DEHYDROGENASE ACTIVITY IN RATS 
WEANED AT 20 AND 18 DAYS
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Pyruvate dehydrogenase in Rats Weaned at 20 and 18 Days
3.1 INTRODUCTION
The spontaneous weaning situation described in chapter 2 allows slow 
adaptation of metabolic processes to the gradually changing diet. However, more 
commonly in the laboratory, young are abruptly weaned by removing the mother 
from her pups. With rats, this typically occurs around 20 days when the pups are 
already consuming a considerable amount of solid diet (Redman & Sweney 1976) and 
are old enough to be able to find their own food and water easily. Whilst imposed 
weaning prevents any further consumption of milk and requires the young to adjust 
to the solid diet immediately, in spontaneously weaned rats, the adaptation is much 
slower and the milk contribution to the diet is still 20% even at 25 days (Redman & 
Sweney 1976).
Work by Casado and Snell (1993) has shown that the ability of the liver to 
extract glucose from the blood and to synthesise glycogen is present in 15 day old 
suckling rats, despite the low activity of glucokinase at this time (Walker & Holland 
1965). Glycogen synthesis is seen within one hour of elevating glucose 
concentrations but whether this synthesis is via direct or indirect routes has not yet 
been established (Casado & Snell 1993). However, previous developmental studies 
in rats force-fed a high-carbohydrate diet at 21 days found a rapid fall in PEPCK 
levels to less than 40% within two hours in the liver and adipose tissue, an inverse 
relationship to that seen for insulin concentrations which rise rapidly over the same
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time period (Coupé et al 1990; Perdéreau et al 1990). Hence gluconeogenesis 
appears to be very susceptible to inhibition by elevated glucose concentrations at 2 1  
days. The activity of the gluconeogenic enzyme, pyruvate carboxylase also falls after 
weaning but the time course has not been measured in such detail (Duff & Snell 
1982). Glycolytic, glycogenic and lipogenic enzymes such as pyruvate kinase, acetyl- 
CoA carboxylase, fatty acid synthase and malic enzyme are all activated after 
weaning to a high-carbohydrate diet at around 20 days (Taylor et al 1967; Duff & 
Snell 1982; Perdereau et al 1990; Kochan & Swierczynski 1992). Hepatic lipogenic 
rates, as measured by the incorporation of radioactive lactate into lipid, increase after 
weaning at 21 days, but there appears to be a delay of 3 or 4 days (Taylor et al 
1967). Therefore the capacity for glucose and/or insulin inhibition of gluconeogenesis 
appears to be mature at 20 days. In addition, the ability for glucose metabolism and 
glycogen synthesis are present and active. The ability for lipogenesis appears to be 
present as assessed by enzyme activity, but actual measurements of lipogenesis 
suggest that lipid synthesis is delayed for 3-4 days. Thus the lipogenic capacity must 
be controlled at a point before acetyl-CoA. Pyruvate dehydrogenase is important in 
controlling the metabolic flux during refeeding after starvation in adults (see Sugden 
& Holness 1990) and hence may be an important regulatory locus for flux control 
during the change from milk to the adult diet.
Abrupt weaning to a high-carbohydrate diet provides a more defined end for 
suckling, from which the sequence of the subsequent metabolic changes can be 
investigated. Previous studies in starved adult rats have shown hepatic PDH 
activation to be delayed after refeeding. Since PDH activity allows flow of glucose
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metabolites into lipogenesis or the citric acid cycle, activation of PDH after refeeding 
would redirect a large proportion of the potential precursors for glycogen synthesis. 
Hence delayed PDH reactivation after refeeding allows rapid glycogen synthesis 
before lipogenesis becomes active. The activation lag period is dependent on the 
duration of starvation. In the heart, PDH is even less responsive to refeeding, despite 
the very low levels of glycogen stored there (see Sugden & Holness 1990). At 
weaning the change in diet from an essentially fat diet to a carbohydrate diet is similar 
to the change from endogenous fats during starvation to carbohydrates at refeeding, 
and hence there may be some similarities in the metabolic response to these two 
situations.
Whilst PDH activity has been shown to increase throughout weaning, it is of 
interest to separate the influence of diet from any possible age effects. Endogenous 
(age-related) changes are unaffected by the timing of weaning or by the dietary 
composition. The use of imposed weaning alters the timing of metabolic changes and 
hence by comparison with the spontaneous weaning situation, endogenous factors, 
unaffected by the change in diet, and due to age effects may be identified. 
Concentrations of hormones such as triiodothyronine, thyroxine and steroids increase 
slowly throughout development, unaffected by diet, and may act as important time- 
cues in the regulation of some enzymes, either directly or indirectly (Partridge et al 
1975; Kumegawa et al 1980; Henning 1981; see sections 1.5.3 & 1.5.4).
Changes in activity of PDH at weaning may be due to dephosphorylation of 
phosphorylated PDH or synthesis of new enzyme. There are three possible
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mechanisms by which PDH can be activated at weaning: a) the total PDH enzyme (ie 
active +  inactive form) is high at birth and remains high but inactive until weaning; 
b) the total enzyme concentration is low at birth and increases steadily throughout 
suckling; c) total enzyme content is low at birth and does not begin to increase until 
weaning begins at around day 16. Since two of these three potential routes suggest 
that the total PDH content is already higher than the active form at weaning, the 
measurement of active +  inactive PDH throughout suckling and weaning is of 
obvious interest. Whilst providing information about the mechanism involved with 
PDH activation at weaning, measurement of the total activity will give further 
information about any endogenous age-effect.
The influences of age versus diet can be further investigated by premature 
weaning, before the onset of spontaneous weaning. In this way a solely dietary effect 
should be reproduced at any age where the young will eat the adult diet. However, 
an altered response would indicate that more than one factor is involved in activation 
of the enzyme. Hence, in order to maximise the effects of premature weaning, the 
rats have to be mature enough to fend for themselves (or be hand reared) but 
consuming as little of the adult diet as possible before weaning.
Although the comparison between spontaneous and imposed weaning allows 
closer examination of metabolic changes around the suckling-weaning transition, one 
disadvantage of the use of imposed weaning is the possibility of adding a stress effect 
by removal of the mother. Adrenaline is known to stimulate PDH activity by 
activation of PDH phosphatase (see Denton et al 1987). In the spontaneously weaned
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rats used in chapter 2 , the mother was not removed from the cage until the pups were 
36 days old, at which time they were completely independent of her. Imposed 
weaning removes the mother whilst the pups are still suckling for a large proportion 
of their food, and hence the interaction of the pups with the mother is much greater.
The aim of the work reported in this chapter was to investigate the effects of 
imposed weaning on the activities of PDH and citrate synthase in the liver and heart, 
and glycogen content of the liver. In view of the rapid changes in other key glucose 
metabolising enzymes after imposed weaning it is of interest to see whether the 
increase in PDH activity seen at spontaneous weaning is accelerated by rapid 
weaning. Determination of the total activity of PDH in rats weaned at 20 days and 
of the active PDH form in prematurely weaned rats, will allow closer examination of 
the possible involvement of an age-related factor. This may help establish whether 
PDH may play a regulatory role in controlling the flux of carbohydrate derivatives 
into lipogenesis in the liver, and the citric acid cycle in the heart, in the young rat.
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3.2 METHODS
3.2.1 Animals
Animals were housed as detailed in 2.2.1. When the pups reached 18 or 20 
days of age, weaning was imposed between 0800 and 0930 hours by removing the 
mother from the cage. The pups were given standard laboratory chow as detailed 
before. Pellets of the chow diet and a petri dish containing water were placed in the 
bottom of the cage to encourage the rats to adapt quickly to the imposed change in 
diet. The pups weaned at 18 days were closely observed initially to see that they 
adjusted quickly and did not become dehydrated.
3.2.2 Dissection of Tissues
Liver and heart tissue was dissected as detailed in section 2.2.2.
3.2.3 Assay of Active Form of Pyruvate Dehydrogenase, Citrate Synthase and 
Glycogen
As detailed in section 2.2.4
132
3.2.4 Measurement of Total Form of Pyruvate Dehydrogenase
There is currently a variety of published methods of measuring total PDH 
activity which act either by inhibiting the PDH kinase or stimulating PDH 
phosphatase activity (for examples see Portenhauser & Wieland 1972; Whitehouse & 
Randle 1973; Knowles & Ballard 1974; Weiss et al 1974; Bailey et al 1976; Claus 
& Pilkis 1977; Hems et al 1978; Chitra et al 1985; Marchington et al 1987; 
Constantin-Teodosiu et al 1991). For this work dichloroacetate (DCA) was used to 
stimulate the conversion of inactive PDH to the active form in a method adapted from 
Constantin-Teodosiu et al (1991). DCA is known to activate PDH in the heart, liver 
and hepatocytes via inhibition of PDH kinase (Whitehouse & Randle 1973; Blackshear 
et al 1974; Whitehouse et al 1974; Claus & Pilkis 1977; Agius & Vaartjes 1985; 
Chitra et al 1985; Holness & Sugden 1990). In comparison with activation with 
exogenous PDH phosphatase, values for activation of the heart with DCA ranged 
between 90-100% of total activity (Whitehouse & Randle 1973; Whitehouse et al 
1974; Dennis er al 1979), and 60-100% for the liver (Claus & Pilkis 1977; Chitra et 
al 1985; Holness & Sugden 1990) although the precise details of the methods 
employed varied. Hence, it must be noted that the ‘total’ activity measured in this 
work may not have represented 100% of the PDH enzyme present but was designed 
to show that more PDH complex was present than was seen in the active form.
For the measurment of total activity in samples, approximately 0.2g of tissue 
was homogenised in 1ml of homogenisation buffer containing 200mM sucrose, 50mM 
KCl, 50mM Tris HCl, 5mM MgCl2 , 5mM EGTA, lOmM glucose and 2U/ml
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hexokinase. Samples were freeze/thawed three times and centrifuged as in section
2.2.4.1. 50111 aliquots of homogenates were then incubated at 37°C for 1 hour with 
a further 200jLtl of homogenisation buffer also containing 4.8mM CaClg, 120mM 
MgCl2  and 25mM DCA. Activity was measured spectrophotometrically as in section
2.2.4.2. using the AABS dye. Total activity was measured in liver and heart samples 
from 10, 14, 18, 22, 25 and 30 day old rats.
3.2.5 Assay of Blood for Insulin
Insulin was measured in serum samples using a double antibody 
radioimmunoassay routinely used in our laboratories (see Hampton et al 1983). ^^ I^- 
Insulin was purchased from Amersham International, Buckinghamshire, insulin 
antiserum and donkey anti-guinea pig serum (DAGP) from Guildhay Antisera 
(Guildford), normal guinea pig antiserum (NGPS) from Sigma Chemicals (Poole) and 
rat insulin standard from Novo (Copenhagen, Denmark).
Blood was collected with a plastic pipette from the rat chest cavity, after the 
removal of the heart, and placed in heparin tubes and gently mixed to prevent 
clotting. Between 0.2 and 1.5ml were collected, depending on the size of the rat. 
Samples were centrifuged at 2000g for 20 minutes and the serum transferred to a 
clean eppendorf tube. Serum samples were stored at -20°C until assayed.
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Reagent Total NSB Zero Standard NSB
Sample
Sample NSB
QC
QC
Buffer - - 100 50 - 100 200 100
NGPS - 200 - - 200 - - -
Standard - - - 50 - - - -
Sample - - - - 50 50 - -
QC - - - - - - 50 50
Antisemm - - 100 100 - 100 - 100
CSS - 50 50 50 - - - -
Label 200 200 200 200 200 200 200 200
Table 3.1 Insulin assay protocol. Additions for assay of insulin in serum are given 
in jul for solutions prepared as in text.
The insulin assay buffer contained 30mM Na2 HP 0 4 , 8 mM NaIÎ2 P 0 4 , 0.6mM 
thiomersal, lOmM EDTA and 0.5% BSA, pH7.4 and was used to dilute all reagents. 
Standards were made using a 20 U/1 rat insulin stock solution and assay buffer to 
dilute. The top standard was 200^uU/ml and 2-fold dilutions were made down to 
3.175/AU/ml. lOjLil of normal guinea pig serum (NGPS) was diluted in 5ml assay 
buffer. Insulin antiserum was diluted 1:10 000 in assay buffer and NGPS added to 
give a 1:500 dilution. Porcine charcoal-stripped serum (CSS) was used in place of
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rat serum sample for non-specific binding (NSB), zero and standards. Blood samples 
collected from rats were thawed and spun briefly to remove serum clot. Quality 
controls (QC) were included in each assay. The protocol for additions in fil for the 
assay was as shown in table 3.1 above.
^^^I-Insulin was diluted in assay buffer to give approximately 6500 cpm per 
200^1. ^^^I-Insulin was added last to minimise risk from spillage. All samples were 
measured in duplicate and NSB were placed between every 10 tubes to allow 
detection of any variation across the assay. Tubes were mixed and incubated 
overnight at room temperature. The following morning donkey anti-guinea pig serum 
(DAGP) was diluted 1:64 (v/v) in a 15% (v/v) polyethylene glycol 2000 solution and 
200/zl added to each tube. After mixing, the tubes were incubated for a further 2 
hours at room temperature. Tubes were then centrifuged at /500 j  for 30 mins at 
4°C and the supernatant aspirated for all tubes except the totals. Radioactivity of the 
pellet was measured in a Beckman gamma counter and insulin concentrations were 
read from the standard curve.
3.2.6 Protein Assays
Protein was measured by the method of Lowry et al (1951). A standard curve 
made using Bovine Serum Albumin was used. Liver and heart tissue samples, 
retained from the PDH assays, were diluted 1/100 and 1/200 in PDH assay buffer. 
lOOfil aliquots were incubated with 400/ri of IM NaOH and 500/zl HgO for 15 
minutes at 37°C. 5ml of freshly prepared copper tartrate solution, containing 185mM
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Na2 C0 3 , 0 .4 mMCuSO4  and 0.7mM Na/K tartrate, were added and the mixture was 
left at room temperature for 10 minutes. 0.5ml of l^ F o lin s  reagent was added and 
left at room temperature for 30 minutes after which time the absorbance at 700nm 
was measured.
3.2.7 Statistical Analysis
Statistical differences within developmental profiles were determined by one 
factor analysis of variance (ANOVA) and comparisons of means made by post-hoc 
analysis using Duncans Multiple Range as in section 2.2.8. For comparison of 
profiles for different weaning conditions, 2  factor analysis of variance tests were used 
(factors: ‘age’ =  age of rat, ‘treatment’ =  changes in overall levels of PDH; ‘age by 
treatment’ interaction effect =  change in overall PDH levels are dependent on the 
time of weaning). Only points after the weaning time were used for these 
comparisons.
Comparison of PDH activity in pups weaned at either 18 or 20 days was 
performed in two ways; 1 ) by comparing the activity at each age point or 2 ) by 
shifting one profile by two days thereby superimposing the two weaning points and 
comparing activity at specified days after weaning.
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3.3 RESULTS
Throughout this chapter, the data used for animals before 18 or 20 days are 
the same as those used in the spontaneously weaned experiments (chapter 2 ) since 
weaning has not yet occurred. These data have only been included here to allow a 
comparison between pre- and post-weaning to be made.
Weight gains throughout weaning were approximately constant at 2-3g per 
day, with the exception of the first two days after weaning at either day 18 or 2 0 , 
when the weight remained the same as before weaning or dropped slightly (Figure 
3.1). This loss was compensated for the following day. The rats appeared to be 
otherwise healthy and alert.
3.3.1 Pilot Studies for DCA Activation of I^nivate Dehydrogenase
Since the use of DCA for activation of liver and heart PDH has not been used 
for neonatal tissues before, some verification of the method was necessary. Higher 
concentrations of MgCl2  were necessary for the measurement of total PDH activity 
than for measurement of the active form, and hence a sucrose/Tris buffer was 
employed to avoid precipitation of magnesium phosphate that occurs with phosphate- 
based homogenisation buffers (Constantin-Teodosiu et al 1991). Initially, active PDH 
was measured in both the sucrose and phosphate buffers. The activity measured in 
the sucrose buffer was found to give slightly lower values for the active PDH than 
the phosphate buffer but the values were linearly related (r=0.952, p < 0.0001;
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Figure 3.2). Optimum conditions of DCA concentration and incubation time for PDH 
activation were established by incubation of samples with between 5 and 50mM DCA 
for between 5 and 120 minutes. 25mM DCA for 60 minutes was chosen. In order 
to demonstrate that the activity measured for PDH was proportional to the volume of 
homogenate added to the cuvette, differing volumes were added (10 to lOO/d) and 
activity measured. Within the range of volumes used for this work the activity of 
PDH was proportional to the volume of homogenate added.
3.3.2 Weaning a t 20 Days
Pyruvate dehydrogenase activity increased rapidly in liver after weaning at 20 
days. Hepatic PDH rose approximately 10-fold from suckling levels at 20 days to 
levels at 22 days (Figure 3.3). Thereafter, activity fell at 23 and 25 days but still 
remained well above suckling levels. There was a significant increase in activity with 
age (p<  0.001) and activity between days 22 and 36 was significantly higher than 
<21 days (p<0.05). Comparison of data with that for spontaneously weaned 
animals showed a significant combined increase in activity with age (p<  0 .0 0 1 ), an 
increase in overall PDH levels with weaning at 20 days (p<  0.001) and an age by 
treatment effect (p=0.001; changes in overall PDH levels were dependent on the time 
of weaning).
Cardiac PDH also increased with weaning at 20 days (Figure 3.4) but the 
increase was more gradual than that found in the liver and the overall profile was 
very similar to the increase seen in the heart during spontaneous weaning (see Figure
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2.3). Cardiac activity began to increase before weaning was induced at 20 days. A 
3-fold rise in activity was seen between 18 and 22 days but activity fell over the next 
3 days before rising again to 30 days. A significant increase in activity with age was 
seen (p<  0.001) and activity on days 21, 22, 30 and 36 was higher than in suckling 
rats < 20  days old (p<0.05). When compared with the cardiac data from 
spontaneously weaned rats (chapter 2 ), the increase in activity with age was seen 
(p <  0 .0 0 1 ) but no significant difference was seen in the treatment or age by treatment 
effects suggesting that the cardiac PDH developmental profiles are very similar for 
both spontaneously weaned and 2 0  day weaned rats.
Measurements of the total activity of PDH during suckling and weaning 
showed a steady increase in the concentrations of PDH per g wet weight in the liver 
and heart and total activity was seen to be higher than active form (Figures 3.5 and 
3.6). Hepatic total PDH concentrations rose 4-fold between 10 and 14 days, and 
thereafter by a further 50% at 30 days. During suckling active hepatic PDH 
accounted for 10-45% of total activity but after weaning this figure increased to 
between 70 and 110%. In the heart, a similar profile was seen with total PDH rising 
nearly 10-fold between 10 and 14 days and remaining high thereafter. Before 
weaning, the active form of cardiac PDH accounted for 30-50% of the total activity 
and after weaning this increased to between 50 and 100%.
The glycogen content of the liver increased promptly and rapidly with age 
after weaning at 20 days, to peak at 25 days (p < 0.001; Figure 3.7). Concentrations 
doubled between 20 and 22 days. Thereafter the glycogen content fell slowly to 75 %
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of the peak at 36 days. The overall profile was very similar to that seen during 
spontaneous weaning (see Figure 2.4). Significantly higher values were seen at 25, 
30 and 36 days when compared to values for ages below 20 days (p<0.05). When 
compared to the data for spontaneously weaned rats (chapter 2 ), an increase with age 
(p <  0.05) but no significant treatment or age by treatment effect was seen, suggesting 
that the profiles for spontaneous and imposed weaning are very similar.
Hepatic citrate synthase activity began to rise at 21 days and remained elevated 
until 25 days when it fell slightly (Figure 3.8). Values throughout suckling (14 to 20 
days) ranged from 7.2 to 9.1U/gww and from 10.1 to 10.9U/gww between 21 and 
25 days. There was a significant age effect (p<  0.001) and days 21 to 25 were 
statistically higher than days 14, 19 and 20 (p<0.05). When compared with 
spontaneously weaned rats a significant treatment (p <  0 .0 0 1 ; change in overall citrate 
synthase levels) and age by treatment effect was seen (p<  0 .0 0 1 ; change in overall 
citrate synthase levels dependent on the time of weaning). Cardiac citrate synthase 
activity rose steadily throughout development as for spontaneously weaned rats 
(Figure 3.9; also see figure 2.6) and a significant age effect was seen ( p < 0.001). 
Days 10 and 14 were significantly lower than all other points (p<0.05). When 
compared to spontaneously weaned rats (Figure 2.6), a significant age effect 
(p < 0.001) and increase in overall citrate synthase levels were seen (p<0.05).
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AGE PROTEIN CONTENT (mg/gww)
LIVER HEART
1 0 1 0 2 . 1  ±  2 . 1 6 6 . 8  ±  2 . 1
14 101.1 ±  3.8 64.4 ±  5.9
18 110.5 ±  4.0 50.6 ±  1.4
2 2 93.6 ±  3.4 49.3 ±  2.2
25 86.0 +  3.7 41.2 ±  1.2
30 125.4 ±  4.5 81.2 ±  1.5
Table 3.2. Supernatant protein content of the rat liver and heart, measured in 
homogenates used for total activity estimations, during suckling and after weaning 
imposed at 20 days. Each point represents the mean (n >  5) ±  S.E.M.
Protein content of the homogenate supernatant was measured to allow 
expression of PDH levels relative to protein and hence comparable to other studies. 
Insulin concentrations appeared to fall after weaning at 20 days and remained low for 
48 hours (Figure 3.10). Levels were apparently higher at 25 days, although they 
appeared to have fallen again by 30 days. Analysis of variance showed no significant 
differences in insulin concentrations in any of the ages studied.
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3.3.3 Weaning at 18 Days
Attempts were made initially to wean rats at 16 days but their limited eye sight 
and mobility meant they were unable to find their own food and water and they 
became dehydrated. As a result older animals were used. At 18 days the pups were 
more mobile and alert and were already consuming some of the adult chow. After 
weaning at 18 days, activity of PDH, citrate synthase and glycogen content were 
measured in rats up to 25 days old.
After weaning at 18 days, hepatic PDH activity began to increase between 19 
and 20 days (Figure 3.11). Activity rose 1 0 -fold between 18 and 21 days. Activity 
then fell slightly only to increase again at 23 days. There was a significant age effect 
( p < 0.001) and days 21-25 were significantly higher than days 10 to 19 (p<0.05). 
When age points were compared with weaned at 20 days rats, a significant age 
(p < 0.001), treatment (p<  .0001; increase in overall PDH levels) and age by 
treatment effect (p<  0.001; time of weaning on overall PDH levels) were seen. 
Comparison of the weaned at 20 and weaned at 18 day profiles, superimposed by 
shifting one profile by two days and aligning the points of weaning with each other, 
gave a significant age (p<  0.001), treatment (p<  0.001; increase in overall PDH 
levels) and age by treatment effect (p<  0.001; time of weaning on overall PDH 
levels).
Cardiac PDH rose steadily from 11.5mU/U at 18 days to peak at 38.5mU/U 
at 21 days (Figure 3.12). Since activity had increased by 19 days, there was no
143
apparent lag period at weaning before activity began to increase. After peaking at 21 
days activity remained high until at least 25 days. Again, the increase with age was 
statistically significant (p<  0 .0 0 1 ) and days 1 0  to 18 had lower activity than days 2 0  
and above (p<0.05). Comparison of cardiac PDH for weaned at 18 and weaned at 
20 also showed a significant increase with age (p < 0.001), treatment ( p < 0.005; 
change in overall PDH levels), and age by time of weaning effect (p<0.01). When 
the two profiles were superimposed (i.e. by shifting one profile by two days), the age 
by treatment effect was significant (p<  0 .0 0 1 ), however, if the profiles were 
superimposed by shifting one profile by only one day the age by treatment effect was 
lost.
Glycogen concentrations in the liver increased rapidly from suckling levels of 
153/iM/g wet weight to peak at 19 days, 24 hours after weaning at 374^M/g wet 
weight (Figure 3.13). Thereafter, levels fell by 25%. Comparison with the glycogen 
content of liver in pups weaned at 2 0  days showed a significant decrease in overall 
glycogen levels for the 18-day weaned rats (p<0.05) and a significant age by 
treatment effect (p<  0 .0 0 1 ; change in total glycogen concentration dependent on time 
of weaning).
Hepatic citrate synthase activity followed approximately the same profile as 
seen in rats weaned at 20 days, with activity increasing with age (p < 0.001). Days 
18, 22 and 25 were higher than days 10, 14 and 20 (p<0.05; Figure 3.14). Weaning 
at 18 days gave a significant treatment effect (p<  0 .0 0 1 ) when compared to weaning 
at 20 days. This effect was also seen if the developmental profiles were
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superimposed (p<  0.001). The cardiac enzyme increased slowly (Figure 3.15) and as 
for spontaneous weaning and weaned at 20 days. There was a significant age effect 
(p<  0 .0 0 1 ) but no differences between treatments when compared to weaned at 2 0  
days (p>0.5).
Insulin levels appeared to be slightly lower during after weaning at 18 days 
than at 20 days (Figure 3.16).
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Figure 3.1 Weight Increases in Rats
Weaned at 18 and 20 Days
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Increases in weights during suckling and weaning at 18 
(# )  and 20 (■) days. Each value represents the mean 
(n ^ 4) ± S.E.M. Where errors are not shown, S.E.M. is 
below the limit of the symbol.
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Figure 3.2 Comparison of PDH Activity Measured 
in Phosphate and Sucrose Buffer
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The active form of PDH was measured in the phosphate 
buffer used regularly for active form measurements and 
sucrose buffer used for measurement of total activity. 
r=0.95, p<0.001.
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Figure 3.3 The Development of Active Hepatic Pyruvate 
Dehydrogenase in the Rat during Suckling and After Weaning
at 20 Days
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Active hepatic pyruvate dehydrogenase is expressed relative to 
citrate synthase activity during development of the rat and 
weaning imposed at 20 days. Each point represents the mean (n 
^ 4) ± S.E.M. Significant increase in PDH is seen with age, 
p<0.0001 (ANOVA). 22 days and above significantly higher 
than 21 days and below, *p<0.05, **p<0.01 (Duncans Multiple 
Range).
Figure 3.4 The Development of Active Cardiac Pyruvate
Dehydrogenase in the Rat during Suckling and after
Weaning at 20 Days
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Cardiac pyruvate dehydrogenase activity is expressed relative 
to citrate synthase activity during development of the rat and 
weaning imposed at 20 days. Each point represents the mean 
(n ^ 4) ± S.E.M. Significant age effect seen, p<0.0001 
(ANOVA) and ages ^20 significantly higher than days ^18 
*p<0.05, **p<0.01 (Duncans Multiple Range).
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Figure 3.5 Total and Active Hepatic PDH during Suckling 
and after Weaning at 20 Days
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(a) Total hepatic PDH # )  and active form (•) throughout development and 
after weaning at 20 days. Each point represents the mean (n 4) ±  S.E.M. 
Significant age effect seen for total PDH, p<0.05 (ANOVA; for details of 
weaned at 20 days see figure 3.3). Total PDH at 10 days significantly lower 
than at all other days, *p<0.05, **p<0.01 (Duncans Multiple Range).
(b) Ratio of active to total PDH (♦).
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Figure 3.6 Total and Active Cardiac PDH during 
Suckling and after Weaning at 20 Days
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(a) Total (■) and active ( • )  cardiac PDH throughout suckling and after 
weaning at 20 days. Each point represents the mean (n.> 4) ±  S.E.M. 
Significant age effect seen for total PDH, p<0.001 (ANOVA; for details of 
active form see Figure 3.4). Total PDH significantly higher at days >10, 
**p<0.01 (Duncans Multiple Range), (b) Ratio active to total PDH (♦).
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Figure 3.7 Hepatic Glycogen Content during
Suckling and after Weaning at 20 Days
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Hepatic glycogen content during development of the rat 
and weaning imposed at 20 days. Each point represents the 
mean (n > 4) ±  S.E.M. Significant age effect, p<0.0001 
(ANOVA) and days > 22 significantly higher than days c  
20; *p<0.05, **p<0.01 (Duncans Multiple Range).
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Figure 3.8 The Development of Hepatic Citrate
Synthase Activity in the Rat during Suckling and
after Weaning at 20 Days
12-1
1 1 -
10 -
co
1—I—r T— I— I— r T—I—r T—r
0 10 15 20 25
Age in Days
30 35 40
Hepatic citrate synthase activity during development and 
weaning at 20 days. Each point represents the mean (n :^4) ± 
S.E.M. Significant age effect, p<0.001 (ANOVA). Days 21, 
22,23 and 25 significantly higher than days 10,14,19 and 20; 
*p<0.05, **p<0.01 (Duncans Multiple Range).
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Figure 3.9 The Development of Cardiac Citrate
Synthase Activity in the Rat during Suckling and
after Weaning at 20 Days
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Cardiac citrate synthase activity during development and weaning 
at 20 days. Each point represents the mean (n ^ 4) ± S.E.M. 
Significant age effect, p<0.001 (ANOVA). Days 20-30 
significantly higher than days 10 and 14, **p<0.01, *p<0.05 
(Duncans Multiple Range).
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Figure 3.10 Serum Insulin Concentrations After 
Weaning to a High-Carbohydrate Diet at 20 Days
60-1
22 25
Age in Days
The serum concentrations of insulin in the rat after weaning at 20 
days to a high-carbohydrate diet. Each point represents the mean 
(n^ 4) ± S.E.M.
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Figure 3.11 Active Hepatic Pyruvate Dehydrogenase
during Development Compared in Rats Weaned at 18
and 20 Days
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The development of hepatic pyruvate dehydrogenase/citrate synthase 
activity ratio in the rat during suckling and after weaning at 18 (# )  is 
compared to weaning at 20 days (O). Each point represents the mean 
(n > 4) + S.E.M. Statistical increase with age for weaned at 18 days, 
p<0.0001 (ANOVA) and days ^ 22 significantly higher than days ^ 
19; *p<0.05, **p<0.01 (Duncans Multiple Range; see figure 3.3 for 
details for weaned at 20 days). When compared with weaned 20 day 
data, there was a significant age effect, p<0.0001, treatment (time of 
weaning) effect, p<0.001, and age by treatment effect, p<0.0001, 
(ANOVA). 156
Figure 3.12 Active Cardiac Pyruvate Dehydrogenase
during Development compared in Rats Weaned at 18
and 20 Days
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The development of cardiac pyruvate dehydrogenase/citrate synthase 
activity ratio during development of the rat is compared after weaning 
at either 18 (# ) or 20 (O) days. Each point represents the mean (n 4) 
±  S.E.M. Significant increase with age for weaned at 18 days 
p<0.0001 (ANOVA) and days >20 significantly higher than days ^18; 
**p<0.01 (Duncans Multiple Range; see figure 3.4 for details of 
weaned at 20 days). Significant treatment (time of weaning) effect, 
p<0.01 and age by treatment effect, p<0.05 between weaning at 18 and 
20 days (ANOVA).
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Figure 3.13 Hepatic Glycogen Content during
Development compared in Rats Weaned at 18 and 20 Days
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Hepatic glycogen content throughout development is compared after 
weaning at either 18 (# ) or 20 (O) days. Each point represents the 
mean (n :^4) ± S.E.M. Significant increase with age for weaned at 18 
days, p<0.0001, (ANOVA) and days 19,20 and 21 higher than days 
10 and 18, ** p<0.01 (Duncans Multiple Range; see figure 3.5 for 
details for weaned at 20 days). Significant age by treatment effect 
seen between weaned at 18 and 20 days, p<0.0001 (ANOVA).
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Figure 3.14 Hepatic Citrate Synthase Activity after
Weaning at 18 Days compared to Weaned at 20 Days.
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The development of hepatic citrate synthase activity during 
suckling and after weaning at 18 ( • )  is compared to weaned at 
20 days (O). Each point represents the mean (n ^ 4) ±  S.E.M. 
Significant increase in activity with age for weaned at 18 days, 
p<0.001 (ANOVA), and days 18, 22 and 25 significantly higher 
than days 10,14 and 20; *p<0.05, **p<0.01 (Duncans Multiple 
Range; see figure 3.6 for details of weaned at 20). Significant 
age effect, p<0.001 and treatment effect (time of weaning), 
p<0.05, seen when compared to weaned at 20 days (ANOVA).
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Figure 3.15 Cardiac Citrate Synthase Activity during
Development compared in Rats Weaned at 18 and 20 Days
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The development of cardiac citrate synthase activity during 
suckling and after weaning at 18 (# ) is compared to weaned at 
20 (O) days. Each point represents the mean (n 4) dr S.E.M. 
Significant increase in activity with age for weaned at 18 
days, p<0.001 (ANOVA) and days 20 - 25 significantly higher 
than days 10 and 14, *p<0.05, **p<0.01 (Duncans Multiple 
Range; see Figure 3.7 for details for weaned at 20). No 
significant difference between weaned 18 and 20 (ANOVA).
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Figure 3.16 Serum Insulin Concentrations during 
Development in Rats Weaned at 18 or 20 Days
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The serum concentrations of insulin after weaning at 18 
( 01) or 20 ( 0 )  days are shown. Each point represents 
the mean (n < 4) jr S.E.M.
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3.4 DISCUSSION
The intention of using imposed weaning to investigate changes in PDH activity 
was to accelerate the effects of weaning, condensing an adaptation that normally takes 
10-12 days into an essentially immediate effect. Premature weaning at 18 days was 
intended to further emphasise this by minimising the carbohydrate intake before 
weaning, since in the 2 0  day old rats, a large part of the dietary intake is already 
provided by the solid adult diet, whereas at 18 days the carbohydrate intake is still 
very low (only about 8 % by weight; Redman & Sweney 1976). At 18 days, the pups 
adjusted well to imposed weaning and their new diet. It should be noted that in our 
laboratory, the day of birth is taken as day 1 , unlike in some other laboratory where 
the day of birth is taken as day 0 , and hence our 16, 18 or 2 0  day old rats are a day 
younger in comparison to apparent equal-aged rats used in some other studies.
Abrupt weaning at 20 days rather than allowing rats to wean slowly and 
spontaneously, has differing effects on the PDH activity of the liver and the heart. 
In the liver, PDH activity rises faster when the pups are rapidly weaned than when 
they are spontaneously weaned: activity increased 1 0 -fold between 2 1  and 2 2  days for 
imposed weaning, and only 1.5-fold for spontaneously weaned rats (cf. Figures 2.2 
and 3.3). In the heart the rise in PDH activity is very similar in 20 day weaned rats 
to that observed in spontaneously weaned animals (cf. Figures 2.3 and 3.4).
The rapid rise in hepatic PDH activity after weaning at 20 days did not begin 
until day 22, 48 hours after weaning and the change to the high-carbohydrate solid
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diet (chow). Increased activity of hepatic PDH was also delayed by 48 hours in rats 
weaned at 18 days (Figure 3.11). After weaning at 18 days a significant treatment 
effect was seen and the overall PDH levels attained were higher than those seen for 
weaning at 20 days. Whether the high PDH levels are physiologically important or 
due to an overshoot in activation is unclear. However, an overshoot in activation 
may suggest that the regulatory systems for PDH are immature at 18 days.
In starved rats, the delayed activation of PDH at refeeding is thought to be 
part of a mechanism that ensures maximal glycogen synthesis and replenishment of 
glycogen stores, before channelling of substrates into fat and energy (Sugden et al 
1989). The ability of the liver for glucose uptake is high even at 15 days (Casado & 
Snell 1993), and glucokinase activity is high by 20 days (Walker & Holland 1965) 
and is stimulated further at weaning (Perdereau et al 1990). Therefore, at the time 
of imposed weaning glucose uptake into the liver is expected to increase rapidly as 
a result of the increased dietary glucose availability. However, whether the increased 
glucose uptake makes a large, direct contribution to glycogen synthesis at weaning 
or whether glycogen is synthesised indirectly via 3-carbon units and gluconeogenesis 
is unclear. Gluconeogenesis remains active for some time after spontaneous weaning 
(Vernon & Walker 1968a) and prolonged starvation (Tilgham et al 1976; see Sugden 
et al 19896). However, PEPCK activity falls to 20% of suckling levels within the 
first 24 hours of imposed weaning (Coupé et al 1990; Perdereau et al 1990). 
Nevertheless, delayed PDH activation would prevent pyruvate being directed into 
acetyl-CoA and would favour efficient production of glucose 6 -phosphate for the 
synthesis of glycogen. Once glycogen stores are filled, PDH is activated to allow
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either complete oxidation of glucose or lipogenesis.
The glycogen content of the liver rose at approximately the same rate in the 
weaned at 2 0  days and spontaneously weaned rat, with a slow increase in content 
between day 1 0  and 2 0  and a rapid increase to a peak at 2 1  days (in agreement with 
Shelley 1961 and Snell & Walker 19736), i.e. 24 hours before PDH activity peaked. 
In the rats weaned at 18 days the glycogen content also rose immediately after 
weaning and in advance of the rise in PDH levels. The rise in glycogen levels in 
spontaneously weaned rats at 2 0  days indicates that the carbohydrate intake at this 
time is sufficient for glycogen synthesis. After imposing weaning at 18 or 20 days 
the carbohydrate intake rises quickly and glycogen concentrations also increase. 
Hence, the slowly increasing carbohydrate content of the diet during the late suckling 
period, appears to reach adequate levels for rapid glycogen synthesis around 2 0  days. 
Imposed weaning at 18 days allows precocious glycogen synthesis as a result of the 
prematurely elevated carbohydrate intake.
The rise in activity of hepatic PDH from 20 days onwards is due to activation 
of enzyme already present, rather than an increase in total activity by new enzyme 
synthesis. Measurements of total PDH activity show that the amount of enzyme is 
high even by 14 days of age. Total PDH complex activity at 14 days is comparable 
to the levels of the active form found at 30 days and hence, the potential for 
stimulation through activation appears to be present as early as 14 days, although total 
complex concentrations continue to rise until at least 30 days. The proportion of 
hepatic enzyme in the active form decreased throughout suckling to reach a minimum
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at 18 days and then rose rapidly at weaning, as might be expected given the rapid 
change in dietary composition. Previous studies of PDH activity in the young rat also 
found a steady increase in total activity between 1-3 days and > 30 days (Knowles & 
Ballard 1974; Bailey et al 1976). An increase in the % active form was also reported 
by Bailey and colleagues, but not by Knowles and Ballard who found the proportion 
in the active form remained approximately constant between 2 and 14 days and fell 
between 14 days and adulthood. The discrepancy between the results presented here 
and those found by Knowles and Ballard would appear to be due to methodological 
differences in the measurements of the active form as discussed previously; section 
2.4.
The situation in the heart is somewhat different to the liver. PDH activity in 
the heart increased 6 -fold between 18 and 22 days (Figure 3.4) after which activity 
fell by 30% at 23 days only to increase again more slowly to peak values at 36 days. 
In contrast to the liver, the activity actually began to increase before weaning giving 
an elevated PDH activity by 20 days. No lag period was seen between weaning and 
activation of cardiac PDH. In addition, the profile seen for pups weaned at 20 days 
was almost identical to that seen in pups weaned spontaneously. Comparison of the 
two profiles revealed no difference in the overall levels of PDH between days 20 and 
36 arising from weaning conditions or in the time at which the peak was seen. Hence 
the rise in cardiac activity from 2 0  days onwards does not seem to be influenced by 
the dramatic change in diet imposed by weaning but appears to be determined by 
other endogenous influences. The observed peak may therefore be due to an age- 
effect or the carbohydrate content of the diet increasing sufficiently before 2 0  days
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to allow activation of PDH.
Weaning at 18 days activated cardiac PDH which increased to a peak at 21 
days (Figure 3.12). The increments by which activity rose were very similar to those 
found after weaning at 2 0  days, however, the increase only began the following day 
making day 19 the first day with elevated activity. Hence, the actual difference in 
the age of appearance of the peaks for weaning at 18 and 2 0  days is only one day. 
It would appear that at 18 days, the carbohydrate intake of the rat is insufficient for 
PDH activation but weaning increases that intake. In rats not weaned until 20 days 
the dietary carbohydrate intake appears to have already increased sufficiently to allow 
stimulation of cardiac PDH.
Total cardiac PDH increased from days 10 through to day 25. As in the liver, 
the total PDH content of the heart at 14 days was sufficient for activities observed 
around day 22. Thus, the increased activity of PDH observed from 20 days onwards 
(or 19 days onwards in rats weaned at 18 days) is due to activation of enzyme already 
present and not enzyme synthesis. The proportion of enzyme in the active form 
decreased throughout suckling but rose at weaning to reach a maximum at 2 2  days 
(Figure 3.10). This is consistent with the increasing total activity but restricted active 
form seen throughout suckling, and activation of the enzyme at weaning.
The dramatic increase in hepatic glycogen content at weaning was 
accompanied by a rapid rise in the activity of hepatic citrate synthase between days 
20 and 21 (Figure 3.6). The difference between the profiles for spontaneous (see
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Figure 2.5) and imposed weaning would suggest stimulation of citrate synthase 
ah
activity^weaning. Activity after weaning at 18 days does not reproduce the activity 
profile seen for 2 0  day weaning or at spontaneous weaning, suggesting that more than 
one factor is responsible for the regulation of citrate synthase throughout 
development. Citrate synthase activity is not thought to be regulated by 
phosphorylation or end-product inhibition and remains approximately constant under 
various physiological conditions in adult animals, making it a good mitochondrial 
marker (see Caterson et al 1982).
Citrate synthase activity in the heart increased from 10 days through to 30 
days (Figure 3.7) as with spontaneous weaning (see Figure 2.6) suggesting that the 
change in diet at weaning has no effect on citrate synthase activity but that an age- 
effect is more likely. The increased citrate synthase activity of the heart is likely to 
be associated with an increased oxidative capacity.
Therefore, the factors involved in regulation of PDH activity in the liver and 
heart appear to be different. The liver enzyme appears to be largely regulated by the 
diet and the level of glycogen stores. Cardiac PDH activity is raised by the 
increasing carbohydrate content of the diet at weaning but may also be under the 
control of other endogenous factors. Whether the elevated levels of glucose and other 
hexoses are directly responsible for PDH activation or whether an indirect method of 
stimulation is involved is presently unknown.
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CHAPTER 4
THE DEVELOPMENT OF PDH AFTER WEANING TO 
A HIGH-FAT DIET AND THE LONG TERM EFFECTS 
OF DIFFERENT WEANING CONDITIONS ON PDH.
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The Development of PDH after Weaning to a High-Fat Diet and the Long Term 
Effects of Different Weaning Conditions on PDH.
4.1 INTRODUCTION
Previous studies involving weaning of suckling rats to a high-fat diet have 
shown that the overall metabolic profile remains similar to that found during suckling. 
Whilst the typical chow diet normally used for weaning contains 50-60% 
carbohydrates, a high-fat diet typically contains <1%  carbohydrate, 25-37% protein 
and 30-72% fat, the remainder being made up with cellulose and vitamin and mineral 
mix (wt/wt; Vernon & Walker 1968a; Decaux et al 1986; Perdereau et al 1990). Rat 
milk contains only 10% carbohydrates, 40% protein and 50% fat (wt/wt; Jennesse 
1974 see Figure 1.2).
The use of a high-fat diet for weaning instead of the natural high-carbohydrate 
diet allows the effects of the weaning process to be investigated whilst maintaining 
the high-fat content found during suckling. The provision of a high-fat diet mimics 
the maternal milk, and thereby prevents the changes in metabolic flux. This provides 
the ideal environment to firmly establish whether enzyme changes occurring after 
high-carbohydrate weaning are due to the changing diet or are controlled by other 
endogenous factors.
Weaning to a high-fat, carbohydrate-free diet rather than a high-carbohydrate
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diet has been shown to prolong the metabolic state found during suckling. 
Gluconeogenesis remains active after high-fat weaning, with lactate incorporation into 
glucose still at 75% of suckling values, 9 days after weaning (Decaux et al 1986). 
In the liver, PEPCK mRNA remains at suckling levels and activity falls only slightly 
to 75% of suckling levels (Perdereau et al 1990). In adipose tissue, weaning to a 
high-fat diet causes a 33 % rise in PEPCK activity compared to suckling values and 
PEPCK mRNA fell slightly (Coupé et al 1990). Closer examination of the time 
course for the changes in adipose PEPCK mRNA after high-fat weaning by force- 
feeding 21 day old pups showed PEPCK mRNA levels to fall to approximately 50% 
of suckling levels within 1 hour of weaning (Coupé et al 1990). Other hepatic 
gluconeogenic enzymes such as glucose 6 -phosphatase and fructose 1 ,6 -biphosphatase 
also remain active after weaning to a high-fat diet (Vernon & Walker 1968a).
During normal weaning to a diet with a higher carbohydrate content than milk, 
insulin concentrations increase and glucagon concentrations decrease (Girard et al 
1977; Perdereau et al 1990). Weaning to a high-fat diet, prevents the large increase 
in insulin concentrations seen in high-carbohydrate weaning and insulin levels remain 
low (31 ±  6  compared to 49 ±  6  /xU/ml) but higher than in suckling rats (23 ±  
3/xU/ml; Issad et al 1988; Coupé et al 1990; Foufelle et al 1992a). Coupé et al 
(1990) demonstrated a small increase in insulin concentrations compared to water-fed 
controls after force-feeding a high-fat carbohydrate-free diet, although levels were still 
lower than in carbohydrate-weaned equivalents. These increases in insulin 
concentrations in the absence of glucose are thought to be due to insulinotropic factors 
such as gastric inhibitory polypeptide (GIP) and may be partly responsible for the
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decrease in PEPCK mRNA levels seen after high-fat forced weaning (Brown et al 
1975; Falko et al 1975; Hampton et al 1983).
After weaning to a high-fat diet, hepatic glucokinase activity and mRNA 
increase to 40-50% of levels found in high-carbohydrate-weaned controls. These 
values are 4- to 5-fold higher than those found in 15 day old suckling pups (Perdereau 
et al 1990) and suggest that gene transcription is activated at weaning despite the low 
substrate levels for glucokinase.
The activity of the lipogenic enzymes, fatty acid synthase and acetyl-CoA 
carboxylase (ACC), remain low after weaning to a high-fat diet, in contrast to the 
rapid increase observed after weaning to a high-carbohydrate diet in the liver and 
adipose tissue (Coupé et al 1990; Perdereau et al 1990). Concentrations of mRNA 
also remain at suckling levels after imposed weaning, suggesting enzyme regulation 
at the gene expression level (Coupé et al 1990). These results were further 
substantiated by experiments in which force-feeding a high-fat diet produced no 
increase in fatty acid synthase mRNA and only a very small increase in ACC mRNA 
(to less than 15% of levels in carbohydrate force-fed controls) in adipose tissue 
(Coupé et al 1990).
The fatty acid composition of the diet appears to be important in regulating 
fatty acid synthase and ACC, since a high-fat diet containing long-chain fatty acids 
prevents the increase in lipogenic enzyme activities and mRNA despite less than 1 % 
carbohydrate content, but medium-chain fatty acids only slow the increase seen with
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a carbohydrate-rich diet (Foufelle et al 1992a; see section 1.4.5.1). The medium- 
chain diet stimulated a similar insulin release to that found with a high-carbohydrate 
diet but the long-chain diet induced much lower insulin concentrations, although 
levels were still higher than during suckling.
Thus, during high-fat feeding of newly weaned rats, glucose homeostasis is 
maintained by continued gluconeogenesis, and lipogenic enzyme activities remain low. 
Insulin levels are decreased compared to high carbohydrate weaned rats but are 
elevated from suckling levels. Glucokinase activity is sufficient to allow some 
glucose metabolism in the liver. Therefore, in order to preserve the glucose units for 
resynthesis, hepatic PDH activity would be expected to be low during high-fat 
feeding, to facilitate gluconeogenesis and to only rise if the glucose content of the diet 
increases. Although the heart is unable to synthesize glucose via gluconeogenesis, 
rapid flow of glucose units through cardiac PDH and into the citric acid cycle would 
quickly deplete glucose supplied by the liver. Therefore, since the heart readily 
adapts to fatty acid oxidation, it is likely that after high-fat weaning, jS-oxidation is 
the primary energy supply in the heart, as in suckling.
Hence in this study, PDH activity in the liver and heart have been assessed in 
rats weaned to a high-fat diet at 20 days in order to establish whether PDH activity 
is low after high-fat weaning allowing preservation of the minimal glucose supplies 
available. The dietary influence of the high-fat diet on total PDH activity was 
measured since continued j8 -oxidation after weaning might be expected to down- 
regulate PDH synthesis. From these results it was hoped that the possible
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interference of a stress effect as a result of the removal of the mother using the high- 
fat diet could be clarified, since the weaning process as such continued as before but 
the dietary adaptation is removed. The concentration of hepatic glycogen was 
measured since it acts as an indicator of the carbon flux and is strongly influenced by 
the PDH activity. The influence of the diet and maturity of the rat on the citrate 
synthase activity was determined after high-fat weaning since it acts as a marker of 
mitochondrial activity.
The longer-term effects of different weaning regimes (high-fat, high- 
carbohydrate, imposed weaning and spontaneous weaning) on PDH activity (total and 
active) were assessed by comparing activity in 36 days old and adult rats weaned at 
2 0  days to a high-carbohydrate or high-fat diet, or weaned spontaneously, in order 
to establish whether reduced PDH activity in 36 day old rats persists into adulthood, 
regardless of diet. In this way the effects of high-fat weaning in particular on the 
expression of PDH after reverting to the ‘normal’ diet could be determined.
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4.2 METHODS
4.2.1 Animals
Animals were housed as detailed in 2.2.1. When the pups reached 18 days 
of age the maternal diet was changed to a high-fat diet to prevent access to the pups 
of the carbohydrate containing chow. The mother was left with the pups until 20 
days when they were weaned by removing the mother. The pups were maintained 
on the high-fat diet until 36 days.
For the longer term studies through to adulthood, three groups of 10 pups 
were used. One group of pups were allowed to spontaneously wean to chow (high- 
carbohydrate), the second group were weaned to chow at 2 0  days and the third group 
were changed to a high-fat diet at 18 days and weaned at 20 days. At 36 days half 
of each group were taken for total PDH assays and the remaining animals all given 
a chow diet and the mother removed from the spontaneously weaned group. The rats 
were then allowed to grow to maturity (50 days).
4.2.2 Diet
The high-fat diet contained approximately 72% fat and 28% protein in 
calorific terms. The diet contained;
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37g Caesin 
13g Peanut Oil 
30g Lard (animal)
15g Cellulose
5g Vitamin and Minerai Mix
(Decaux et al 1986) i 
Caesin, cellulose and vitamin mix were obtained from Special Diet Services, 
Manea, Cambridgeshire. Peanut oil was obtained from Sigma Chemicals, Poole.
4.2.3 Enzyme Assays
PDH (total and active), citrate synthase, glycogen and insulin were measured 
as detailed before in sections 2.2 and 3.2.
4.2.4 Statistical Analysis
Statistical analysis was performed as detailed in section 3.2.8. For 
comparison with high-carbohydrate weaning, 2  factor analysis of variance were used 
(factors: ‘age’ =  age of rats, ‘treatment’ =  diet type, ‘age by treatment’ =  interaction 
of age and diet). Only points after the diet was changed, i.e. 18 days were used for 
these comparisons.
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4.3 RESULTS
Throughout this chapter, the data reported for animals before 18 days are the 
same as those used in the spontaneously weaned experiments (chapter 2 ) since the diet 
was not changed until 18 days. In addition, activity found in rats weaned to the 
normal high-carbohydrate chow diet at 20 days is also shown on the graphs. These 
data have only been included here to facilitate comparison between pre- and post- 
weaning situations and the different diets.
The weight gains after weaning to the high-fat diet were similar to those seen 
for high-carbohydrate-weaned rats (Figure 4.1).
4.3.1 High-Fat Weaned
PDH activity in the liver remained at suckling levels between 18 and 36 days 
after weaning to a high-fat diet (Figure 4.2). Although an age effect was seen 
(p <  0 .0 1 ) in the weaned rats, no overall difference was obvious between suckling and 
post-weaning. When compared with high-carbohydrate-weaned animals, significantly 
lower overall PDH levels were seen with the high-fat diet (p < 0.001).
Total PDH activity was 8  to 10-fold higher than the active PDH form in the 
liver from 14 days onwards (Figure 4.3). Total PDH levels appeared to be 
unaffected by the high-fat diet and to reach the same levels found in rats weaned to 
a carbohydrate rich diet. The ratio of active form to total PDH was between 10 and
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20% throughout suckling and after weaning to high-fat diet.
Cardiac PDH also remained at low levels after weaning to the high-fat diet 
(Figure 4.4). A significant decrease in PDH activity with age was seen (p < 0.001). 
Comparison with high-carbohydrate weaned rats showed a significant decrease in the 
overall PDH levels with the high-fat diet (p<  0.001).
Cardiac total PDH activity was also 2 to 3-fold higher than the active PDH 
form (Figure 4.5). The increase in total PDH seen with the high-fat diet was smaller 
than with the high-carbohydrate diet (25.0 ±  2.9 to 30.5 ±  4.2mU/U for high-fat 
compared with 32.7 ±  0.7 to 39.3 ±  2.4mU/U for the high-carbohydrate diet). The 
ratio of active to total PDH was between 10 and 50% after weaning.
The glycogen content of the liver fell after weaning and remained low until 
30 days when it rose slightly (Figure 4.6). A significant age effect was seen for 
weaning to a high-fat diet alone (p < 0.001). Comparison with high-carbohydrate 
weaned rats showed a significant decrease in the glycogen content of the liver with 
the high-fat diet (p<  0 .0 0 1 ).
Hepatic citrate synthase increased after weaning (p<  0.001; Figure 4.7) and 
values at days 21 to 36 were significantly higher than suckling levels (p<0.05; 
Duncans Multiple Range). A significant increase in citrate synthase activity with age 
was seen when compared with high-carbohydrate-weaned rats (p<  0 .0 0 1 ) but no diet 
effect. A combined age and diet effect was seen and activity was marginally lower
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with the high-carbohydrate diet (p<0.05).
The cardiac citrate synthase activity was also altered little by the high-fat diet 
compared to the high-carbohydrate diet (Figure 4.8). Activity rose steadily for the 
high-fat-weaned rats with days 21 to 36 higher than during suckling (p<0.01; 
Duncans Multiple Range). Comparison of activity in high-fat and high-carbohydrate- 
weaned rats showed no effect of diet overall on the citrate synthase activity.
Insulin levels were lower for high-fat weaning than high-carbohydrate 
(p<  0.005) although no comparison could be made with suckling levels (Figure 4.9).
4.3.2 Long-term Effects of Weaning Conditions on PDH
Activity of hepatic PDH was significantly higher in the rats weaned at 20 days 
to a high-carbohydrate diet (48.8 ±  4.5mU/U) than in the other two dietary groups 
at 36 days (20.6 ±  3.0mU/U, spontaneously weaned; 5.7 ±  O.lmU/U, high-fat 
weaned; p< 0 .01 ; Figure 4.10). By adulthood, the activity seen was approximately 
the same for all three groups. Total PDH activity in adults was lower in the high-fat- 
weaned than in the high-carbohydrate-weaned rats (p<0.05; Figure 4.11). Cardiac 
PDH activity was higher in 36 day old rats in the high-carbohydrate-weaned groups 
than in the high-fat-weaned groups, regardless of the time of weaning (p < 0 .0 1 ; 
Figure 4.12). Adult values however, were approximately the same for all dietary 
groups. Total PDH activities in the adults were not significantly different (Figure 
4.13).
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Figure 4.1 Weight Increases in Rats Weaned
to High-Fat Diet at 20 Days
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Increases in weight throughout suckling and 
weaning to a high-fat diet. Each point represents 
the mean (n 5) ± S.E.M. Where errors are not 
shown, S.E.M. is below the limit of the symbol.
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Figure 4.2 Development of Active Hepatic Pyruvate
Dehydrogenase Activity in Rats Weaned to a High-Fat
or High-Carbohydrate Diet at 20 Days
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The development of PDH/citrate synthase activity ratio is 
compared in rats weaned at 20 days to either a high-fat (# )  or 
high-carbohydrate diet (O). Each point represents the mean (n 
^ 4) ±  S.E.M. Significant increase with age seen for high-fat 
diet, p<0.01 (ANOVA). A significant age effect, p<0.001, 
treatment effect, p<0.001 and age by treatment effect, p<0.001 
seen when compared to high-carbohydrate diet weaning.
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Figure 4.3 Total and Active Hepatic PDH during Suckling
and After Weaning to a High-Fat Diet at 20 Days
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(a) Total hepatic PDH (■) and active form ( # )  throughout 
suckling and after weaning at 20 days to a high-fat diet. Each 
point represents the mean (n ^ 4) ± S.E.M. Significant age effect 
seen for total PDH, p<0.001 (ANOVA; see figure 4.2 for details 
of active form), (b) Ratio active to total PDH ( ♦ )
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Figure 4.4 Development of Active Cardiac Pyruvate
Dehydrogenase Activity in Rats Weaned to a High-Fat
or High-Carbohydrate Diet at 20 Days
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The development of PDH/citrate synthase activity ratio is compared in 
rats weaned at 20 days to either a high-fat (# )  or high-carbohydrate diet 
(O). Each point represents the mean (n ^  4) ±  S.E.M. Significant 
increase with age seen for high-fat diet, p<0.001 (ANOVA). A 
significant treatment effect, p<0.001 and age by treatment effect, p<0.05, 
seen when compared to high-carbohydrate diet weaning (ANOVA).
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Figure 4.5 Total and Active Cardiac PDH during Suckling
and After Weaning to a High-Fat Diet at 20 Days
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(a) Total (■ ) and active form ( # )  of cardiac PDH throughout 
development and after weaning at 20 days to a high-fat diet. 
Each point represents the mean (n > 4) ± S.E.M. Significant age 
effect seen for total PDH, p<0.001 (ANOVA; see figure 4.3 for 
details of active form), (b) Ratio active to total PDH (♦).
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Figure 4.6 Comparison of Glycogen Content of Liver
in Rats Weaned to Either a High-Fat or High-
Carbohydrate Diet at 20 Days
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The glycogen content of the liver is compared throughout 
development after weaning to a high-fat (# ) or high-carbohydrate 
(O) diet. Each point represents the mean (n > 4) ± S.E.M. 
Significant increase in glycogen content with age for high-fat 
weaning, p<0.001 (ANOVA). A significant age effect, p<0.01, 
treatment effect, p<0.001, and age by treatment effect, p<0.001, 
seen when compared to high-carbohydrate weaning (ANOVA).
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Figure 4.7 Development of Hepatic Citrate Synthase
Activity in Rats Weaned at 20 Days to Either a High-Fat
or High-Carbohydrate Diet
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The development of hepatic citrate synthase is compared in rats 
weaned at 20 days to either a high-fat (# )  or high-carbohydrate 
diet (O). Each point represents the mean (n ^ 4) ± S.E.M. 
Significant increase in activity with age seen for high-fat 
weaned, p<0.001 (ANOVA). Significant age by treatment effect 
seen when high-fat weaned is compared to high-carbohydrate 
weaned, p<0.05 (ANOVA).
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Figure 4.8 Development of Cardiac Citrate Synthase in
Rats Weaned at 20 Days to Either a High-Fat or High-
Carbohydrate Diet.
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The development of cardiac citrate synthase throughout 
suckling and weaning at 20 days to a high-fat diet (# )  is 
compared to weaning to a high-carbohydrate diet (O).
Each point represents the mean (n 4) ± S.E.M. Significant 
increase with age seen for high-fat diet, p<0.001 (ANOVA).
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Figure 4.9 Serum Insulin Concentrations in Rats
Weaned at 20 Days to Either a High-Fat or High-
Carbohydrate Diet.
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or
high-carbohydrate (^ )  diet are compared. Each point 
represents the mean (n ^ 4) ± S.E.M.
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Figure 4.10 Hepatic Pyruvate Dehydrogenase Activity 
in 36 Day Old and Adult Rats after Weaning to 
Different Diet Regimes.
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Hepatic PDH activity in rats weaned to high-fat (HF) or high- 
carbohydrate (HCHO) diet at 20 days or maintained with mother 
until 36 days (spontaneous) is compared in 36 day olds ( |D  and 
adults (□ ). AU groups were changed to high-carbohydrate diet at 
36 days and mother removed from spontaneous group. Each point 
represents the mean (n ^ 4) ± S.E.M. **p<0.01; significant 
differences seen for HCHO and spontaneous compared to HF at 36 
days (ANOVA followed by Duncans Multiple Range).
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Figure 4.11 Total and Active Form of Hepatic PDH
in Adults after different Weaning Conditions
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Hepatic total ( ^ )  and active (HI) PDH was measured in adult rats 
after weaning to either a high-carbohydrate (HCHO) or high-fat (HF) 
diet or maintaining with mother until 36 days (spontaneous). At 36 
days all groups were changed to high-carbohydrate diet and mother 
was removed from spontaneous group. Each point represents the 
mean (n ^ 4) ± S.E.M. *p<0.05; significant differences for HCHO 
total activity compared to HF (ANOVA followed by Duncans 
Multiple Range).
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Figure 4.12 Cardiac Pyruvate Dehydrogenase Activity 
in 36 Day Old and Adult Rats after Weaning to 
Different Diet Regimes
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Cardiac PDH activity in rats after weaning at 20 days to either a 
high-carbohydrate (HCHO) or high-fat (HF) diet or maintained 
with mother until 36 days (spontaneous) is compared in 36 day 
olds (H )  and adults ( □ ) .  All groups were changed to high- 
carbohydrate diet at 36 days and mother removed from 
spontaneous group. Each point represents the mean (n ^  4) ± 
S.E.M. **p<0.01; significant differences seen for HCHO and 
spontaneous compared to HF (ANOVA followed by Duncans 
Multiple Range).
190
Figure 4.13 Total and Active Cardiac PDH in Adults
after different Weaning Conditions
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Cardiac total (Q )  and active ( II)  PDH was measured in adult 
rats after weaning to either high-carbohydrate (HCHO) or high-fat 
(HF) diet or maintained with mother until 36 days (spontaneous). 
All groups were changed to high-carbohydrate diet at 36 days and 
mother removed from spontaneous group. Each point represents 
the mean (n ^ 4) ± S.E.M.
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4.4 DISCUSSION
The solid high-fat diet used throughout this study contained 43% fat as peanut 
oil and lard and 37% protein compared to rat milk which typically contains 50% fat, 
40% protein and 10% carbohydrate (wt/wt; Jennesse 1974; Decaux et al 1986). A 
comparison of the fatty acid composition of the diet and milk is shown below (Table 
4.1).
Fatty Acid 1 2 : 0 14:0 16:0 18:0 18:1 18:2 Other
Milk 1 0 1 2 30 3 19 1 1 15
High-Fat
Diet
Peanut
Oil
Tr Tr 1 1 3 49 29 8
Lard Tr 2 27 16 41 9 5
Total - 2 2 2 1 2 43 15 6
Table 4.1 Fatty acid composition of the milk and high-fat diet as a percentage of the 
overall fat content of the two diets. ‘Tr’ =  trace amounts. Data from Jennesse 1974 
and McCance 1992.
Weaning to a high-fat diet proved a useful tool for confirming the extent of 
the dietary influence on the changing PDH activity and total PDH content and the 
activity of citrate synthase. Although in the previous chapters hepatic PDH appeared
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to be mainly regulated by the increased carbohydrate content of the diet at weaning, 
the heart activity rose before weaning suggesting that an endogenous factor may also 
be involved. Citrate synthase activity was also increased by carbohydrate feeding, 
but the timing of enzyme activation suggested that hepatic citrate synthase was 
regulated by the dietary carbohydrate whereas the heart enzyme activity increased at 
the same rate in both spontaneous and imposed weaning (see Chapters 2 and 3).
Weaning rats to a high-fat diet completely suppressed the increase of PDH 
activity observed after carbohydrate weaning and activity remained near suckling 
levels in both the liver and the heart. The low levels of PDH after high-fat weaning 
suggests that either the oxidation of exogenous fats or the lack of carbohydrate 
prevents activation of PDH, as might be expected. Since no change in PDH activity 
was seen in the absence of increased carbohydrate intake, these results would also 
preclude the influence of a stress or age effect at weaning. Thus PDH activity is 
under dietary control at weaning and not an age effect.
In contrast, after high-fat weaning, total PDH activity increased to similar 
values to those seen in the high-carbohydrate-weaned rats and appeared to be 
unaffected by the diet suggesting the involvement of an age-effect (see Figures 3.5, 
3.6, 4.3 and 4.5). Since the increase in total activity begins before 14 days, there 
cannot be an effect of stress associated with the weaning process on the synthesis of 
total PDH. Total PDH enzyme content of the liver and heart therefore appears to 
increase in preparation for a high-carbohydrate diet in advance of weaning. Indeed, 
total PDH content appears to be sufficient for substantial activation as early as 14
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days. At weaning to a high-fat diet therefore, the PDH complex remains in its 
phosphorylated, inactive form but a high-carbohydrate diet permits activation.
Previous studies on total PDH activity after high-fat feeding in adults suggest 
that PDH content is not reduced by fat-containing diets compared to chow, in the 
liver (Stansbie et al 1976; Da Silva et al 1993) and heart (Vary & Randle 1984). 
Total activity is reported to remain constant throughout prolonged periods of 
starvation despite the increase in fatty acid oxidation (Caterson et al 1982; Denyer et 
al 1986). Thus synthesis of total PDH does not seem to be reduced by fatty acid 
oxidation but is increased by a fat-free diet.
The glycogen content of the liver remains low after weaning to a high-fat diet. 
The low PDH activity would favour glycogen synthesis in the presence of sufficient 
carbohydrate, however, during high-fat feeding the low carbohydrate intake would 
preclude this. Therefore the low glycogen synthesis rate and PDH activity confirms 
the view that hepatic glucose production via gluconeogenesis is sufficient for use by 
other tissues but cannot produce enough for glycogen synthesis. Hence, glycogen 
synthesis is regulated by the carbohydrate content of the diet at weaning.
As with spontaneous weaning and 20 day weaning to a carbohydrate diet, 
cardiac citrate synthase rises steadily after high-fat weaning. Cardiac citrate synthase 
appears to be unaffected by the time of weaning or the composition of the diet and 
hence, an endogenous, age effect is considered to be instrumental in the activation of 
cardiac citrate synthase. In contrast, hepatic citrate synthase rises rapidly after
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weaning to the high-fat diet. This is similar to the situation found in the high- 
carbohydrate-weaned but not in the spontaneously-weaned rat, implying that the 
weaning process itself has an effect on hepatic citrate synthase rather than the 
composition of the diet.
Studies of the long-term effects of the time of weaning and dietary 
composition on the activity of PDH showed no difference in the active form of the 
enzyme in either the liver or heart of adults, whether they had been spontaneously 
weaned or weaned at 2 0  days to either a high-fat or high-carbohydrate diet before 
changing to the chow at 36 days. Activity at 36 days was considerably lower in the 
high-fat weaned rats (Figures 2.2, 3.3 and 4.2) but after changing to the same 
carbohydrate-rich diet as the other groups, the activity increased to the same levels. 
Total PDH concentrations in the heart were unaffected by the weaning regime and 
were equal in all three groups of adults. In the liver however, total PDH activity was 
slightly lower in the high-fat weaned adults despite the dietary change at 36 days. 
Hence the weaning diet could have a long-term effect on the PDH content of the 
liver. This may not be detrimental to the rat, however, since the percentage of the 
active from of PDH in adults normally ranges between 10-20% (for examples see 
Holness et al 1990; Da Silva et al 1993) and a small reduction in the total PDH 
content of the liver could be compensated for by an increase in the active proportion.
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CHAPTER 5 
PYRUVATE DEHYDROGENASE KINASE mRNA 
DURING DEVELOPMENT.
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Pyruvate Dehydrogenase Kinase mRNA during Development
5.1 INTRODUCTION
Investigation of enzyme synthesis can be made using molecular biological 
techniques. Activation of enzyme synthesis can be investigated at gene transcription 
level by measuring specific messenger ribonucleic acids (mRNA) expression using 
deoxyribonucleic acid (DNA) or RNA probes which encode for the enzyme.
To date DNA probes have been isolated for a number of metabolic enzymes 
including PDH (Dahl et al 1987; Matuda et al 1987; Koike et al 1988; De Meirleir 
et al 1988; Ho et al 1988; Fitzgerald et al 1992), glucokinase (lynedjian et al 1987), 
PEPCK (Yoo-Warren et al 1981), ACC (Bai et al 1986), hexokinase 1 (Schwab & 
Wilson 1989; Nishi et al 1988), fatty acid synthase (Nepofroeff et al 1984), 3- 
hydroxy 3-methylglutaryl-CoA synthase (Ayte et al 1990Z?) and pyruvate kinase 
(Simon et al 1983). The human insulin receptor (Ebina et al 1985), and rat 
pancreatic pro-glucagon cDNA have also been cloned (Heinrich et al 1984). These 
clones have been used to investigate precisely some of the regulatory properties and 
mechanisms of enzyme activation or inhibition (for examples see Benvenisty et al 
1987; Bossard et al 1993).
Developmental changes in mRNA levels for glucokinase, hexokinase, fatty 
acid synthase, PEPCK, ACC, L-type pyruvate kinase and 3-hydroxy 3-methylglutaryl- 
CoA synthase have been measured in the rat (see Table 1.2; lynedjian et al 1987;
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Lyonnet et al 1988; Coupé et al 1990; Perdereau et al 1990; Griffin et al 1992; Serra 
et al 1993; Bossard et al 1993). Hepatic 3-hydroxy 3-methylglutaryl-CoA synthase 
and PEPCK mRNA levels decrease with increased carbohydrate intake and insulin 
concentrations at weaning (Garcia-Ruiz et al 1978; Perdereau et al 1990; Serra et al
1992), and largely in parallel with changes in activity. Glucokinase, ACC and fatty 
acid synthase, activity and mRNA increase at weaning (lynedjian et al 1987; Coupé 
et al 1990; Perdereau et al 1990) or after glucose administration to 10 day old 
suckling rats (Bossard et al 1993). Hence, the activation or inactivation of these 
enzymes at weaning is due to altered transcription of the gene and not simply due to 
a change in enzyme stability, phosphorylation state or substrate regulation.
The potential for transcription of some genes involved in metabolism appears 
to be altered during development. PEPCK has been shown to be heavily methylated 
in the early foetus and undergoes déméthylation before birth allowing transcription 
to occur (Benvenisty et al 1985a & 1985Z?). Use of a methylase inhibitor 
(Azacytidine) induced premature accumulation of mRNA in the foetus, suggesting that 
cessation of méthylation at birth may allow PEPCK mRNA synthesis (Benvenisty et 
al 1985Z?; Rothrock et al 1988). Additionally, the gene appears to change from a 
‘closed’ structure (in which DNA is in double-helical, unreadable form) to an ‘open’, 
readable structure before birth (Benvenisty et al 1987) possibly under the control of 
regulatory proteins that bind to the PEPCK gene around this time (Trus et al 1990).
Hepatic glucokinase mRNA has been shown to remain low in foetuses after 
artificial elevation of the insulin/glucagon ratio, but to be increased in 1 0  day old rat
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neonates after a similar rise in the insulin/glucagon ratio (Bossard et al 1993). It is 
suggested that this may also be due to a change in the configuration of the gene from 
‘closed’ in the foetus to ‘open’ after birth. The increased glucokinase activity at 
weaning is due to increased expression of the glucokinase gene and mRNA synthesis 
(lynedjian et al 1987) as a result of the raised insulin/glucagon ratio (Bossard et al 
1993).
Complementary DNA (cDNA) clones for the E l a  and EljS (Dahl et al 1987; 
Koike et al 1988; De Meirleir et al 1988; Ho et al 1988; Fitzgerald et al 1992), E2 
(Matuda et al 1987) and E3 (Thekkumkara et al 1987; Thekkumkara et al 1988; Pons 
et al 1988; see Patel et al 1990) subunits of mammalian PDH and PDH kinase (Popov 
et al 1993) have been isolated and characterised. The somatic E la  unit has been 
shown to map to the X chromosome in humans (De Meirleir et al 1988; Brown et al 
1989) and a testis-specific form encodes to chromosome 4 (Takakubo & Dahl 1992). 
The EljS subunit is located on chromosome 3 (Chun et al 1990). Northern blotting 
analysis of concentrations of E la  mRNA in different tissues showed adult rat heart 
and kidney concentrations to be approximately equal and 5-fold higher than in the 
liver, with brain concentrations slightly higher than in the liver (Cullingford et al
1993).
At present, information about the transcription of the PDH subunits either at 
birth or during subsequent growth is scarce. Weaning at 19 days has been shown to 
increase the E l a  mRNA concentration in adipose tissue, compared to suckling rats 
(Maury et al 1992). Western blotting techniques have shown an increase in the E l a  
protein immediately after birth, with a parallel increase in PDH activity (Serrano et
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al 1989) but no measurements were made of the mRNA. Whether PDH regulatory 
mechanisms alter at birth, as with glucokinase and PEPCK, is unknown at present.
In contrast to PEPCK and glucokinase, PDH activity is controlled by an 
associated kinase. Alterations in PDH activity must therefore also be considered in 
the light of possible changes in the activity of the regulating PDH kinase. Increases 
in PDH activity at weaning have been shown to be due to activation of inactive PDH 
enzyme already present and may be due to the changing hormonal balance of insulin 
and glucagon. However, in the adult, eardiovc PDH has been shown to be relatively 
insensitive to insulin stimulation and therefore another factor may also be involved 
in PDH stimulation at weaning. The activity and synthesis of PDH kinase throughout 
development is therefore of some interest.
A cDNA probe for PDH kinase from rat heart has recently been isolated 
(Popov et at 1993). This probe encodes a 434 amino acid protein, similar to 
branched chain a-ketoacid dehydrogenase kinase (Popov et al 1992) and showing 
PDH kinase activity. In the present work, using this probe kindly donated by Dr 
R.A.Harris, Indiana University School of Medicine, Indiana, it was possible to 
measure the levels of PDH kinase mRNA expression during the development of the 
rat. Northern blotting techniques with both digoxigenin and ^^ P labelling were 
employed to measure the levels of expression of PDH kinase during the suckling and 
weaning transition and in high-fat weaned rats.
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5.2 MATERIALS AND METHODS
5.2.1 Summary of Methods
Two methods of detection were employed for measurement of PDH kinase 
expression in liver samples, using either digoxigenin or ^^ P labelling. Digoxigenin 
labelling required transfer of the probe from the pUC18 vector to pSPT18. This was 
achieved by cutting the cDNA probe/pUC18 vector by digestion and purifying the 
band corresponding to the 1.1Kb of the probe. This DNA was then inserted into the 
pSPT18 plasmid DNA by ligation and introduced into competent bacterial cells by 
transformation, allowing replication. After replication, the circular plasmid DNA was 
separated from the bacterial DNA and linearised to allow transcription using 
digoxigenin labelled UTP. After binding (hybridising) the resulting RNA probe to 
the PDH kinase in the liver samples, the digoxigenin was detected with a specific 
antibody which could be labelled with the fluorescent dye, Lumigen, and exposed to 
X-ray film for 1 hr.
^^ P labelling of the probe was also used since it allowed the production of the 
probe in a different plasmid and is thought to be more sensitive. Use of the ^^ P label 
did not require the transfer of the probe to another plasmid, but required 2-3 weeks 
exposure of the radiolabel to the X-ray film. The probe required amplification and 
purification as for the digoxigenin labelled probe and transcription to produce the 
radiolabelled DNA probe. The probe was hybridised to the liver PDH kinase and 
exposed to X-ray film for 3 weeks.
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5.2.2 Materials 
RNAzol; Biogenesis
REact 3, EcoRl, Glassmax DNA Purification Kit and RNA ladder Marker (9.5, 7.5,
4.4, 2.4, 1.4 & 0.24Kb); Gibco BEL 
Spermidine and Herring sperm DNA; Sigma
4»X174/Hae HI marker (1.353, 1.078, 0.872, 0.603, 0.310, 0.275, 0.234, 0.194, 
0.118 & 0.072Kb), X/Hind III marker (23.13, 9.416, 6.557, 4.361, 2.027, 0.564 & 
0.125Kb), DIG RNA Labelling Kit, Lumigen, Positively charged nylon membrane 
and Blocking agent; Boehringer Mannheim Biochemica
Hind III enzyme, Pvu II enzyme. Digestion Buffer B Wizard MiniPrep Kit and
pSPT18 Vector (3.1Kb); Promega
^2p-dCTP; ICN Flow
Nick Column and buffer; Pharmacia
Megaprime Labelling Kit, Amersham
5.2.3 General Experimental Procedures
All of the molecular biology techniques used in this chapter were performed 
under sterile conditions using sterile equipment and buffers. Gloves were worn at all 
times. Throughout this work 0.1% diethyl-pyrocarbonate (DEPC) water was used. 
RNA is extremely susceptible to degradation and therefore all RNA samples were 
kept at -70°C or on ice when in use.
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5.2.4 Digestion and Purification of cDNA Probe
The cDNA probe was supplied as a 1.1Kb insert in pUC18 plasmid (2.7Kb). 
The probe was cut from the pUC18 vector by digestion with 3fil EcoRl, 6fil 
REact 3, 6fil 40mM spermidine and 5^1 water, for 2hrs at 3TC. The resulting digest 
(60/d) was incubated with 6fil of running dye (bromophenol blue) at 65°C for 5 
minutes and then run on a 0.8% agarose in Tris Acetate EDTA buffer gel. Two 
DNA size markers were run alongside, $X174/Hae III and X/Hind III. The gels 
were run at 100-150mA for Vz-lhr. The gels were stained with ethidium bromide and 
viewed under UV light (Figure 5.1). The band corresponding to the PDH kinase 
cDNA probe was removed from the gel with a sterile scalpel and placed in a pre­
weighed Greiner tube.
Purification of the band from the residual gel was undertaken using a 
Glassmax kit containing binding solution, wash buffer and filter cartridges. 4.5ml 
of binding solution (containing Nal) was added per gram of gel/cDNA sample, and 
the gel dissolved by incubation at 65°C for 5-10 minutes. The resulting solution was 
filtered through provided cartridges into an eppendorf tube, by centrifuging at 2 0 0 g 
for 20 seconds. The cartridge was washed 3 times with 400jxl wash buffer and 
centrifugation for 20 seconds. The cartridge was then spun for a final minute at 200g 
before transferring to a clean tube and the cDNA was eluted by addition of 40^1 
water at 65°C and spinning for 20 seconds.
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The cDNA sample was concentrated by ethanol precipitation. 8 /xl of 7.5M 
NH4 OAC and lOOjul ethanol was mixed with the cDNA sample and left in liquid 
nitrogen for 15 minutes, before spinning at 200g, 4°C for 25 minutes. The 
supernatant was discarded and the pellet washed with 70% ethanol (to remove salt). 
After re-centrifugation and removal of the supernatant, the pellet was dried and 
resuspended in 5fjd water. The resulting cDNA solution was stored at -20°C.
5.2.5 Preparation of cDNA Probe for Detection with Digoxigenin-UTP
5.2.5.1 Ligation
Ligation was performed to insert the cDNA into pSPT18 (3 .1Kb) vector DNA 
using a ligase enzyme. 5^1 of cDNA was incubated with 3/xl vector DNA, Ijul 10 x 
ligation buffer and 1^1 T4 DNA ligase at 16°C overnight.
5.2.5.2 Transformation
Competent cells are used for transformations since they absorb the plasmid and 
allow rapid replication of the plasmid DNA. 200^1 of E.coli Y1090 competent cells 
were added to Ijul of ligation reaction or 1 / 1 0  dilution of the ligation reaction in 
water, and held on ice for 40 minutes. The cells were heat shocked at 42°C for 1 
minute and then returned to the ice. 1ml of Luria-Bertaini (LB) media was added and 
the cells shaken for l-lVihrs at 37°C, to allow recovery of the cells. lOOpl or 200jul 
of the cells were then plated out on to LB agar plates, containing 50jng/ml ampicillin
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and incubated at 37°C overnight.
LB media contains lOg Bacto-tryptone, 5g Bacto-yeast extract and 5g NaCl, 
pH 7.5 (adjusted with NaOH).
5.2.5.3 Cracking of Transformed Cells
Cracking of the competent cells was performed to permeabilise the cells and 
recover the DNA, before verifying that the cDNA probe had successfully been ligated 
into the pSPTlS plasmid. Individual colonies resulting from the overnight incubation 
were labelled, picked, and transferred to an eppendorf containing 50^1 lOmM EDTA, 
pH8.0 and 50^1 of freshly prepared cracking buffer. 50ml of cracking buffer 
contained 0.2M NaOH, 0.5% sodium dodecylsulphate (SDS) and lOg of sucrose. 
Samples were mixed and incubated at 70°C for 30-40 minutes to lyse the bacteria, and 
then left to cool to room temperature. 1.5ftl of 4M KCl and 2ptl of DNA running dye 
were added to each tube, mixed and held on ice for 5 minutes before centrifuging at 
200g, 4°C for 3 minutes to precipitate the cell debris. 25^1 of the supernatant was 
run in a 1% agarose gel with suitable DNA markers as before. Samples that 
contained a plasmid band corresponding to the 4.2Kb for PDH kinase cDNA-sPT18, 
were selected for overnight culture (Figure 5.2).
Samples from the previous overnight culture on the plates, corresponding to 
the selected bands in the cracking procedure were incubated in 10ml of LB buffer 
containing 50/^g/ml ampicillin overnight at 37°C.
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5.2.5.4 Plasmid Purification with Miniprep System
After amplification of the plasmid by growing it in culture, the plasmid was 
extracted from the cells. This involved the use of a Wizard MiniPrep DNA 
purification kit from Promega containing cell suspension solution, cell lysis solution, 
neutralisation solution, purification resin, column wash solution and minicolumns.
3 ml of each overnight culture were centrifuged for 30 seconds at 200g in 
eppendorfs and the cell pellet resuspended in 2 0 0 ^ 1  cell suspension solution containing 
50mM Tris HCl (pH7.5), lOmM EDTA and lOO^g/ml RNase A. 200^1 of cell lysis 
solution (200mM NaOH and 1 % SDS) was added and mixed by inversion until the 
suspension cleared. 200/xl of neutralising solution (2.55M potassium acetate) was 
added and mixed again by inversion. The neutralised mixture was centrifuged at 
200g for 5 minutes, the pellet discarded and the supernatant decanted to a clean tube. 
1 ml of shaken purification resin was added to the supernatant and mixed before 
filtering through a minicolumn under vacuum. The genomic DNA was removed by 
washing twice with 2ml of wash solution provided (200mM NaCl, 20mM Tris HCl, 
pH 7.5, 5mM EDTA and diluted 1:1 in 95% ethanol) and the column maintained 
under vacuum for a further 2 minutes to dry the samples. The minicolumn was 
transferred to a clean eppendorf and centrifuged at 2 0 0 g for 2 0  seconds to complete 
drying. The column was transferred to another clean eppendorf and 50^1 of water 
added for 1  minute before centrifuging at 2 0 0 g for 2 0  seconds to collect the plasmid 
DNA. A sample of the purified plasmid cDNA was digested with EcoRl and run on 
a 0.8% agarose gel to check cloning of PDH kinase cDNA in to the pSPT18 plasmid.
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5.2.5.5 Linearisation of Plasmid DNA
The remaining plasmid was digested to linearise the DNA by incubating 35/xl 
of cDNA with either 3^1 Hind III or Pvu 11, 6 /d digestion buffer B and 16/d water 
at 37°C for 2 hrs. The reaction mixture was then held on ice. Some of the reaction 
mixture was run on a gel as before (section 5.2.3) to check the digestion (Figure 5.3). 
The remaining digested cDNA was precipitated with ethanol and resuspended in 13/il 
of water. Digestion was performed with two enzymes since a restriction map of the 
probe was unavailable at this time and hence we were uncertain of the orientation of 
the probe. Digestion with the two enzymes allowed us to produce two probes with 
both orientations.
5.2.5.6 7/1 Vitro Transcription of cDNA with Digoxigenin-UTP
Linear plasmid DNA was used to synthesise an RNA probe by in vitro 
transcription using a DIG-RNA labelling kit containing transcription buffer, NTP 
labelling mix, RNasin (RNase inhibitor) and T7 RNA polymerase for the Hind III 
digested probe and SP6  polymerase for the Pvu II digested probe.
13/il of cDNA was mixed with 2/d lOx transcription buffer, 2/d NTP labelling 
mix (containing lOmM ATP, GTP and CTP, 6.5mM UTP and 3.5mM DIG-UTP), 
2/d enzyme and 1/d RNasin and incubated at 37°C for 2 hrs. The reaction was 
stopped with 2/tl 0.2M EDTA, pH 8.0, and precipitated with ethanol as above. 
Samples were resuspended in lOO/tl water.
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5 .2 .6  In  V itro Transcription of cDNA with ^^P-dCTP
A ^^P-DNA labelled probe was prepared as an alternative to the DIG-labelled 
RNA probe. Throughout this work, care was taken in the use of ^^ P and all 
radioactive waste disposed of in accordance with the University of Surrey 
Radioactivity Regulations.
The Megaprime labelling kit used for this work contained primer (random 
sequences of nonomers), the nucleotide mix and the DNA polymerase (Klenow 
fragment). 3/tl of the cDNA probe prepared in section 5.2.4 was boiled with 5/d 
primer and 22/tl water for 5 minutes in an eppendorf tube. After cooling on ice the 
mixture was centrifuged at 200g for 10 seconds. The tube was transferred to the 
radioactive area and 10/d nucleotide mix, 3/d ^^P-dCTP, and 2/d of DNA polymerase 
added. After mixing and centrifuging, the tube was incubated for 10 minutes at 37°C.
A Nick column was prepared by emptying, rinsing with Nick buffer and 
washing through once with Nick buffer. The reaction mixture was filtered through 
the Nick column into a clean eppendorf. The Nick column was then washed through 
with 4 X 400/il of Nick buffer into 4 separate eppendorfs. Tube 2 contained the 
labelled probe and was retained for use in hybridisation.
208
5.2.7 Preparation of RNA Samples
Liver samples were collected from 5, 10, 20 day suckling rats, 25 and 30 day 
old rats weaned to high-carbohydrate diet and 25 and 30 day olds weaned to high-fat 
diet, as in section 2.2.2. Samples were placed in liquid nitrogen until required for 
RNA extraction later the same day.
Total RNA was isolated using a method developed by Chomczynski & Saachi 
(1987), using RNAzol. The RNAzol solution contains phenol and guanidium 
thiocyanate. Throughout the extraction procedure, all solutions were kept as cold as 
possible and all equipment was previously sterilised. 50mg of tissue sample was 
homogenised in 1ml of cold RNAzol solution in a Greiner tube, for approximately 
1 minute. 100/d of chloroform was added and the tube shaken for 15 seconds before 
leaving to stand on ice for 15 minutes. The tubes were then spun at 200g, 4°C for 
10 minutes and the supernatant transferred to a clean eppendorf tube. An equal 
volume of isopropanol was added, shaken and left to stand in ice for 30 minutes, 
before centrifugation again at 200g, 4°C for 15 minutes. The supernatant was 
discarded and 1ml of ethanol added to wash the samples. After brief mixing, the 
tubes were centrifuged at 200g, 4°C for 15 minutes. Again the supernatant was 
discarded and the tube left open in 3TC  oven to dry (approximately 10 minutes). 
The pellet was resuspended in 50/il of 0.1% DEPC water and heated to 65®C for 5 
minutes to aid solubilisation.
209
The purity of the isolated RNA was determined spectrophotometrically by 
scanning a 1:250 dilution of the RNA in 0.1% DEPC water between 200nm and 
300nm. A clean peak should be seen at 259nm for RNA. The ratio between 260nm 
and 280nm was determined to give the purity and should approximate 1.9. The 
concentration of RNA was calculated assuming 1 optical density unit to be equal to 
40/tg/ml RNA.
Conc.RNA =  Abs2 6 o x dilution factor x conversion factor x OD units.
Conc(/ig/ml) =  Abs2 6 o x 250 x 1/1000 x 40
Samples were stored at -70°C. The integrity of the samples was checked by 
RNA electrophoresis (see section 5.2.8 below).
5.2.8 RNA Electrophoresis
The purified RNA samples were separated by size by running on an agarose 
gel containing Ig of agarose melted in 72ml of water, 10ml of 10 x MOPS/EDTA 
buffer (0.5M MOPS and O.OIM EDTA) and 18ml of formaldehyde. For each gel, 
12/tg of RNA sample (as calculated from the absorbance measurements; see section 
5.2.6), was added to 4.4/d 10 x MOPS/EDTA buffer, 2.8/xl formaldehyde and 8.8/d 
formamide. The samples were heated to 70°C for 10 minutes before adding 1.5/d 
running dye and spinning. The gels were run at 100-150mA. Markers were prepared 
in the same way and also run on the gels. The markers used were the digoxigenin
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marker provided with the kit which shows RNA bands at 0.3, 0.4, 0.6, 1.0 and 
1.6Kb and a RNA ladder marker which contains 6  RNA components at 0.24, 1.4,
2.4, 4.4, 7.5 and 9.5Kb. Three gels were run initially. The RNA marker band was 
cut from two electrophoresis gels and along with the other complete gel, detected with 
ethidium bromide (Figure 5.4).
5.2.9 Northern Blotting
A system of capillary blotting was used to transfer the RNA in the 
electrophoresis gel to a nylon membrane for detection. 3 layers of filter paper were 
soaked in 20 x SSC solution (containing 3M NaOH and 300mM Na Citrate, pH 7.0) 
and draped over a raised platform whilst still trailing in the bottom tray. The tray 
was also filled with 20 x SSC. The gel was placed upside down on the filter paper 
and a positively charged nylon membrane placed on top. 4 more layers of filter paper 
and a box of tissues were added, and strips of plastic pushed in around the gel to 
prevent the top and bottom layers of filter papers from touching (this prevents 
‘shorting’ of the blot). A heavy weight was placed on top and the whole system left 
overnight at room temperature (see Figure 5.5). This was performed for both 
unstained gels.
The nylon membranes were wrapped in cling film and dried in an oven for 
approximately 10 minutes before covalently bonding the RNA to the blot under ultra 
violet light for 1  minute.
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5.2.10 Prehybridisation
5.2.10.1 Prehybridisation for Digoxigenin-UTP Detection
The membranes were sandwiched between two layers of fine nylon mesh 
soaked in 2 x SSC and after removing all the air bubbles, rolled up and placed in 
hybridisation bottles. The membrane was unrolled around the inside of the bottle. 
Excess SSC was removed and 10ml of prehybridisation buffer added. The bottle was 
incubated at 42°C for l-2hrs in a rotating Hybaid oven.
Prehybridisation Buffer; 50% Formamide
1 0 ml 20 X SSC
80/d SDS
400/cl Lauroyl sarcosine
8 ml Blocking agent
40ml
5.2.10.2 Prehybridisation for ^^P-dCTP Detection
The membrane was prepared as above (section 5.2.8) and incubated in 25ml 
of prehybridisation buffer at 42°C for 2-3 hrs.
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Prehybridisation Buffer: 35 ml 
15ml 
50ml 
7g
0 .2 ml
IM Na^HPO^ }
IM NaH^PO^ } 
Formamide } pH 7.0 
SDS }
0.5M EDTA }
5.2.11 Hybridisation
This stage allows hybridisation of either the Digoxigenin-UTP RNA or ^^P- 
dCTP cDNA probe to the RNA bound to the membrane, for detection of the PDH 
kinase mRNA bands. For the digoxigenin-UTP, 100/d of the labelled RNA probe 
was added to 1 0 ml fresh prehybridisation buffer and incubated with the membrane 
overnight, rotating at 42°C in a Hybaid oven. For the ^^P-dCTP, 400/d of the probe 
was boiled in an eppendorf for 5 minutes before adding to 25ml prehybridisation 
buffer containing 50/d lOmg/ml herring sperm DNA, and incubating overnight at 
42°C.
5.2.12 Post-Hybridisation Washing and Detection
5.2.12.1 Post-Hybridisation Washing and Detection of Digoxigenin-UTP
The probe solution was removed and stored in a universal tube at -20°C for 
re-probing at a later date.
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All incubations throughout the washing and detection process were carried out 
in the hybridisation bottle, rotating either on a rotating table or in the Hybaid oven. 
At the end of each incubation step, the buffer was removed and approximately 10ml 
of the next buffer used to briefly wash out any residue.
The membrane was stringently washed twice in 30ml of 2 x SSC/0.1 % SDS 
at room temperature for 5 minutes and then twice in 30ml of 0.1 x SSC/0.1 % SDS 
at 42°C for 20 minutes.
The detection procedure was carried out at room temperature.
following buffers.
Wash Buffer; lOOmM Maleic acid }
150mM NaCl } pH 7.5
0.3% (w/v) Tween-20 }
2% Blocking Buffer; 80ml Wash Buffer
2 0 ml 10% Blocking reagent
Buffer 3; lOOmM Tris HCl }
lOOmM NaCl } pH 9.5
50mM MgCl }
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The membrane was washed in 30ml of wash buffer for 5 minutes to equilibrate 
before blocking with 80ml of blocking buffer for 30 minutes. The remaining 20ml 
of blocking buffer containing 2/d AntiDIG AP antibody was added for a further 30 
minutes incubation. After washing for 2 x 20 minutes with wash buffer, 20ml of 
buffer 3 was added for 2 minutes to equilibrate the membrane before adding 10ml of 
0.235mM Lumigen PPD (4-methoxy-4-(3-phophatephenyl)spiro(l,2-dioxetane-3,2’- 
adamantane)) in buffer 3 for 5 minutes. The Lumigen was retained for reuse. The 
membrane was removed from the bottle and, after removing the excess liquid, 
wrapped in cling film and dried in a 37°C incubator for 10 minutes. The bands in the 
membrane were detected by exposure to X-ray film for up to Ihr.
The X-ray film was developed in an automatic developer initially after Ihr 
exposure but 10 minutes was found to be sufficient (Figure 5.6).
5.2.12.2 Post-Hybridisation Washing and Detection of ^^P-dCTP
As above, all incubations throughout the washing and detection process were 
carried out in the hybridisation bottle, mixing in the Hybaid oven. At the end of each 
incubation step, the buffer was removed and approximately 1 0 ml of the next buffer 
used to briefly wash out any residue.
The membrane was stringently washed in 50ml of 5 x SSC/0.1 % SDS at room 
temperature for 30 minutes and checked for radioactivity. The membrane was then 
incubated in 50ml of 2 x SSC/0.1 % SDS for 30 minutes at 50°C. 50ml of 5 x SSC
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was then added and incubated at room temperature for 10 minutes to remove the 
SDS. The membrane was then exposed to X-ray film for 1-3 weeks before 
developing (Figure 5.7).
5.2.13 Stripping of Digoxigenin-UTP Label from RNA Membrane
Since the RNA samples have been covalently bound to the membrane using 
UV light, it is possible to remove the probe but leave the RNA intact. This allows 
the membrane to be re-probed if the initial probing has been unsuccessful either due 
to mistakes in the procedure or the probe being non-specific.
For stripping the membrane was washed thoroughly in water before incubating 
in 50% dimethylformamide and 1% SDS in 50mM Tris HCl, pH 8.0, for 2 x 30 
minutes. The membrane was then washed in 2 x SSC before prehybridisation as 
before.
5.2.14 Analysis of RNA Bands
Identification of the RNA bands seen after developing the X-ray film was 
performed by comparison with the size markers run in gel. The size of the bands 
seen could then be compared to the size of the PDH kinase mRNA expected (Popov 
et al 1993). For the digoxigenin, the marker that was removed for ethidium bromide 
staining was also used.
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The amount of RNA loaded onto each channel is important for quantitative 
analysis of the PDH kinase mRNA and the second RNA gel run was used to assess 
total RNA concentrations in the different lanes. The total RNA and mRNA for PDH 
kinase concentrations could be measured by densitometry.
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5.3 RESULTS
5.3.1 Digoxigenin-UTP Probing of PDH kinase mRNA
The digest of the PDH kinase cDNA in the pUC18 vector produced a 1.1Kb 
band corresponding to the PDH kinase cDNA (Figure 5.1). This band was then 
purified and ligated in to the pSPT18 vector. The vector was transformed into 
competent cells cultured overnight on a LB plates containing ampicillin. Successful 
ligations were identified as growing colonies since the PDH kinase cDNA plasmid 
carries with it ampicillin resistance. The cDNA was extracted from the cells by 
cracking with a strong sucrose solution containing the detergent SDS and run in an 
electrophoresis gel to check that the pSPT18 vectors contained only one copy of the 
PDH kinase cDNA. A corresponding band was seen at 4.2Kb, the larger band 
corresponding to the genomic DNA (Figure 5.2).
2 colonies were selected for overnight culture in order to amplify the PDH 
kinase cDNA-pSPT18. The cDNA was purified and a sample digested with EcoRl 
to check the size of the insertion (Figure 5.3). The remaining cDNA-pSPT18 was 
linearised by digestion with Hind III and Pvu II, nucleases which cut at only one site 
in the pSPT18 vector, either side of the ligation site to produce both orientations of 
DNA.
With the DIG-labelled RNA it should have been possible to probe the 
Northern blots and identify mRNA homologous to the cDNA for PDH kinase. Bands
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had previously been seen at 1.2, 1.8 and 3.5Kb (Popov et al 1993). No binding was 
seen with the Pvu II probe but binding was seen with the Hind III probe. However, 
the probe appeared to be non-specific and also labelled rRNA (Figure 5.6). 
Unfortunately, the rRNA bands are found at 075-, 2.3 and 4.2Kb and the wide 2.3Kb 
band migrated approximately the same distance in the gel as the 1.8Kb PDH kinase 
mRNA and may therefore have been obscuring the required band.
Several attempts were made to improve these results with the DIG system 
including increasing the stringency of the wash and selecting new RNA samples to 
minimise degradation but no satisfactory results were obtained.
5.3.2 ^^P-dCTP Probing of PDH kinase mRNA
DNA can also be labelled with ^^P-dCTP. The probe developed for ^^ P 
probing is more specific for the corresponding RNA since the cDNA is not attached 
to plasmid DNA and the probe is therefore a smaller molecule. In addition, DNA 
strands of both orientations are made simultaneously. One of the membranes from 
the unsuccessful probing with the DIG system was retained and used for ^^P-probing. 
The DIG label was stripped using stringent washing conditions.
A new probe was developed in the pUC18 vector and ^^P-labelled PDH kinase- 
pUC18 cDNA produced by transcription with ^^P-dCTP. The ^^P-probe was used to 
probe the stripped membrane.
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A faint band was seen at approximately 1.8Kb in some lanes using this probe, 
however, it was not possible to make any quantitative measurements (Figure 5.7). 
Since has a half-life of only 2 weeks and the membrane had already been exposed 
to the film for 3 weeks it was not possible to enhance the bands. Some of the RNA 
samples had also degraded slightly. Comparison with the ethidium bromide stained 
gel suggested that the concentration of mRNA loaded on to the gels was not constant 
throughout.
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Figure 5,1 Digestion of Pyruvate Dehydrogenase Kinase
cDNA-pUC18
1 . 3 5 Kb
1.1Kb
0 . 9 Kb
0 . 6 Kb
0. 3 1 Kb
2 3 . 1 Kb
9 . 4 2 K b
6 . 5 6 K b
4 . 3 6 K b
2 . 3 K b
2 . 0 3 K b
Lanes 1 2
Lanes 1 and 3 contain markers as detailed in methods section. 
Lane 2 contains digest of PDH kinase-pUC18 DNA. Bands are 
seen at 1.1, 2.7 and 3.8Kb corresponding to the PDH kinase 
cDNA, pUC18 DNA and PDH kinase cDNA-pUC18 respectively.
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Figure 5.2 Ligation of Pyruvate Dehydrogenase
Kinase cDNA to pSPTlS Vector after Cracking
L i n e a r  _ _
Coi l ed
S u p e r c o i l e d  —  
p G E M + V e c t o r  
( 3 . 8K b )
-  B a c t e r i a l  DNA
L i n e a r  pGEM 
C o i l e d  pGEM 
S u p e r c o i l e d  P D H -  
k i n a s e - p S P T I B  
S u p e r c o i l e d  pGEM
Lanes 1
Lane 1 contains linear, coiled and supercoiled pGEM+vector 
(3.8Kb). Lanes 2-6 contain supercoiled PDH kinase cDNA- 
pSPT18 (4.2Kb). Lane 7 contains linear, coil and supercoiled 
pGEM (3Kb). pGEM was used as a marker for supercoiled DNA.
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Figure 5.3 Digestion of Pyruvate Dehydrogenase
Kinase cDNA-pSPT18 after Purification
3. 1Kb
p S P T 1 8
1 . 3 5 Kb
1.1Kb
0 . 9 K b
0 . 6 K b
0 . 3 1 Kb
2 3 . 1 Kb
9 . 4 2 K b
6 . 5 6 K b
4 . 3 6 K b
2 . 3 K b
2 . 0 3 K b
1.1Kb P D H  
k i n a s e  cDNA
Lanes 1 2
Lanes 1 and 3 contain markers as detailed in metliods. 
Lane 2 contains digest of PDH kinase-pSPT18. Bands 
are seen at 1.1 and 3.1Kb corresponding to the PDH 
kinase and pSPT18 respectively
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Figure 5.4 Ethidium  Bromide Stained Northern Blot
4.2Kb (285) _ 
2.3Kb (185) - I
4.4Kb
— 2.4Kb
0.24Kb
Lanes 1 3 4 5 6 7 8
The ethidium bromide stained Northern Blot was used to determine 
the relative quantity of RNA loaded into each lane in the gels.
Lanes 1-7 contain liver RNA samples; lanes 1 & 2 contain samples 
from 25 & 30 day old rats weaned to a high-fat diet, lanes 3 & 4 
contain samples from 25 & 30 day old rats weaned to a high- 
carbohydrate diet and lanes 5, 6 & 7 contain samples from 5, 10 and 
20 day old suckling rats. Lane 8 contains RNA ladder marker.
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Figure5.5 Diagrammatic Representation of
a Northern Blot
Weight
Positively charged 
Nylon Membrane
Tissues
1 ................ ....... 1
Filter Paper 
Plastic Strips
^  Filter Papers
Raised Platform
f
20 X SSC
Northem blotting was used to transfer RNA in 
liver samples from the agarose gel to positively 
charged nylon membrane via capillary action
225
Figure 5.6 Digoxigenin Labelled Northern Blot
4.2Kb (285) J
2.3Kb (IBS)
 ^ -  1.0Kb
_  0.6Kb 
_  0.4Kb
- 0 . 3 K b
Lanes 1 2 3 4 5 6 7
The digoxigenin labelled Northem Blot was used to identify mRNA 
specific for PDH kinase for each RNA sample. Lanes 1-7 contain 
liver RNA samples; lanes 1 & 2 contain samples from 25 & 30 day 
old rats weaned to a high-fat diet, lanes 3 & 4 contain samples from 
25 & 30 day old rats weaned to a high-carbohydrate diet and lanes 5, 
6 & 7 contain samples from 5, 10 and 20 day old suckling rats.
Lane 8 contains digoxigenin marker.
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Figure 5.7 Labelled N orthern Blot
I
Lanes 1 2 4 7 8
32The P labelled Northem Blot was used to identify mRNA specific 
for PDH kinase for each RNA sample. Lane 1 contains RNA ladder 
marker. Lanes 2-8 contain liver RNA samples; lanes 2,3 & 4 
contain samples from 5, 10 and 20 day old suckling rats, lanes 5 &
6 contain samples from 25 & 30 day old rats weaned to a high- 
carbohydrate diet and lanes 7 & 8 contain samples from 25 & 30 day 
old rats weaned to a high-fat diet.
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5.4 DISCUSSION
Using the digoxigenin labelled probe the background binding measured was 
high and prevented the detection of bands that may have corresponded to PDH kinase. 
Since increased stringency of the washes did not enhance potential bands, it was 
suggested that the probe may not have been sufficiently specific for the PDH kinase. 
The digoxigenin labelled probe is synthesised by transcibing the PDH kinase 
cDNA/pSPT18 DNA and hence the probe contains a large section of RNA derived 
from the pSPTlS. The digoxigenin label is therefore a large molecule and the chance 
of non-specific binding may therefore be increased.
The radiolabelled probe DNA probe is transcribed from the PDH kinase 
cDNA only and is smaller and potentially more specific than the digoxigenin labelled 
counterpart. Using this probe, however, the low intensity of the signal from the ^^ P 
resulted in a very faint bands on the X-ray film and combined with degradation of 
some of the RNA samples made detailed analysis impossible. Therefore, no 
indication could be gained from this work of the expression of PDH kinase mRNA 
throughout development and the influence of this enzyme during the suckling-weaning 
transition. Time constraints precluded further work on this.
The probe used for this work was developed from rat heart RNA by Popov 
et al (1993). Since completing this work however, preliminary evidence has been 
found suggesting that the probe used for this work may be a PDH kinase isozyme, 
largely specific to the heart (R.A.Harris, personal communication). A second
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isozyme has now been isolated, by the same group, which has approximately 70% 
homology to the original kinase but may correspond to a more universal kinase.
Popov et al (1993) measured the relative mRNA expression in the adult rat 
heart, liver, kidney, and skeletal muscle. The detection of PDH kinase in the liver, 
skeletal muscle and kidney with the apparently specific heart cDNA probe may be 
accounted for by the 70% homology to the found between the two PDH kinases. The 
apparent lack of PDH kinase detection in the work described in this thesis may be due 
to the difference in ages of rats and techniques used. At the time of performing the 
work described in this thesis, the paper reporting the original work had not been 
published and hence, it was not possible to use exactly the same conditions. The 
probe used by Popov et al differed from that used in the present study and was 0.9Kb 
(compared with 1. 1Kb used in present study) and digested with AvallA fll 11 enzymes. 
Labelling of the probe was with ^^ P but the wash conditions used in the original work 
were less stringent than those used here. The lower stringency of the wash may have 
prevented the probe from being washed from the PDH kinase RNA on the membrane. 
Thus, the lack of PDH kinase mRNA detection shown here, may be due to a 
combination of the use of the different experimental conditions used and/or the PDH 
kinase encoded by the probe being specific to the heart. Further work would be 
necessary, however, to verify the specificity of the probe and to optimise the 
conditions for measurement of the development of PDH kinase in the liver and heart.
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CHAPTER 6 
GENERAL DISCUSSION
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GENERAL DISCUSSION
6.1 The Development of PDH during the Suckling-Weaning Transition
The developmental activity profile for many key metabolic enzymes 
throughout the suckling-weaning transition has been studied in some detail (see Girard 
et al 1992). However, the role of PDH during this important transition period has 
received comparatively little attention. In adults, PDH occupies a pivotal role as 
metabolic priorities change, ensuring optimal utilisation of available fuels. This 
regulatory role might be expected to be essential during suckling and the transition 
from milk to solid diet (see Figures 6.1 & 6.2).
Previous developmental studies of PDH include activity measurements between 
birth and adulthood in rat and mouse liver (Knowles & Ballard 1974; Bailey et al 
1976; Hron & Menahan 1983), adipose tissue (Bailey et al 1976; Hron & Menahan 
1983) and rat brain (Cremer & Teal 1974), hepatic activity changes around the 
foetal/neonatal transition (Chitra et al 1985; Serrano et al 1989), comparison of 
adipose tissue activity in suckling and weaned rats (Issad et al 1989; Maury et al 
1992) and development in the clinical situation (Sperl et al 1992). However, detailed 
studies of the sucking-weaning transition do not appear to be available. Hepatic PDH 
activity appears to increase immediately after birth to a transient peak after Ihr and 
then falls to foetal levels at 6 hrs (Chitra et al 1985; Serrano et al 1989). Total 
activity has been reported to increase progressively throughout growth (Knowles & 
Ballard 1974; Bailey et al 1976), but reports of the active form of PDH during
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Figure 6.1 Schematic Representation of Glucose Metabolism
and Pyruvate Dehydrogenase Activity Throughout Suckling
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Pyruvate Dehydrogenase 
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Acetyl-CoA
Citric Acid Cycle Lipogenesis
232
Figure 6.2 Schematic Representation of Glucose Metabolism
and Pyruvate Dehydrogenase Activity After Weaning to a
Carbohydrate-Rich Diet
Glycogen
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1
Pyruvate Dehydrogenase 
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Oxaloacetate
Acetyl-CoA
Citric Acid Cycle Lipogenesis
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development are conflicting (Knowles & Ballard 1974; Bailey et al 1976; see section 
2.4). Hence, in this work both the total and active form of PDH has been measured 
in the liver and heart throughout development, but particularly around the suckling- 
weaning transition.
In the present work spontaneous weaning of rats and the gradual change in 
dietary composition from the high-fat milk to the high-carbohydrate chow induced a 
steady increase in active hepatic PDH activity (in agreement with Bailey et al 1976). 
This activation could be accelerated by imposed weaning and the maximal activity 
attained increased to approximately double, an effect that was redressed in adults (see 
Figure 6.3). The increased carbohydrate, together with the decreased dietary fat 
intake at weaning, reduces the requirement for hepatic gluconeogenesis (see Vernon 
& Walker 1968a), fatty acid oxidation and ketogenesis (Lockwood & Bailey 1971; 
Page gf aZ 1971; Benito et al 1979) and allows increased metabolism of carbohydrate 
in extrahepatic tissues. Excess carbohydrates can be stored, and glycogen and fat 
stores are seen to increase after weaning (Ballard & Hanson 1967; Smith & Abraham 
1970; Gandemer et al 1982). Changes in PDH activity, facilitate the metabolic 
adaptations, and activity increases to allow initiation of lipogenesis or oxidation. 
Additionally, activation of hepatic PDH appears to facilitate glycogen synthesis.
An increase in hepatic glycogen synthesis around weaning from low levels 
during early suckling has been reported previously (Shelley 1961; Snell & Walker 
1973). However, the increase in hepatic glycogen content, measured at closer time 
intervals, has been shown in this thesis to be due to a sharp increase at 2 0  days in
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Figure 6.3 Summary of Hepatic Pyruvate Dehydrogenase
Activity after Different Weaning Regimes.
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synthase activity ratio in rats after spontaneous weaning (■), or 
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(À) diet, is shown. Each point represents die mean (n ^  4) ± 
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Figure 6.4 Summary of Hepatic Glycogen and Pyruvate
Dehydrogenase Activity after Different Weaning Regimes
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spontaneously weaned rats and rats for which weaning was imposed at 20 days. 
Hepatic PDH stimulation appeared to be delayed after carbohydrate feeding, and no 
increase in activity was seen until after the glycogen content of the liver had increased 
substantially (Figure 6.4). A similar pattern of refractory hepatic PDH stimulation 
has been reported in adult rats fed chow after a period of starvation, an effect that is 
reversed by administration of DCA, but glycogen synthesis is then impaired (Holness 
et al 1986; see Sugden et at 1989Z?). Activation of PDH allows potential 
gluconeogenic precursors to be ‘lost’ to lipogenesis and complete oxidation, and 
delayed activation at refeeding is thought to be metabolically advantageous for 
glycogen synthesis and part of a mechanism that ensures maximal rates of glycogen 
synthesis. The requirement for glycogen synthesis is similar in the weaning transition 
and hence the delayed activation of hepatic PDH is also likely to promote glycogen 
synthesis. Hepatic glycogen acts as an immediate glucose supply during periods of 
reduced intake or danger and it appears that the metabolic priority at weaning is to 
replenish the depleted glycogen stores, as with the situation in the adult after a period 
of starvation.
Premature imposed weaning at 18 days induced early activation of both hepatic 
and cardiac PDH. In the liver, PDH activity increased 2 days earlier than in 20 day- 
weaned rats suggesting that the dietary composition was a key stimulatory factor for 
PDH at weaning and that the potential for activation was present before normal 
spontaneous weaning began. Hence the lack of PDH activity before weaning appears 
to be due to inhibition or a lack of stimulation, but not due to immaturity of the 
regulatory systems. Glucokinase activity has been shown by others to begin to
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increase at 16 days (Walker & Holland 1965; Jamdar & Greengard 1970) allowing 
the regulatable phosphorylation of any available glucose for use either in glycolysis 
or glycogen synthesis. It would have been of interest to measure PDH activity in rats 
weaned at 16 days and to investigate the effect of glucokinase activation on PDH 
activity and whether PDH activation at weaning is reduced in the absence of 
glucokinase activity. However, the inability of the pups to fend for themselves 
prevented this.
Although cardiac PDH activity also increases dramatically at weaning, the 
regulation of activation appears to differ from that found in the liver. During 
spontaneous weaning cardiac PDH increased from low levels in the suckling pup to 
values more than double at 21 days. Imposed weaning failed to accelerate the 
activation of cardiac PDH and the initiation of activation, the rate at which the PDH 
was activated and the levels attained at peak activity were almost identical during 
either imposed or spontaneous weaning (Figure 6.5). Precocious weaning at 18 days 
also induced cardiac PDH activity but whereas hepatic PDH activation was advanced 
by 2 days, cardiac PDH activation was only advanced by one day.
Cardiac PDH activity increased earlier than the hepatic enzyme at weaning. 
Activity was seen to increase significantly at 19 days in rats weaned spontaneously 
or forcibly at 18 or 20 days. This is in marked contrast to the situation found in the 
liver where the time of activation of PDH varied depending on the weaning 
conditions. The activation of the cardiac enzyme is not due to an endogenous factor 
(‘age-effect’) or stress associated with the weaning process since weaning to a high-fat
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Figure 6.5 Summary of Cardiac Pyruvate Dehydrogenase
Activity after Different Weaning Regimes
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diet completely prevents stimulation (Figure 6.5). It is probable that both in 
spontaneous and imposed weaning, the carbohydrate intake increases before 20 days 
as the rats begin to wean themselves, with a consequential reduction in the need for 
glucose conservation by extrahepatic tissues. Cardiac CPT 1 is 10-100 times more 
sensitive to inhibition by malonyl-CoA than the liver in adult rats (Saggerson et al 
1982; see Sugden & Holness 1994) and hence, cardiac fatty acid oxidation is more 
susceptible to inhibition. Hepatic CPT 1 sensitivity to malonly-CoA has previously 
been shown to increase at weaning (Decaux et al 1988), an effect that may be 
paralleled in the heart. Hence the increased carbohydrate intake at weaning may 
allow increased synthesis of malonyl-CoA or increase the sensitivity of CPT 1 to 
malonyl-CoA, reducing fatty acid oxidation and the inhibitory effects of NADH and 
acetyl-CoA on cardiac PDH (Cate & Roche 1978).
The influence of the carbohydrate content of the diet on PDH activation and 
glycogen synthesis was confirmed by studies involving weaning to a high-fat diet, in 
which PDH activation and glycogen synthesis were completely prevented. Activity 
levels remained at suckling values both in the liver and heart.
That stimulation of PDH activity after weaning is due to activation of inactive 
PDH and not due to enzyme synthesis has been shown for the first time in this thesis. 
Total PDH content increased progressively throughout the neonatal period and before 
weaning in agreement with the limited observations of Knowles & Ballard (1974) and 
Bailey et al (1976). The synthesis of PDH therefore appears to be regulated by an 
endogenous age effect which ensures that the potential for PDH activity is present
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well before weaning. In adipose tissue, measurement of the E l a  subunit of the PDH 
using antiserum raised to the pig heart complex, suggested an 18-fold increase from 
15 day old suckling rats to 30 day old carbohydrate-weaned rats (Maury et al 1992), 
although enzyme activity only increased 3-fold (Issad et al 1989). In addition, 
Northem blot analysis demonstrated an 11-fold increase in the E la  mRNA in adipose 
tissue induced by high-carbohydrate weaning (Maury et al 1992). However, since 
in this thesis total PDH was measured by converting the inactive form to active PDH 
with DCA, the increase seen with age implies that the PDH enzyme complex is 
present intact throughout suckling, but inactive. In the liver and heart a small 
increase of 15% in total activity is seen between 15 and 30 days which may be due 
to increased E la  subunit synthesis but the increase is far smaller than is reported for 
the adipose tissue. This may reflect the different functions of these tissues or may 
suggest that different regulatory mechanisms are involved with transcription in 
different tissues. Thus in adipose tissue PDH is required for lipogenesis which means 
that activation is dependent on an excess metabolites. In the liver, PDH controls the 
direction of carbon flux and may therefore be present but inactive during suckling to 
allow rapid activation if necessary.
Whilst the influence of the diet on the PDH activity at weaning has been 
investigated in this work, the mechanisms through which the increased carbohydrate 
intake is able to activate PDH and the individual steps involved remain unknown. 
Since the increase in carbohydrate intake and subsequent insulin/glucagon ratio (see 
Girard et al 1977) does not have an immediate effect on hepatic PDH, activation does 
not appear to be via a simple on/off switch. Rather, activation would appear to occur
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as a result of a coordinated change, possibly involving several factors which may 
include indirect and direct actions of insulin, the effects of KAP, multiple site 
phosphorylation, fatty acid oxidation and glycogen storage levels (Sugden et al 1978Z?; 
Kerbey & Randle 1982; Denyer et al 1986; Holness et al 1988).
Sensitivity of PDH to insulin is tissue dependent, with adipose tissue 
sensitivity being high, liver being much less sensitive and the heart PDH being 
insensitive (Cooney et al 1993). In contrast, cardiac PDH is inhibited by fatty acid 
oxidation but the liver appears to be less sensitive (Caterson et al 1982). Hence, 
although hepatic PDH may be directly stimulated by the increased insulin/ glucagon 
ratio, cardiac PDH is not, although some of the indirect effects of insulin may allow 
activation of the heart enzyme. Insulin induces activation of glucokinase in 
hepatocytes (Narkewicz et al 1990) and hence increases the rate of glucose 
phosphorylation and glycogen synthesis. During suckling, insulin reverses the 
induction of fatty acid oxidation by glucagon in foetal liver (Pegorier et al 1989) and 
may reduce ketone synthesis via HMG-CoA synthase (Quant et al 1991). In addition, 
inhibition of adipose tissue fatty acid oxidation (Benito et al 1979; Decaux et al 1988) 
and the reduced levels of circulating NEFA (Snell 1981), induced by insulin action 
on adipose tissue, may prevent cardiac fatty acid oxidation and therefore reduce the 
inhibitory effects of NADH and acetyl-CoA on cardiac PDH.
The rate of dephosphorylation of PDH during activation has previously been 
shown to depend on the degree to which the enzyme is phosphorylated (Sugden et al 
1978/?), with multiple site phosphorylation slowing activation. Phosphorylation is
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expected to be more extensive after prolonged inactivation of PDH and prolonged, 
reduced carbohydrate intake, as is found in starvation and suckling. However, no 
information is yet available as to whether PDH is phosphorylated at multiple sites 
during suckling.
The influence of PDH kinase during suckling is also unknown but may play 
an important role, as in starvation. Starvation, diabetes or high-fat feeding have been 
shown to induce stable increases in PDH kinase activity in hepatocytes (Fatania et al 
1986; Marchington et al 1987), liver homogenates (Denyer et al 1986; Sugden et al 
1992), cardiomyocytes (Orfali et al 1993) and heart homogenates (Kerbey & Randle 
1982; Kerbey et al 1984; see Randle 1986; Randle et al 1988). Since the increased 
activity is prevented by protein synthesis inhibitors, long-term starvation is thought 
to induced stable increases in the PDH kinase enzyme concentrations, at least in the 
heart (Kerbey & Randle 1982).
Hence, it has been shown here that PDH activity increases markedly at 
weaning in the liver and heart, and that this activation is a result of the change of diet 
to a higher carbohydrate content. Activation of PDH in both tissues could be 
advanced by precocious weaning at 18 days, indicating that the changes in enzyme 
activity were not due to age-effects. The delay in hepatic PDH activation after 
carbohydrate feeding suggests that the hepatic PDH is instrumental in the control of 
metabolism during the transition period and plays an important regulatory role, 
preventing the flow of pyruvate into lipogenesis before glycogen stores are 
replenished. The cardiac enzyme is activated earlier and does not appear to have the
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same regulatory properties. Total PDH though, is not regulated by the diet but 
increases throughout suckling and weaning regardless of diet. Synthesis of PDH is 
therefore controlled by factors other than the components of the diet, which may 
include changes in thyroid hormones or glucocorticoids (see Henning 1981; Walker 
et al 1980; Figure 1.6).
Citrate synthase was measured throughout these studies as a mitochondrial 
marker to which PDH could be compared and the efficiency of mitochondrial 
extraction accounted for. In adult rats, citrate synthase activity is unaffected by 
starvation or diabetes in both the heart and liver (Caterson et al 1982). However, the 
studies presented here indicate a gradual increase in cardiac citrate synthase under all 
weaning conditions and after imposed weaning in the liver. The steady increase in 
activity in the heart is indicative of the increasing respiratory capacity of the heart 
during development (Baldwin et al 1977) as a result of the increased number and 
protein content of mitochondria (Kinnula & Hassinen 1977), and is in agreement with 
other studies (Glatz & Veerkamp 1982). A similar increase in the mitochondrial 
protein content is found in the liver (Kinnula & Hassinen 1977) however, the citrate 
synthase activity reported in this thesis appears to remain approximately constant 
during spontaneous weaning and until 30 days where activity may begin to increase, 
but after imposed weaning to either a high-fat or high-carbohydrate diet activity 
appears to increase steadily. These adaptations in citrate synthase activity will mask 
the amplitude of the activation of PDH at weaning to some extent.
244
6.2 Clinical Defects in PDH Activity
The essential role of PDH in controlling metabolic flux can be seen by 
examination of clinical defects in PDH activity (for examples see Robinson & 
Sherwood 1975; Robinson et al 1987; Sperl et al 1990; Brown 1992; Sperl et al 
1992; Bonne et al 1993; De Meirleir et al 1993). PDH deficiencies are relatively 
common inborn errors of metabolism and result in lactic acidaemia, central nervous 
system damage and motor retardation, often resulting in death before the age of 2 
years. The severity of the deficiency is varied and ranges from 1.6 to 68.5% of 
control activity (Robinson et al 1987). The areas of the brain most affected include 
the basal ganglia, thalamus and brain stem which have the highest energy 
requirements (Sperl et al 1990) and are therefore most likely to be affected by a 
deficit in PDH activity. The most common defect is the absence or deficiency of the 
E la  subunit of the complex, although E3 and PDH phosphatase defects have also 
been reported (Robinson & Sherwood 1975; Robinson et al 1987; Sperl et al 1990; 
Brown 1992; Bonne et al 1993; De Meirleir et al 1993).
Treatment of PDH deficiencies have included maintenance on a high-fat/low 
carbohydrate diet, thiamine supplements, DCA administration and treatment of severe 
lactic acidosis with sodium bicarbonate (Robinson & Sherwood 1975; Robinson et al 
1987; Bonne et al 1993). However, the long-term success of these procedures are 
limited. The high-carbohydrate content of the human milk (60%; see Figure 1.1) is 
in sharp contrast to rat milk (10%) and the neonatal human is therefore far more 
dependent on endogenous PDH than the rat. Hence PDH deficiencies are seen at an
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early age in humans.
6.3 Future Studies
The work presented here suggests that PDH is instrumental in controlling the 
flux of glucose metabolites during the suckling weaning transition and facilitating the 
synthesis of glycogen. The pivotal role of PDH is therefore very important in 
maintaining glucose homeostasis during development. In order to clarify the extent 
of the regulatory role of PDH at weaning and to establish the mechanisms involved, 
however, there is still much work needed.
The delay in PDH activation after weaning is attributed to the requirement for 
immediate glycogen synthesis, with PDH activity increasing once glycogen stores are 
largely filled. The effect of inhibition of glycogen synthesis on PDH activation and 
post-weaning lipogenic activity is unknown, but might be expected to either prevent 
PDH stimulation or to advance activation.
During suckling and immediately after weaning, PDH activity is low 
suggesting that flow of metabolites into lipogenesis remains minimal initially, possibly 
until glycogen stores are replenished. The role of PDH in controlling lipogenesis 
requires confirmation by simultaneous measurement of lipogenesis, PDH activity and 
glycogen synthesis throughout suckling and weaning. Determination of the sequence 
in which the metabolic profile changes after weaning and the point of PDH activation 
will promote a clearer understanding of the role of PDH in controlling carbon flux.
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One complicating factor is likely to be the delay between weaning and consumption 
of the diet by the pups. It may therefore be necessary to standardise the time and 
amount of high-carbohydrate diet consumed, by force-feeding the rats, thereby 
minimising variance across the study and allowing the timing of the subsequent 
glycogen synthesis and lipogenesis to be clearly established.
The influence of /3-oxidation on PDH activity in the liver during suckling and 
weaning is unknown. Inhibition of fatty acid oxidation in the absence of increased 
glucose intake and determination of the subsequent PDH activity in the suckling rat 
would allow the effects of fatty acid oxidation on PDH to be ascertained in the 
absence of an insulin effect. The limited insulin action on hepatic PDH and complete 
lack of action on cardiac PDH suggests that the inhibition of fatty acid oxidation or 
the enhanced carbohydrate metabolism is likely to act in different ways on the two 
tissues.
The mechanisms involved with PDH activation at weaning and the influence 
of factors such as PDH kinase, KAP, PDH phosphatase, multiple-site phosphorylation 
and hormones, especially insulin, require much attention since they will influence the 
time, rate and degree of activation. Whether these factors develop at the same rate 
as the PDH complex or not, may influence the activity of PDH throughout growth 
of the rat pup and its ability to metabolise carbohydrates efficiently.
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